Free AccessResearch Article

Tools

Facebook
Twitter
Linked In
Mendeley
Reddit

Free AccessResearch Article

Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction

Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

Roberto Marchioli

Roberto Marchioli

From the Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti (R.M., F.B., E.B., R.D.M., R.M.M., G.T.); Ospedale Civile, Caserta (C.C.); Ospedale Civile, Lanciano (D.D.G., L.M., G.M., C.T.); Department of Cardiovascular Research, Istituto Mario Negri, Milano (M.G.F.); Ospedale Cervello, Palermo (E.G.); Ospedale Civile, Vasto (G.L.); Centro Studi ANMCO, Firenze (A.P.M.); Ospedale Civile, Napoli (N.M.); Ospedale S. Maria degli Angeli, Pordenone (G.L.N.); Ospedale San Filippo Neri, Roma (M.S.); Ospedale Civile, Presidio di Riabilitazione, Passirana di Rho, Milano (C.S.); and IRCCS Policlinico San Matteo, Pavia (L.T.); Ospedale San Gerardo Nuovo, Monza (F.V.), Italy.

Search for more papers by this author

Federica Barzi

Federica Barzi

Search for more papers by this author

Elena Bomba

Elena Bomba

Search for more papers by this author

Carmine Chieffo

Carmine Chieffo

Search for more papers by this author

Domenico Di Gregorio

Domenico Di Gregorio

Search for more papers by this author

Rocco Di Mascio

Rocco Di Mascio

Search for more papers by this author

Maria Grazia Franzosi

Maria Grazia Franzosi

Search for more papers by this author

Enrico Geraci

Enrico Geraci

Search for more papers by this author

Giacomo Levantesi

Giacomo Levantesi

Search for more papers by this author

Aldo Pietro Maggioni

Aldo Pietro Maggioni

Search for more papers by this author

Loredana Mantini

Loredana Mantini

Search for more papers by this author

Rosa Maria Marfisi

Rosa Maria Marfisi

Search for more papers by this author

G. Mastrogiuseppe

G. Mastrogiuseppe

Search for more papers by this author

Nicola Mininni

Nicola Mininni

Search for more papers by this author

Gian Luigi Nicolosi

Gian Luigi Nicolosi

Search for more papers by this author

Massimo Santini

Massimo Santini

Search for more papers by this author

Carlo Schweiger

Carlo Schweiger

Search for more papers by this author

Luigi Tavazzi

Luigi Tavazzi

Search for more papers by this author

Gianni Tognoni

Gianni Tognoni

Search for more papers by this author

Corrado Tucci

Corrado Tucci

Search for more papers by this author

Franco Valagussa

Franco Valagussa

Search for more papers by this author

and

Search for more papers by this author

and on behalf of the GISSI-Prevenzione Investigators

Originally published8 Apr 2002https://doi.org/10.1161/01.CIR.0000014682.14181.F2Circulation. 2002;105:1897–1903

Other version(s) of this article
- You are viewing the most recent version of this article. Previous versions:
  - April 8, 2002: Previous Version 1

Abstract

Background— Our purpose was to assess the time course of the benefit of n-3 polyunsaturated fatty acids (PUFAs) on mortality documented by the GISSI-Prevenzione trial in patients surviving a recent (<3 months) myocardial infarction.

Methods and Results— In this study, 11 323 patients were randomly assigned to supplements of n-3 PUFAs, vitamin E (300 mg/d), both, or no treatment (control) on top of optimal pharmacological treatment and lifestyle advice. Intention-to-treat analysis adjusted for interaction between treatments was carried out. Early efficacy of n-3 PUFA treatment for total, cardiovascular, cardiac, coronary, and sudden death; nonfatal myocardial infarction; total coronary heart disease; and cerebrovascular events was assessed by right-censoring follow-up data 12 times from the first month after randomization up to 12 months. Survival curves for n-3 PUFA treatment diverged early after randomization, and total mortality was significantly lowered after 3 months of treatment (relative risk [RR] 0.59; 95% CI 0.36 to 0.97; P=0.037). The reduction in risk of sudden death was specifically relevant and statistically significant already at 4 months (RR 0.47; 95% CI 0.219 to 0.995; P=0.048). A similarly significant, although delayed, pattern after 6 to 8 months of treatment was observed for cardiovascular, cardiac, and coronary deaths.

Conclusions— The early effect of low-dose (1 g/d) n-3 PUFAs on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies.

A growing consensus for a direct relationship between increased intake of n-3 polyunsaturated fatty acids (PUFAs) either from dietary sources or as a pharmacological supplementation and decreasing risk of coronary heart disease has become apparent over the years.^1–15

See p 1874

As a large-scale, clinical trial of patients surviving recent myocardial infarction, GISSI-Prevenzione^16–18 has provided solid evidence of the efficacy of low-dose (1 g/d) n-3 PUFAs in reducing overall and cardiovascular mortality without affecting the risk of nonfatal coronary events. Such results support the hypothesis, already suggested by laboratory, epidemiological, and clinical data, that the benefit of n-3 PUFAs may not be mediated via antiatherosclerotic and antithrombotic effects.¹⁹ On the other hand, the large size of the trial and the number of end-point events allow the ad hoc detailed analysis of the time course of the benefit of n-3 PUFAs, focusing on the different causes of death in the early phase of treatment, to explore the hypothesis of an antiarrhythmic effect of the drug on sudden death.

Methods

For the purpose of this analysis, the essential information of the study protocol^16–18 can be summarized as follows. In the study, 11 323 patients with recent (≤3 months, median 16 days) myocardial infarction were enrolled in a multicenter, open-label, parallel, clinical trial with a follow-up duration of 3.5 years on the efficacy of n-3 PUFAs 1 g/d, vitamin E 300 mg/d, a combination of the 2, and control. Regardless of their allocation, all patients received the same strategies of care, including lifestyle recommendations and up-to-date preventive interventions. The main demographic, clinical, and cardiological characteristics of the study population were balanced across randomized groups and depict a relatively low-risk population of acute myocardial infarction survivors (Table 1).

**Table 1107297.** Baseline Characteristics of Randomized Patients
	All (n=11 323)
AMI indicates acute myocardial infarction; CCVS, Canadian Cardiovascular Society; and NYHA, New York Heart Association. In some sections, numbers do not add up because of missing values. Patients alive at baseline, 11 323; 6 months, 11 089; and 42 months, 10 081.
*Number and percentage of patients revascularized during study are cumulative.
Female	1665 (14.7%)
Age, y, mean (SD)	59.3 (10.6)
Days since diagnosis of AMI, median	16
Total blood cholesterol, mg/dL	211±42
Arterial hypertension	4026 (35.6%)
Diabetes mellitus	1683 (14.9%)
Ex-smokers	3935 (35.0%)
Smokers before the index event	4808 (42.8%)
Body mass index 30 kg/m²	1644 (14.7%)
Previous myocardial infarction	1357 (12.1%)
Claudication	501 (4.4%)
Angina grade (CCVS)
No angina	6729 (60.9%)
No limitation (I)	3596 (32.6%)
Slight limitation (II)	509 (4.6%)
Severe limitation (III)/at rest (IV)	209 (1.9%)
Dyspnea grade (NYHA)
No dyspnea	3829 (34.1%)
No limitation (I)	6252 (55.7%)
Dyspnea on normal/mild exertion (II–III)	1136 (10.1%)
Ejection fraction >0.40	8319 (86.3%)
Premature ventricular beats >10/h	1068 (13.5%)
Previous sustained ventricular tachycardia	73 (0.9%)
Ventricular arrhythmias	1876 (23.5%)
Positive exercise-stress test	2137 (28.9%)
Dietary habits
Fish (1 per week)
Baseline	8212 (73.2%)
42 months	6558 (87.7%)
Fruit (1 per day)
Baseline	9009 (80.3%)
42 months	6546 (88.0%)
Fresh vegetables (1 per day)	6546 (88.0%)
Baseline	4460 (39.7%)
42 months	4085 (54.5%)
Olive oil (regularly)
Baseline	8259 (73.6%)
42 months	6161 (82.5%)
Pharmacological therapy
Antiplatelet drugs
Baseline	10 309 (91.0%)
42 months	6699 (82.9%)
ACE inhibitors
Baseline	5280 (46.9%)
42 months	3162 (39.1%)
β-Blockers
Baseline	4986 (44.3%)
42 months	3108 (38.4%)
Cholesterol-lowering drugs
Baseline	534 (4.7%)
42 months	3934 (45.5%)
Revascularization procedures^*
CABG or PTCA
Baseline	560 (5.0%)
42 months	2723 (24.0%)

The combined efficacy end points of the trial were the cumulative rate of all-cause death, nonfatal myocardial infarction, and nonfatal stroke; and the cumulative rate of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke. The validation of the clinical events included in the primary end points was ensured by an ad hoc committee of expert cardiologists and neurologists unaware of the patients’ treatment assignments on the basis of available documents (case report forms, original clinical records, death certificates).

With respect to published data,¹⁶ the completion of the ascertainment of the vital status of 5 of the 13 patients who had been censored alive with incomplete follow-up, together with the modification of the vital status of 18 patients (the dates reported in the death certificates obtained from census offices only after publication imposed a different qualification with respect to the index day of the right-censoring at 3.5 years of follow-up), determined an increase of the number of deaths from 1017 to 1031. A careful check of the database, in addition, allowed us to identify and eliminate from the analysis 1 patient erroneously randomized twice.

Definition and Validation of Causes of Death

The causes of death were classified according to codes in the International Classification of Diseases, Ninth Revision (ICD-9) (Table 2). Information on the causes of the 1031 deaths was retrieved through the study case report forms (760, 73.7%), clinical records (217, 21.0%), and death certificates from census offices (495, 48.0%). More than one source of information was available for 47.6% of deceased patients.

**Table 2107297.** Distribution of Causes of Death (n=1031) in the GISSI-Prevenzione Trial
AMI indicates acute myocardial infarction; CHD, coronary heart disease; and ND, not defined.
Cardiovascular	680
Cardiac	553
CHD	467
AMI	98
Sudden coronary death	265
Instantaneous	146
<1 hour	103
Arrhythmic	10
ND	6
Other CHD	104
Heart failure	85
ND	1
Noncardiac	127
Stroke	57
Ischemic	13
Hemorrhagic	13
ND	31
Other noncardiac	70
Pulmonary embolism	8
Haemorrhage	9
Surgical procedure	33
Other	10
ND	10
Noncardiovascular	207
Cancer	157
Infection	15
Surgical procedure	2
Other	33
Unknown	144

Sudden death was defined as natural death, instantaneous or within 1 hour of the onset of acute symptoms, and unexpected as to the time and mode of death. Because of the characteristics of the studied population (patients with recent myocardial infarction and relatively preserved heart function), it was stipulated that unwitnessed deaths with no known preceding illness other than coronary heart disease were classified as sudden cardiac deaths.

Because of the interest raised by the results of the sudden death component of the mortality end point, an ad hoc reanalysis of all causes of death was performed blinded to randomized treatments and relying also on the documentation received after the closure of the main analysis.

Overall, the validation processes led to the retention of 251 cases of sudden death out of the 314 reported in the case report forms by the investigators; on the other hand, 14 cases not classified as sudden deaths by the investigators were validated as sudden death cases by the ad hoc committee, thus leading to the total of 265 patients considered in the present analysis: 146 instantaneous, 103 within 1 hour of symptoms onset, 10 definitely arrhythmic, and 6 unwitnessed sudden deaths.

It should be noted that the analyses conducted on the figures of the database used in the original publication (with 286 attributed sudden deaths)¹⁶ yielded strictly overlapping results.

Statistical Methods

Data analysis was carried out according to intention to treat and adjusted for interaction between treatments to ensure the full assessment of the independent effects of n-3 PUFAs.^20–22 Such an approach allows the optimal exploitation of the database by using in the analysis all the fatal events observed in patients allocated to n-3 PUFA treatment versus control and consequently increases its statistical robustness.

The various causes of death have been managed in the analysis according to a Chinese box–like approach. Coronary heart disease death included death from coronary heart disease (eg, myocardial infarction and sudden death); cardiac death included death from coronary heart disease plus any death of cardiac origin (eg, from heart failure); and cardiovascular death included cardiac death plus any death of cardiovascular origin (eg, stroke). Early efficacy of n-3 PUFA treatment for the various outcome measures was assessed by repeatedly right-censoring follow-up data during the first 12 months of follow-up after randomization. We analyzed data by Kaplan-Meier survival curves and the log-rank test. Treatment efficacy was assessed by baseline values of the risk-stratification variables fitting various Cox regression models adjusted for the confounding effect of relevant prognostic indicators.²³ The following confounding variables known to be relevant prognostic indicators were included in the multivariable analysis based on the Cox proportional hazards model: (1) nonmodifiable risk factors: age and sex; (2) complications after myocardial infarction: left ventricular dysfunction (defined as signs or symptoms of acute left ventricular failure during hospitalization, or afterward, left ventricular ejection fraction ≤40%, extent of left ventricular asynergy ≥36% at echocardiography), electrical instability (defined as ≥10 premature ventricular beats per hour, sustained or repetitive arrhythmias during 24-hour Holter monitoring), residual ischemia (spontaneous angina pectoris, class I to IV, according to the Canadian Angina Classification and positive exercise testing), heart rate; and (3) cardiovascular risk factors: smoking habits, history of diabetes mellitus and arterial hypertension, total blood cholesterol, HDL cholesterol, fibrinogen, leukocyte count, and claudicatio intermittens.

All probability values are 2-sided. All computations used the SAS statistical package (SAS Institute Inc).

Results

Over the 38 417.9 person-years of follow-up, 1031 deaths (9.1%) from any cause were recorded. Mortality rate was higher in the first year (3.4%) after randomization than in the second (2.0%) and in the third (2.3%) years of follow-up. Deaths from noncardiovascular disease and from unknown causes were balanced across the treatment groups.

Time Course of Benefit

Table 3 provides the full details of the time course of n-3 PUFA benefit. Patients allocated to n-3 PUFA treatment had a significantly lower mortality even after only 3 months of treatment (1.1% versus 1.6%; RR 0.59; 95% CI 0.36 to 0.97; P=0.037), which was confirmed at the end of the trial (8.4% versus 9.8%; RR 0.79; 95% CI 0.66 to 0.93; P=0.006). The reduction in risk of sudden cardiac death by n-3 PUFA treatment was nearly significant at only 3 months, accounting for up to 57% of the overall mortality benefit (0.5% versus 0.7%; RR 0.44; 95% CI 0.19 to 1.02; P=0.058); it became significant at 4 months (0.5% versus 0.7%; RR 0.467; 95% CI 0.219 to 0.995; P=0.048) and was highly statistically significant at 42 months (2.0% versus 2.7%; RR 0.55; 95% CI 0.39 to 0.77; P=0.0006), when it accounts for 59% of the n-3 PUFA advantage on mortality. As shown in Figure 1, A and B, the early divergence of survival curves of n-3 PUFA and control groups (Figure 1A) is paralleled by a similar profile for sudden death (Figure 1B).

**Table 3107297.** Overall Efficacy Profile of n-3 PUFAs During GISSI-Prevenzione Follow-Up
	T (%) vs C (%) RR (95% CI)
	3 mo	6 mo	9 mo	12 mo	42 mo
Relative risk, calculated by Cox regression analysis adjusted for main confounders. CVD indicates cardiovascular disease; MI, myocardial infarction; and CHD, coronary heart disease. Patients with ≥2 events of different types appear more than once in columns but only once in rows.
*P<0.10,
†P<0.05,
‡P<0.01,
§P<0.001.
Main end points
Death, nonfatal MI, and nonfatal stroke	130 (2.3%) vs 148 (2.6%)	197 (3.5%) vs 229 (4.1%)	254 (4.5%) vs 296 (5.2%)	304 (5.4%) vs 354 (6.3%)	718 (12.7%) vs 795 (14.1%)
	0.86 (0.61–1.22)	0.78 (0.60–1.03)^*	0.76 (0.60–0.97)^†	0.79 (0.63–0.98)^†	0.85 (0.74–0.98)^†
CVD death, nonfatal MI, and nonfatal stroke	122 (2.2%) vs 136 (2.4%)	179 (3.2%) vs 207 (3.7%)	224 (4.0%) vs 265 (4.7%)	265 (4.7%) vs 310 (5.5%)	556 (9.8%) vs 621 (11.0%)
	0.93 (0.65–1.35)	0.80 (0.60–1.07)	0.75 (0.58–0.97)^†	0.78 (0.62–0.99)^†	0.80 (0.68–0.94)^‡
Secondary analyses
All fatal events	63 (1.1%) vs 88 (1.6%)	102 (1.8%) vs 130 (2.3%)	140 (2.5%) vs 180 (3.2%)	178 (3.1%) vs 212 (3.8%)	477 (8.4%) vs 554 (9.8%)
	0.59 (0.36–0.97)^†	0.66 (0.45–0.96)^†	0.62 (0.45–0.86)^‡	0.72 (0.54–0.96)^†	0.79 (0.66–0.93)^‡
CVD death	55 (1.0%) vs 76 (1.3%)	84 (1.5%) vs 107 (1.9%)	110 (1.9%) vs 148 (2.6%)	139 (2.5%) vs 166 (2.9%)	310 (5.5%) vs 370 (6.5%)
	0.64 (0.37–1.12)	0.66 (0.43–1.01)^*	0.57 (0.39–0.83)^‡	0.70 (0.51–0.98)^†	0.70 (0.56–0.86)^§
Cardiac death	45 (0.8%) vs 65 (1.2%)	66 (1.2%) vs 95 (1.7%)	86 (1.5%) vs 134 (2.4%)	112 (2.0%) vs 149 (2.6%)	247 (4.4%) vs 306 (5.4%)
	0.62 (0.34–1.15)	0.61 (0.38–0.97)^†	0.50 (0.33–0.75)^§	0.65 (0.45–0.93)^†	0.65 (0.51–0.82)^§
Coronary death	42 (0.7%) vs 56 (1.0%)	60 (1.1%) vs 80 (1.4%)	76 (1.3%) vs 115 (2.0%)	99 (1.8%) vs 127 (2.2%)	209 (3.7%) vs 258 (4.6%)
	0.72 (0.38–1.38)	0.69 (0.42–1.14)	0.54 (0.35–0.83)^‡	0.72 (0.49–1.05)^*	0.68 (0.53–0.88)^‡
Sudden death	26 (0.5%) vs 37 (0.7%)	33 (0.6%) vs 52 (0.9%)	45 (0.8%) vs 72 (1.3%)	59 (1.0%) vs 78 (1.4%)	111 (2.0%) vs 154 (2.7%)
	0.44 (0.19–1.02)^*	0.43 (0.22–0.86)^†	0.37 (0.20–0.67)^‡	0.53 (0.32–0.88)^†	0.55 (0.39–0.77)^§
Nonfatal CVD events
Nonfatal MI	55 (1.0%) vs 58 (1.0%)	81 (1.4%) vs 93 (1.6%)	100 (1.8%) vs 108 (1.9%)	116 (2.1%) vs 131 (2.3%)	223 (3.9%) vs 233 (4.1%)
	0.89 (0.51–1.54)	0.70 (0.45–1.09)	0.81 (0.55–1.20)	0.78 (0.54–1.12)	0.91 (0.70–1.18)
Nonfatal stroke	14 (0.3%) vs 5 (0.1%)	18 (0.3%) vs 10 (0.2%)	20 (0.4%) vs 14 (0.3%)	21 (0.4%) vs 19 (0.3%)	62 (1.1%) vs 57 (1.0%)
	10.51 (1.34–82.42)^†	6.66 (1.50–29.6)^†	3.08 (1.12–8.51)^†	1.88 (0.80–4.45)	1.22 (0.75–1.97)
Subsidiary analyses
CHD death and nonfatal MI	95 (1.7%) vs 114 (2.0%)	138 (2.4%) vs 173 (3.1%)	173 (3.1%) vs 222 (3.9%)	211 (3.7%) vs 256 (4.5%)	418 (7.4%) vs 475 (8.4%)
	0.83 (0.55–1.26)	0.70 (0.50–0.97)^†	0.67 (0.50–0.90)^‡	0.75 (0.58–0.98)^†	0.78 (0.65–0.94)^‡
Fatal and nonfatal stroke	17 (0.3%) vs 10 (0.2%)	23 (0.4%) vs 15 (0.3%)	26 (0.5%) vs 19 (0.3%)	28 (0.5%) vs 25 (0.4%)	92 (1.6%) vs 77 (1.4%)
	3.23 (0.89–11.77)^*	3.20^* (1.04–9.85)^†	2.16 (0.88–5.32)^*	1.48 (0.66–3.30)	1.22 (0.81–1.85)

**Figure 1.** Early benefit of n-3 PUFA therapy. A, Total mortality; B, sudden death; C, coronary heart disease mortality; and D, cardiovascular mortality.

The reduction of the other causes of death became significant somewhat later than that of sudden death: cardiac death at 6 months (1.2% versus 1.7%; RR 0.61; 95% CI 0.38 to 0.97; P=0.036), coronary death at 8 months (1.3% versus 1.8%; RR 0.62; 95% CI 0.40 to 0.98; P=0.040), and cardiovascular death at 8 months (1.8% versus 2.4%; RR 0.64; 95% CI 0.44 to 0.94; P=0.024). The curves related to death for coronary heart disease and cardiovascular disease (Figure 1, C and D) are characterized by an early overlapping and a first evidence of separation after 2 to 3 months.

The 2 main combined end points of the study were significantly lowered after 9 months of treatment, whereas total coronary heart disease events were significantly lower after 5 months (2.2% versus 2.8%; RR 0.707; 95% CI 0.500 to 0.999; P=0.0495). The reduction in risk of nonfatal myocardial infarction never reached the nominal level of statistical significance during the 12-month follow-up: 2.1% versus 2.3%; RR 0.78; 95% CI 0.54 to 1.12; P=0.1727; at 42 months, 3.9% versus 4.1%; RR 0.91; 95% CI 0.70 to 1.18; P=0.473.

Such results were obtained in a population of patients also exposed to standard preventive interventions (Table 1) and with slight modification of blood lipid levels during the study (Figure 2). Compared with baseline values, total and LDL cholesterol levels increased slightly at 6 months and then declined, reaching approximately the same levels as measured at baseline. HDL cholesterol levels were increased in a similar way in active and control groups. Mean triglyceride values during follow-up were 155.1±73.6 mg/dL and 162.6±85.5 mg/dL for the n-3 PUFA and control groups, respectively, documenting a small but significant change in triglyceride concentrations in patients receiving n-3 PUFAs (−4.6%) and not in controls (+0.4%). Finally, compared with controls, n-3 PUFA treatment did not change glycemia and blood fibrinogen levels.

**Figure 2.** Effects of n-3 PUFA treatment on blood lipids.

Discussion

The analysis of the time course of the appearance of the effects of n-3 PUFAs showed an early and highly significant reduction of sudden cardiac death, the major component of total mortality reduction, with no indication of a decrease of nonfatal myocardial infarction. The strength of the results pointing to an antiarrhythmic/antifibrillatory effect of n-3 PUFAs can be seen in a triple consistency, as follows.

Internal

The strength of the relative risk reduction observed at the end of the study with n-3 PUFA treatment clearly increased, passing from total to cardiovascular to coronary mortality, and reached its maximum for sudden death. The early effects on total mortality were closely parallel and well explained by the reduction of sudden death.

External

Several prospective cohort studies found an inverse relationship between n-3 PUFAs from fish intake and coronary heart disease death: the Zutphen study,⁶ the 30-year follow-up in the Western Electric Study,⁷ the Multiple Risk Factor Interventional Trial,⁸ and the Honolulu Heart Program.⁹ In addition, the Lyon Diet Heart Study¹⁰ and the Indian Trial^11,12 strongly suggest a protective effect of n-3 PUFAs. In the 20 551 male subjects of the US Physicians’ Health Study, regular fish consumption (≥1 meals of fish per week) conferred a 52% risk-adjusted reduction in sudden deaths compared with fish intake less than once monthly.⁵ Siscovick et al²⁴ reported that little or no fish intake (or low n-3 PUFA blood levels) was associated with an increased risk of primary out-of-hospital cardiac arrest compared with regular fish consumption. Furthermore, various researchers have found a positive correlation between n-3 PUFA intake and decreased heart rate variability, which in turn is strongly associated with increased risk of sudden death.^25–28 The pattern of results obtained in GISSI-Prevenzione are also consistent with the findings of the DART trial,¹⁴ in which the 29% decrease of total mortality over 2 years corresponds to an unchanged rate of nonfatal myocardial infarction. A similar absence of influence of unsaturated fatty acids on progression of coronary heart disease was noted in the US Health Professionals Study⁵ and in the Alpha-Tocopherol, Beta-Carotene cancer study.²⁹

Growing Evidence in the Experimental Field

The antiarrhythmic and antifibrillatory effects of n-3 PUFAs have been reported in animal studies on marmosets, rats, and dogs, as well as in laboratory experiments on isolated myocytes,^30–32 and were recently comprehensively reviewed.¹⁹ Infusion of an emulsion of n-3 PUFAs just before coronary artery obstruction in an exercising, unanesthetized dog model prevented ischemia-induced sudden cardiac death by preventing ventricular fibrillation. n-3 PUFAs prevented induced fibrillation of cultured neonatal rat cardiomyocytes when various cardiotoxins were tested, and after fibrillation was induced, the arrhythmias were terminated by the PUFAs. According to the results of electrophysiological studies, n-3 PUFAs seem to modulate ion currents (primarily of Na⁺ and Ca²⁺) in the myocyte sarcolemma, shifting the steady-state inactivation potential to more negative values, increasing the depolarizing current necessary to elicit an action potential by ≈50% and prolong the refractory period by ≈3-fold.^19,31,32

The strength of the early effects of n-3 PUFAs on sudden death was maintained and confirmed at the end of the study, whereas the 41% relative risk reduction of total mortality observed after 3 months of treatment was disproved (relative risk reduction 21% at 3 years). Such a decrease of n-3 PUFA benefit, however, was paralleled by (1) a lower rate (1.4%) of death in the last period of the follow-up, this finding being consistent with the well-known higher risk of patients recruited early (median 16 days in GISSI-Prevenzione) after the index event; (2) a decreasing proportion of the ratio of sudden death to the total rate of death during follow-up, with sudden deaths being 42% and 26% of total deaths in the first 3 months and during the whole study, respectively; and (3) an increasing noncompliance with allocated treatment during follow-up. In particular, 8%, 18%, 24%, 29%, and 32% of patients stopped to take the allocated intervention after 6, 12, 18, 30, and 42 months, respectively. Side effects explained the discontinuation of study treatments only in a few cases (4%).

Taken together, the aforementioned findings suggest a redefinition of n-3 PUFAs in terms of an antifibrillatory drug. Such a statement clearly needs a careful qualification. When the GISSI-Prevenzione trial was planned and started, attention was on much higher doses of n-3 PUFAs to aim at antiatherosclerotic and antithrombotic effects¹⁶ via antiplatelet and anti-inflammatory mechanisms, decrease of triglycerides and fibrinogen levels, inhibition of cytokines and gene expression of adhesion molecules, and improvement in arterial compliance and endothelial function.^{3,16–18,33,34} As a consequence, GISSI-Prevenzione was designed to assess the combined effects of n-3 PUFAs on death, nonfatal myocardial infarction, and stroke. Sudden death was not a primary outcome measure, although its documentation was explicitly foreseen in the collection of end-point events.

Further limitations are well known to exist in the definition of sudden deaths: on one hand, the difficulties and differences in the attribution of the cause of death in ambulatory long-term follow-up; on the other, the fact that not all sudden deaths are due to primary ventricular fibrillation initiated by altered membrane ion channel function. Plaque rupture, ischemia, and coronary thrombosis can cause sudden death as a result of pump failure, potassium loss from ischemic cells that initiates injury currents, and inhomogeneities in refractoriness and action potential duration that set up reentrant circuits.

Such an interpretation of the results can find some confirmation in the absence of effects on events more directly attributable to atherothrombosis, which in turn may be partly explained by the full adoption of intensive preventive interventions that were documented for the whole duration of the study (Table 1).

There is no doubt, however, that the antiarrhythmic profile of n-3 PUFAs requires confirmation in settings in which the control of arrhythmia-related events is the direct end point. The spectrum of the clinical conditions that could be considered (eg, patients with implanted cardiac defibrillators, heart failure, prevention of first cardiac event) and an outline of the related ongoing and planned trials were recently reviewed.³⁵

Conclusions

The significant reduction of mortality documented in the GISSI-Prevenzione trial, with a low dose (1 g/d) of n-3 PUFAs appears very early in the course of the treatment and is explained mainly by the decrease of sudden death.

To save 1 patient, in a population at relatively low risk (annual mortality 2.6%), 164 patients would need to be treated for 1 year with n-3 PUFAs.

The findings provide an important support to the hypothesis of an antiarrhythmic and/or antifibrillatory role of n-3 PUFAs, which should be formally tested with adequately sized trials on well-defined candidate clinical conditions.

The names of the GISSI-Prevenzione Investigators have been previously reported (Lancet. 1999;354:447–455).

GISSI is endorsed by the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Firenze, Italy, and by the Istituto di Ricerche Farmacologiche Mario Negri, Milano, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. This study was partially supported by grants from Bristol-Myers Squibb, Pharmacia-Upjohn, and Società Prodotti Antibiotici. Pharmacia-Upjohn and Società Prodotti Antibiotici supplied marketed capsules containing 850 to 882 mg EPA/DHA ethyl esters. Vitamin E (acetyl d,l-α-tocopherol) was supplied by Bracco. We thank Carla Pera, Barbara Ferri, Anna Flamminio, and Anna Polidoro for secretarial help.

Footnotes

Correspondence to Roberto Marchioli, MD, GISSI-Prevenzione Secretariat, Consorzio Mario Negri Sud, Via Nazionale, 66030 Santa Maria Imbaro, Italy. E-mail [email protected]

References

1 Bang HO, Dyerberg J, Hjørne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand. 1976; 200: 69–73.Crossref Medline Google Scholar
2 Kromann N, Green A. Epidemiologic studies in the Upernavik district, Greenland: incidence of some chronic disease 1950–1974. Acta Med Scand. 1980; 208: 401–406.Crossref Medline Google Scholar
3 Simopoulos AP. Omega-3 fatty acids in the prevention-management of cardiovascular disease. Can J Physiol Pharmacol. 1997; 75: 234–239.Medline Google Scholar
4 Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake and the risk of coronary disease among men. N Engl J Med. 1995; 332: 977–982.Crossref Medline Google Scholar
5 Albert CM, Hennekens CH, O’Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998; 279: 23–28.Crossref Medline Google Scholar
6 Kromhout D, Bosschieter EB, de Lezenne CC. The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985; 312: 1205–1209.Crossref Medline Google Scholar
7 Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997; 336: 1046–1053.Crossref Medline Google Scholar
8 Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc Soc Exp Biol Med. 1992; 200: 177–182.Crossref Medline Google Scholar
9 Rodriguez BL, Sharp DS, Abbott RD, et al. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers: the Honolulu Heart Program. Circulation. 1996; 94: 952–956.Crossref Medline Google Scholar
10 De Lorgeril M, Salen P, Martin J-L, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999; 99: 779–785.Crossref Medline Google Scholar
11 Singh RB, Rastogi SS, Verma R, et al. Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ. 1992; 304: 1015–1019.Crossref Medline Google Scholar
12 Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian Experiment of Infarct Survival-4. Cardiovasc Drug Ther. 1997; 11: 485–491.Crossref Medline Google Scholar
13 von Shacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999; 130: 554–562.Crossref Medline Google Scholar
14 Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989; 2: 757–761.Crossref Medline Google Scholar
15 Harris WS. n-3 fatty acids and serum lipoproteins: animal studies. Am J Clin Nutr. 1997; 65 (5 suppl): 1611S–1616S.Crossref Medline Google Scholar
16 GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999; 354: 447– 455.Crossref Medline Google Scholar
17 Marchioli R, Valagussa F, on behalf of GISSI-Prevenzione Investigators. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention. Eur Heart J. 2000; 21: 949–952.Crossref Medline Google Scholar
18 Marchioli R, on behalf of GISSI-Prevenzione Investigators. Treatment with n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Eur Heart J. 2001; 22: D85–D97.Google Scholar
19 Leaf A. The electrophysiologic basis for the antiarrhythmic actions of polyunsaturated fatty acids. Eur Heart J. 2001; 22: D98–D105.Google Scholar
20 Stampfer MJ, Buring JE, Willett W, et al. The 2X2 factorial design: its applications to a randomized trial of aspirin and carotene in U.S. physicians. Stat Med. 1985; 4: 111–116.Crossref Medline Google Scholar
21 Byar DP, Piantadosi S. Factorial designs for randomized clinical trials. Cancer Treat Rep. 1985; 69: 1055–1062.Medline Google Scholar
22 Marubini E, Valsecchi MG, eds. Analysing Survival Data From Clinical Trials and Observational Studies. Chichester, UK: John Wiley; 1995.Google Scholar
23 Marchioli R, Avanzini A, Barzi F, et al, on behalf of GISSI-Prevenzione Investigators. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factors assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J. 2001; 22: 2085–2103.Crossref Medline Google Scholar
24 Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain w-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995; 274: 1363–1367.Crossref Medline Google Scholar
25 Fauchier L, Babuty D, Cosnay P, et al. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1999; 33: 1203–1207.Crossref Medline Google Scholar
26 Christensen JH, Gustenhoff P, Eilersen E, et al. n-3 fatty acids and ventricular extra systoles in patients with ventricular tachyarrhythmias. Nutr Res. 1995; 15: 1–8.Crossref Google Scholar
27 Christensen JH, Korup E, Aaroe J, et al. Fish consumption, w-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol. 1997; 79: 1670–1673.Crossref Medline Google Scholar
28 Sellmayer A, Witzgall H, Lorenz RL, et al. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol. 1995; 76: 974–977.Crossref Medline Google Scholar
29 Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997; 145: 876–887.Crossref Medline Google Scholar
30 McLennan PL, Bridle TM, Abeywardena MY, et al. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J. 1992; 123: 1555–1561.Crossref Medline Google Scholar
31 Kang JX, Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids: recent studies. Circulation. 1996; 94: 1774–1780.Crossref Medline Google Scholar
32 Billman GE, Kang JX, Leaf A. Prevention of ischemia-induced ventricular arrhythmias by dietary pure n-3 polyunsaturated fatty acids in dogs. Circulation. 1999; 99: 2452–2457.Crossref Medline Google Scholar
33 Lands WEM. Biochemistry and physiology of eicosanoid precursors in cell membranes. Eur Heart J. 2001; 22: D22–D25.Crossref Medline Google Scholar
34 De Caterina R, Basta G. Biochemistry and physiology of eicosanoid precursors in cell membranes. Eur Heart J. 2001; 22: D42–D49.Google Scholar
35 Maggioni AP, Tavazzi L, Marchioli R, et al, on the behalf of the GISSI-group. Perspectives on n-3 PUFA: primary prevention, antiarrhythmic effects, congestive heart failure. Eur Heart J. 2001; 22: D106–D109.Google Scholar

eLetters(0)

eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.

Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.

Cited By

Bernhard B, Heydari B, Abdullah S, Francis S, Lumish H, Wang W, Jerosch-Herold M, Harris W and Kwong R (2024) Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial, International Journal of Cardiology, 10.1016/j.ijcard.2023.131698, 399, (131698), Online publication date: 1-Mar-2024.

Luo S, Hou H, Wang Y, Li Y, Zhang L, Zhang H, Jin Q, Wu G and Wang X (2024) Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis, Food & Function, 10.1039/D3FO02522E, 15:3, (1208-1222)

Serhiyenko V, Serhiyenko L, Cherkas A and Serhiyenko A (2023) ICOSAPENT ETHYL AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES (NARRATIVE REVIEW), Proceeding of the Shevchenko Scientific Society. Medical Sciences, 10.25040/ntsh2023.02.06, 72:2

Bayer W, Mahler A, Schmidt K and Willmann M (2023) Langkettige Omega-3-Fettsäuren EPA und DHA, Ernährung & Medizin, 10.1055/a-2151-9012, 38:04, (163-172), Online publication date: 1-Dec-2023.

Saito K and Koizumi S (2023) A promising drug for neuropathic pain: identification of vesicular nucleotide transporter as a novel target of eicosapentaenoic acid, Purinergic Signalling, 10.1007/s11302-022-09918-7, 19:4, (587-589), Online publication date: 1-Dec-2023.

Khan I, Hussain M, Jiang B, Zheng L, Pan Y, Hu J, Khan A, Ashraf A and Zou X (2023) Omega-3 long-chain polyunsaturated fatty acids: Metabolism and health implications, Progress in Lipid Research, 10.1016/j.plipres.2023.101255, 92, (101255), Online publication date: 1-Nov-2023.

von Schacky C, Kuipers R, Pijl H, Muskiet F and Grobbee D (2023) Omega-3 fatty acids in heart disease—why accurately measured levels matter, Netherlands Heart Journal, 10.1007/s12471-023-01759-2, 31:11, (415-423), Online publication date: 1-Nov-2023.

Kinsara A and Sabbour H (2023) Flash’O real-world evidence programme – Attitude and practices toward the use of omega-3 FA by physicians from Middle East Countries, Medicine, 10.1097/MD.0000000000035416, 102:40, (e35416), Online publication date: 6-Oct-2023.

Rao A, Gupta A, Kain V and Halade G (2023) Extrinsic and intrinsic modulators of inflammation-resolution signaling in heart failure, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00276.2023, 325:3, (H433-H448), Online publication date: 1-Sep-2023.

Rosseel Z, Cortoos P, Jonckheer J, Cools W, Vinken M, Reynaert H and De Waele E (2023) Parenteral Nutrition, Sepsis, Acute Heart Failure and Hepatotoxic Drugs Are Related to Liver Test Disturbances in Critically Ill Patients, Nutrients, 10.3390/nu15112612, 15:11, (2612)

Šušnjara P, Mihaljević Z, Stupin A, Kolobarić N, Matić A, Jukić I, Kralik Z, Kralik G, Miloloža A, Pavošević T, Šerić V, Lončarić Z, Kerovec D, Galović O and Drenjančević I (2023) Consumption of Nutritionally Enriched Hen Eggs Enhances Endothelium-Dependent Vasodilation via Cyclooxygenase Metabolites in Healthy Young People—A Randomized Study, Nutrients, 10.3390/nu15071599, 15:7, (1599)

Caldeira D, Nogueira-Garcia B, Abreu A and Pinto F (2022) Fish intake and risk of cardiovascular events: an analysis of the VITAL cohort, European Journal of Clinical Nutrition, 10.1038/s41430-022-01244-w, 77:3, (400-404), Online publication date: 1-Mar-2023.

Sahye-Pudaruth S and Ma D (2023) Assessing the Highest Level of Evidence from Randomized Controlled Trials in Omega-3 Research, Nutrients, 10.3390/nu15041001, 15:4, (1001)

Djuricic I and Calder P (2023) Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health, Annual Review of Pharmacology and Toxicology, 10.1146/annurev-pharmtox-051921-090208, 63:1, (383-406), Online publication date: 20-Jan-2023.

Rodriguez D, Lavie C, Elagizi A and Milani R (2022) Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health, Nutrients, 10.3390/nu14235146, 14:23, (5146)

Streja E and Streja D (2022) Dyslipidemia in Chronic Kidney Disease Evidence‐Based Nephrology, 10.1002/9781119105954.ch34, (549-572), Online publication date: 2-Dec-2022.

O’Connell T, Murphy K, Zhang N, Puccini S, Healy C, Harsch B, Zhang M and Shearer G (2022) Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease, Physiology, 10.1152/physiol.00007.2022, 37:6, (311-322), Online publication date: 1-Nov-2022.

Spahr A and Divnic‐Resnik T (2022) Impact of health and lifestyle food supplements on periodontal tissues and health, Periodontology 2000, 10.1111/prd.12455, 90:1, (146-175), Online publication date: 1-Oct-2022.

Manolis A, Manolis T, Manolis A and Melita H Diet and Sudden Death: How to Reduce the Risk, Current Vascular Pharmacology, 10.2174/1570161120666220621090343, 20:5, (383-408)

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M, Deswal A, Drazner M, Dunlay S, Evers L, Fang J, Fedson S, Fonarow G, Hayek S, Hernandez A, Khazanie P, Kittleson M, Lee C, Link M, Milano C, Nnacheta L, Sandhu A, Stevenson L, Vardeny O, Vest A and Yancy C (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 145:18, (e895-e1032), Online publication date: 3-May-2022.

Wang C, Lee C, Wu D, Chen S and Lee T (2022) Differential effects of EPA and DHA on PPARγ-mediated sympathetic innervation in infarcted rat hearts by GPR120-dependent and -independent mechanisms, The Journal of Nutritional Biochemistry, 10.1016/j.jnutbio.2022.108950, 103, (108950), Online publication date: 1-May-2022.

Heidenreich P, Bozkurt B, Aguilar D, Allen L, Byun J, Colvin M, Deswal A, Drazner M, Dunlay S, Evers L, Fang J, Fedson S, Fonarow G, Hayek S, Hernandez A, Khazanie P, Kittleson M, Lee C, Link M, Milano C, Nnacheta L, Sandhu A, Stevenson L, Vardeny O, Vest A and Yancy C (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, Journal of the American College of Cardiology, 10.1016/j.jacc.2021.12.012, 79:17, (e263-e421), Online publication date: 1-May-2022.

Luo C and Chen Z (2022) Is Omega-3 Index necessary for fish oil supplements for CVD risk prevention?, Cardiology Plus, 10.1097/CP9.0000000000000015, 7:2, (70-76), Online publication date: 1-Apr-2022.

Markozannes G, Ntzani E, Tsapas A, Mantzoros C, Tsiara S, Xanthos T, Karpettas N, Patrikios I and Rizos E (2022) Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events, Clinical Nutrition, 10.1016/j.clnu.2022.02.022, 41:4, (923-930), Online publication date: 1-Apr-2022.

Herrmann W and Herrmann M (2022) The Controversial Role of HCY and Vitamin B Deficiency in Cardiovascular Diseases, Nutrients, 10.3390/nu14071412, 14:7, (1412)

Diffenderfer M, Rajapakse N, Pham E, He L, Dansinger M, Nelson J and Schaefer E (2022) Plasma fatty acid profiles: Relationships with sex, age, and state-reported heart disease mortality rates in the United States, Journal of Clinical Lipidology, 10.1016/j.jacl.2021.12.005, 16:2, (184-197), Online publication date: 1-Mar-2022.

Yamamoto T and Sano M (2022) Deranged Myocardial Fatty Acid Metabolism in Heart Failure, International Journal of Molecular Sciences, 10.3390/ijms23020996, 23:2, (996)

Visioli F and Agostoni C (2022) Omega 3 Fatty Acids and Health: The Little We Know after All These Years, Nutrients, 10.3390/nu14020239, 14:2, (239)

Liao J, Xiong Q, Yin Y, Ling Z and Chen S (2022) The Effects of Fish Oil on Cardiovascular Diseases: Systematical Evaluation and Recent Advance, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.802306, 8

Park Y (2022) Dietary Reference Intake of n-3 polyunsaturated fatty acids for Koreans, Nutrition Research and Practice, 10.4162/nrp.2022.16.S1.S47, 16:Suppl 1, (S47), .

Huang T and Zhuang Z (2022) N-3 polyunsaturated fatty acid and homocysteine metabolism Advances in Dietary Lipids and Human Health, 10.1016/B978-0-12-823914-8.00020-3, (273-284), .

Alexander E, Cristiano E and Miles J (2022) Precision Medicine for Diabetes and Dyslipidemia Precision Medicine in Diabetes, 10.1007/978-3-030-98927-9_3, (65-87), .

Koutoulogenis G and Kokotos G (2021) Nitro Fatty Acids (NO2-FAs): An Emerging Class of Bioactive Fatty Acids, Molecules, 10.3390/molecules26247536, 26:24, (7536)

Gaeini Z, Mirmiran P, Bahadoran Z, Aghayan M and Azizi F (2021) The association between dietary fats and the incidence risk of cardiovascular outcomes: Tehran Lipid and Glucose Study, Nutrition & Metabolism, 10.1186/s12986-021-00624-6, 18:1, Online publication date: 1-Dec-2021.

Barta D, Coman V and Vodnar D (2021) Microalgae as sources of omega-3 polyunsaturated fatty acids: Biotechnological aspects, Algal Research, 10.1016/j.algal.2021.102410, 58, (102410), Online publication date: 1-Oct-2021.

Goldenberg R, Cheng A, Gilbert J, Lonn E, Pedersen S and Verma S (2021) The role of icosapent ethyl in cardiovascular risk reduction, Current Opinion in Cardiology, 10.1097/HCO.0000000000000873, 36:5, (661-671), Online publication date: 1-Sep-2021.

Liu Q (2021) Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction, Journal of Clinical Lipidology, 10.1016/j.jacl.2021.05.007, 15:4, (556-568), Online publication date: 1-Jul-2021.

Henry S, Wijesinghe D, Myers A and McInnes B (2021) Using Literature Based Discovery to Gain Insights Into the Metabolomic Processes of Cardiac Arrest, Frontiers in Research Metrics and Analytics, 10.3389/frma.2021.644728, 6

Gila-Diaz A, Carrillo G, Singh P and Ramiro-Cortijo D (2021) Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases, Antioxidants, 10.3390/antiox10060933, 10:6, (933)

Chazova I, Shestakova M, Zhernakova Y, Blinova N, Markova T, Mazurina N, Ezhov M, Tereshchenko S, Zhirov I, Komarov A, Mironova O, Yuricheva Y, Suhareva O, Kislyak O, Mkrtumyan A, Podzolkov V, Azizov V, Zelveyan P, Grigorenko E, Rahimov Z, Sarybaev A, Kasymova S and Narzullaeva A (2021) EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021), Eurasian heart journal, 10.38109/2225-1685-2021-2-6-61:2, (6-61)

Joo S (2021) Effects of omega-3 fatty acids, vitamins, and chelation therapy in patients with heart diseases, Journal of Medicine and Life Science, 10.22730/jmls.2021.18.1.1, 18:1, (1-10), Online publication date: 30-Apr-2021.

Wake M and Kobayashi D (2021) Associations between plasma levels of omega-3 fatty acids and subsequent allergic diseases, Clinical Nutrition ESPEN, 10.1016/j.clnesp.2021.01.013, 42, (318-324), Online publication date: 1-Apr-2021.

Plonné D (2021) Jenseits von Gut und Böse, Trillium Diagnostik, 10.47184/td.2021.01.01, 19:1, (8-13), Online publication date: 18-Mar-2021.

Abdissa D (2021) Purposeful Review to Identify the Benefits, Mechanism of Action and Practical Considerations of Omega-3 Polyunsaturated Fatty Acid Supplementation for the Management of Diabetes Mellitus, Nutrition and Dietary Supplements, 10.2147/NDS.S298870, Volume 13, (53-65)

Kalstad A, Myhre P, Laake K, Tveit S, Schmidt E, Smith P, Nilsen D, Tveit A, Fagerland M, Solheim S, Seljeflot I and Arnesen H (2020) Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction, Circulation, 143:6, (528-539), Online publication date: 9-Feb-2021.

Rousseau G (2021) Microbiota, a New Playground for the Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Diseases, Marine Drugs, 10.3390/md19020054, 19:2, (54)

Trivedi K, Le V and Nelson J (2020) The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention, Postgraduate Medicine, 10.1080/00325481.2020.1783937, 133:1, (28-41), Online publication date: 2-Jan-2021.

Cheng C, Li H, Liang L, Jin T, Zhang G, Bradley J, Peberdy M, Ornato J, Wijesinghe D and Tang W (2021) Effects of ω-3 PUFA and ascorbic acid combination on post-resuscitation myocardial function, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2020.110970, 133, (110970), Online publication date: 1-Jan-2021.

Visioli F and Poli A (2020) Fatty Acids and Cardiovascular Risk. Evidence, Lack of Evidence, and Diligence, Nutrients, 10.3390/nu12123782, 12:12, (3782)

Zambon A, Pirillo A, Zambon S, Norata G and Catapano A (2020) Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction, Current Atherosclerosis Reports, 10.1007/s11883-020-00893-1, 22:12, Online publication date: 1-Dec-2020.

Ribeiro E, Alves M, Costa J, Ferreira J, Pinto F and Caldeira D (2020) Safety of coffee consumption after myocardial infarction: A systematic review and meta-analysis, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2020.07.016, 30:12, (2146-2158), Online publication date: 1-Nov-2020.

Senftleber N, Albrechtsen A, Lauritzen L, Larsen C, Bjerregaard P, Diaz L, Rønn P and Jørgensen M (2020) Omega-3 fatty acids and risk of cardiovascular disease in Inuit: First prospective cohort study, Atherosclerosis, 10.1016/j.atherosclerosis.2020.08.032, 312, (28-34), Online publication date: 1-Nov-2020.

Ferrari R, Censi S and Cimaglia P (2020) The journey of omega-3 fatty acids in cardiovascular medicine, European Heart Journal Supplements, 10.1093/eurheartj/suaa118, 22:Supplement_J, (J49-J53), Online publication date: 1-Oct-2020.

Casula M, Olmastroni E, Gazzotti M, Galimberti F, Zambon A and Catapano A (2020) Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials, Pharmacological Research, 10.1016/j.phrs.2020.105060, 160, (105060), Online publication date: 1-Oct-2020.

Schlienger J and Monnier L (2020) Acides gras oméga 3 : une trop belle histoire encore en quête de preuves, Médecine des Maladies Métaboliques, 10.1016/j.mmm.2020.04.006, 14:6, (567-575), Online publication date: 1-Oct-2020.

Tereshchenko S, Zhirov I, Uskach T, Saidova M, Golitsyn S, Gupalo E, Nasonova S, Narusov O, Safiullina A, Tereshchenko A and Stukalova O (2020) EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020), Eurasian heart journal, 10.38109/2225-1685-2020-3-6-76:3, (6-76)

Oppedisano F, Macrì R, Gliozzi M, Musolino V, Carresi C, Maiuolo J, Bosco F, Nucera S, Caterina Zito M, Guarnieri L, Scarano F, Nicita C, Coppoletta A, Ruga S, Scicchitano M, Mollace R, Palma E and Mollace V (2020) The Anti-Inflammatory and Antioxidant Properties of n-3 PUFAs: Their Role in Cardiovascular Protection, Biomedicines, 10.3390/biomedicines8090306, 8:9, (306)

Chen W, Chen S, Wu D, Lee C and Lee T (2020) Effect of icosapent ethyl on susceptibility to ventricular arrhythmias in postinfarcted rat hearts: Role of GPR120‐mediated connexin43 phosphorylation, Journal of Cellular and Molecular Medicine, 10.1111/jcmm.15575, 24:16, (9267-9279), Online publication date: 1-Aug-2020.

Welty F (2020) Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk, Current Opinion in Lipidology, 10.1097/MOL.0000000000000689, 31:4, (206-231), Online publication date: 1-Aug-2020.

Cao Z, Schmitt T, Varma V, Sloper D, Beger R and Sun J (2019) Evaluation of the Performance of Lipidyzer Platform and Its Application in the Lipidomics Analysis in Mouse Heart and Liver, Journal of Proteome Research, 10.1021/acs.jproteome.9b00289, 19:7, (2742-2749), Online publication date: 2-Jul-2020.

TARHAN İ (2020) DEVELOPING A NEW ESTERIFICATION METHOD FOR THE DETERMINATION OF FATTY ACID COMPOSITIONS OF MARINE OIL SUPPLEMENTS BY GAS CHROMATOGRAPHY WITH ORTHOGONAL CENTRAL COMPOSITE DESIGN AND RESPONSE SURFACE METHODOLOGY ORTAGONAL MERKEZİ KOMPOZİT TASARIM VE YÜZEY CEVAP METODOLOJİSİNDEN FAYDALANARAK BALIK YAĞI GIDA TAKVİYELERİNİN YAĞ ASİDİ KOMPOZİSYONLARININ GAZ KROMATOGRAFİSİ İLE TAYİNİ İÇİN YENİ BİR ESTERLEŞTİRME METODUNUN GELİŞTİRİLMESİ, Gıda, 10.15237/gida.GD20043, 45:3, (581-589)

Kotlovskiy M, Udut E, Kairov G, Fisenko V and Udut V Effects of Simvastatin on the Metabolism of Fatty Acids in Combined Secondary Prevention of Coronary Heart Disease: Dosage and Gender Differences between the Effects, Cardiovascular & Hematological Disorders-Drug Targets, 10.2174/1871529X20666200109144353, 20:2, (93-107)

Jiménez Jiménez F, Jordá Miñana A and González Iglesias C (2020) Recommendations for specialized nutritional-metabolic treatment of the critical patient: Heart disease. Metabolism and Nutrition Working Group of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC), Medicina Intensiva (English Edition), 10.1016/j.medine.2019.12.006, 44, (77-80), Online publication date: 1-Jun-2020.

Jiménez Jiménez F, Jordá Miñana A and González Iglesias C (2020) Recomendaciones para el tratamiento nutrometabólico especializado del paciente crítico: patologia cardìaca. Grupo de Trabajo de Metabolismo y Nutrición de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC), Medicina Intensiva, 10.1016/j.medin.2019.12.002, 44, (77-80), Online publication date: 1-Jun-2020.

Zhao H, Mikkonen K, Kilpeläinen P and Lehtonen M (2020) Spruce Galactoglucomannan-Stabilized Emulsions Enhance Bioaccessibility of Bioactive Compounds, Foods, 10.3390/foods9050672, 9:5, (672)

Tolpygina S and Martsevich S (2020) Cardiac risk stratification in stable coronary artery disease, The Clinician, 10.17650/1818-8338-2020-14-1-2-24-33, 14:1-2, (24-33)

Nishizaki Y and Daida H (2020) Optimal Dose of n-3 Polyunsaturated Fatty Acids for Cardiovascular Event Prevention, Circulation Reports, 10.1253/circrep.CR-20-0012, 2:4, (260-264), Online publication date: 10-Apr-2020.

Watanabe Y and Tatsuno I (2020) Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.50658, 27:3, (183-198), Online publication date: 1-Mar-2020.

Abdelhamid A, Brown T, Brainard J, Biswas P, Thorpe G, Moore H, Deane K, Summerbell C, Worthington H, Song F and Hooper L (2020) Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003177.pub5, 2020:3

Innes J and Calder P (2020) Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020, International Journal of Molecular Sciences, 10.3390/ijms21041362, 21:4, (1362)

DiNicolantonio J and OKeefe J (2020) The benefits of marine omega-3s for preventing arrhythmias, Open Heart, 10.1136/openhrt-2018-000904, 7:1, (e000904), Online publication date: 1-Feb-2020.

Mach F, Baigent C, Catapano A, Koskinas K, Casula M, Badimon L, Chapman M, De Backer G, Delgado V, Ference B, Graham I, Halliday A, Landmesser U, Mihaylova B, Pedersen T, Riccardi G, Richter D, Sabatine M, Taskinen M, Tokgozoglu L, Wiklund O, Mueller C, Drexel H, Aboyans V, Corsini A, Doehner W, Farnier M, Gigante B, Kayikcioglu M, Krstacic G, Lambrinou E, Lewis B, Masip J, Moulin P, Petersen S, Petronio A, Piepoli M, Pintó X, Räber L, Ray K, Reiner Ž, Riesen W, Roffi M, Schmid J, Shlyakhto E, Simpson I, Stroes E, Sudano I, Tselepis A, Viigimaa M, Vindis C, Vonbank A, Vrablik M, Vrsalovic M, Zamorano J, Collet J, Koskinas K, Casula M, Badimon L, John Chapman M, De Backer G, Delgado V, Ference B, Graham I, Halliday A, Landmesser U, Mihaylova B, Pedersen T, Riccardi G, Richter D, Sabatine M, Taskinen M, Tokgozoglu L, Wiklund O, Windecker S, Aboyans V, Baigent C, Collet J, Dean V, Delgado V, Fitzsimons D, Gale C, Grobbee D, Halvorsen S, Hindricks G, Iung B, Jüni P, Katus H, Landmesser U, Leclercq C, Lettino M, Lewis B, Merkely B, Mueller C, Petersen S, Petronio A, Richter D, Roffi M, Shlyakhto E, Simpson I, Sousa-Uva M, Touyz R, Nibouche D, Zelveian P, Siostrzonek P, Najafov R, van de Borne P, Pojskic B, Postadzhiyan A, Kypris L, Špinar J, Larsen M, Eldin H, Viigimaa M, Strandberg T, Ferrières J, Agladze R, Laufs U, Rallidis L, Bajnok L, Gudjónsson T, Maher V, Henkin Y, Gulizia M, Mussagaliyeva A, Bajraktari G, Kerimkulova A, Latkovskis G, Hamoui O, Slapikas R, Visser L, Dingli P, Ivanov V, Boskovic A, Nazzi M, Visseren F, Mitevska I, Retterstøl K, Jankowski P, Fontes-Carvalho R, Gaita D, Ezhov M, Foscoli M, Giga V, Pella D, Fras Z, de Isla L, Hagström E, Lehmann R, Abid L, Ozdogan O, Mitchenko O and Patel R (2019) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, European Heart Journal, 10.1093/eurheartj/ehz455, 41:1, (111-188), Online publication date: 1-Jan-2020.

Nowicki J, Paul C, Schauss A and Pizzorno J (2020) Fish Oils and Omega-3 Fatty Acids Textbook of Natural Medicine, 10.1016/B978-0-323-43044-9.00080-7, (593-612.e8), .

Tappia P and Shah A (2020) Sex Differences in Response to Fatty Acids in Cardiovascular Health and Disease Sex Differences in Heart Disease, 10.1007/978-3-030-58677-5_11, (191-202), .

Okada M, Hirata A, Kashiwase K, Nakanishi H, Amiya R, Ueda Y, Higuchi Y and Sakata Y (2019) Impact of Preprocedural Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio on Post-Ablation Recurrence of Atrial Fibrillation, International Heart Journal, 10.1536/ihj.19-329, 60:6, (1334-1343), Online publication date: 30-Nov-2019.

Lilleberg H, Cichosz S, Svensson M, Christensen J, Fleischer J, Eide I and Jenssen T (2019) The Effect of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability in Renal Transplant Recipients: A Randomized Controlled Trial, Nutrients, 10.3390/nu11122847, 11:12, (2847)

Izumida S, Kawano H, Muroya T, Motokawa T, Akashi R, Yonekura T, Morimoto Y, Yano Y, Ikeda S and Maemura K (2019) The Relationship between Circulating Polyunsaturated Fatty Acid Levels and Exercise Responses of Patients with Non-ischemic Heart Failure, Internal Medicine, 10.2169/internalmedicine.2849-19, 58:22, (3219-3225), Online publication date: 15-Nov-2019.

Harris W and Zotor F (2019) n -3 Fatty acids and risk for fatal coronary disease , Proceedings of the Nutrition Society, 10.1017/S0029665118002902, 78:4, (526-531), Online publication date: 1-Nov-2019.

Mach F, Baigent C, Catapano A, Koskinas K, Casula M, Badimon L, Chapman M, De Backer G, Delgado V, Ference B, Graham I, Halliday A, Landmesser U, Mihaylova B, Pedersen T, Riccardi G, Richter D, Sabatine M, Taskinen M, Tokgozoglu L, Wiklund O, Windecker S, Aboyans V, Baigent C, Collet J, Dean V, Delgado V, Fitzsimons D, Gale C, Grobbee D, Halvorsen S, Hindricks G, Iung B, Jüni P, Katus H, Landmesser U, Leclercq C, Lettino M, Lewis B, Merkely B, Mueller C, Petersen S, Petronio A, Richter D, Roffi M, Shlyakhto E, Simpson I, Sousa-Uva M, Touyz R, Nibouche D, Zelveian P, Siostrzonek P, Najafov R, van de Borne P, Pojskic B, Postadzhiyan A, Kypris L, Špinar J, Larsen M, Eldin H, Viigimaa M, Strandberg T, Ferrières J, Agladze R, Laufs U, Rallidis L, Bajnok L, Gudjónsson T, Maher V, Henkin Y, Gulizia M, Mussagaliyeva A, Bajraktari G, Kerimkulova A, Latkovskis G, Hamoui O, Slapikas R, Visser L, Dingli P, Ivanov V, Boskovic A, Nazzi M, Visseren F, Mitevska I, Retterstøl K, Jankowski P, Fontes-Carvalho R, Gaita D, Ezhov M, Foscoli M, Giga V, Pella D, Fras Z, Perez de Isla L, Hagström E, Lehmann R, Abid L, Ozdogan O, Mitchenko O and Patel R (2019) 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk, Atherosclerosis, 10.1016/j.atherosclerosis.2019.08.014, 290, (140-205), Online publication date: 1-Nov-2019.

Tummala R, Ghosh R, Jain V, Devanabanda A, Bandyopadhyay D, Deedwania P and Aronow W (2019) Fish Oil and Cardiometabolic Diseases: Recent Updates and Controversies, The American Journal of Medicine, 10.1016/j.amjmed.2019.04.027, 132:10, (1153-1159), Online publication date: 1-Oct-2019.

Mooradian A (2019) Evidence-Based Cardiovascular Risk Management in Diabetes, American Journal of Cardiovascular Drugs, 10.1007/s40256-019-00336-6, 19:5, (439-448), Online publication date: 1-Oct-2019.

Hande L, Thunhaug H, Enebakk T, Ludviksen J, Pettersen K, Hovland A and Lappegård K (2019) Addition of marine omega-3 fatty acids to statins in familial hypercholesterolemia does not affect in vivo or in vitro endothelial function, Journal of Clinical Lipidology, 10.1016/j.jacl.2019.08.004, 13:5, (762-770), Online publication date: 1-Sep-2019.

Block R, Liu L, Herrington D, Huang S, Tsai M, O’Connell T and Shearer G (2019) Predicting Risk for Incident Heart Failure With Omega-3 Fatty Acids, JACC: Heart Failure, 10.1016/j.jchf.2019.03.008, 7:8, (651-661), Online publication date: 1-Aug-2019.

Darwesh A, Sosnowski D, Lee T, Keshavarz-Bahaghighat H and Seubert J (2019) Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system, Chemico-Biological Interactions, 10.1016/j.cbi.2019.04.037, 308, (20-44), Online publication date: 1-Aug-2019.

Colussi G, Catena C, Fagotto V, Darsiè D, Brosolo G, Bertin N and Sechi L (2018) Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids, Critical Reviews in Food Science and Nutrition, 10.1080/10408398.2018.1434126, 59:12, (1937-1948), Online publication date: 4-Jul-2019.

Schwenger K, Arendt B, Smieja M, Ma D, Smaill F and Allard J (2019) Relationships between Atherosclerosis and Plasma Antioxidant Micronutrients or Red Blood Cell Polyunsaturated Fatty Acids in People Living with HIV, Nutrients, 10.3390/nu11061292, 11:6, (1292)

Darwesh A, Jamieson K, Wang C, Samokhvalov V and Seubert J (2019) Cardioprotective effects of CYP-derived epoxy metabolites of docosahexaenoic acid involve limiting NLRP3 inflammasome activation, Canadian Journal of Physiology and Pharmacology, 10.1139/cjpp-2018-0480, 97:6, (544-556), Online publication date: 1-Jun-2019.

Agyei D, Akanbi T and Oey I (2019) Enzymes for Use in Functional Foods Enzymes in Food Biotechnology, 10.1016/B978-0-12-813280-7.00009-8, (129-147), .

Streja E and Streja D (2019) Drugs for Treatment of Dyslipidemia Available in the USA Endocrine Disorders in Kidney Disease, 10.1007/978-3-319-97765-2_13, (171-195), .

Toth P (2019) Management of Dyslipidemia Comprehensive Cardiovascular Medicine in the Primary Care Setting, 10.1007/978-3-319-97622-8_3, (39-69), .

DePace N and Colombo J (2019) Omega-3 Fatty Acids (Prong-1) Clinical Autonomic and Mitochondrial Disorders, 10.1007/978-3-030-17016-5_3, (37-70), .

Ramji D (2018) Polyunsaturated Fatty Acids and Atherosclerosis: Insights from Pre‐Clinical Studies, European Journal of Lipid Science and Technology, 10.1002/ejlt.201800029, 121:1, Online publication date: 1-Jan-2019.

Yang F, Chen G, Ma M, Qiu N, Zhu L and Li J (2018) Fatty acids modulate the expression levels of key proteins for cholesterol absorption in Caco-2 monolayer, Lipids in Health and Disease, 10.1186/s12944-018-0675-y, 17:1, Online publication date: 1-Dec-2018.

Doyle R, Sadlier D and Godson C (2018) Pro-resolving lipid mediators: Agents of anti-ageing?, Seminars in Immunology, 10.1016/j.smim.2018.09.002, 40, (36-48), Online publication date: 1-Dec-2018.

Muroya T, Kawano H, Koga S, Ikeda S, Yamamoto F, Miwa T, Kohno Y and Maemura K (2018) Lower Circulating Omega-3 Polyunsaturated Fatty Acids Are Associated with Coronary Microvascular Dysfunction Evaluated by Hyperemic Microvascular Resistance in Patients with Stable Coronary Artery Disease, International Heart Journal, 10.1536/ihj.17-459, 59:6, (1194-1201), Online publication date: 30-Nov-2018.

Abdelhamid A, Brown T, Brainard J, Biswas P, Thorpe G, Moore H, Deane K, AlAbdulghafoor F, Summerbell C, Worthington H, Song F and Hooper L (2018) Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003177.pub4

Abdelhamid A, Martin N, Bridges C, Brainard J, Wang X, Brown T, Hanson S, Jimoh O, Ajabnoor S, Deane K, Song F and Hooper L (2018) Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012345.pub3

Yamashita S (2018) Lipid Management for Prevention of Atherosclerotic Cardiovascular Diseases 日本総合健診医学会　第46回大会・教育講演 1　動脈硬化性疾患予防のための脂質管理, Health Evaluation and Promotion, 10.7143/jhep.45.755, 45:6, (755-769), Online publication date: 10-Nov-2018.

Adili R, Hawley M and Holinstat M (2018) Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids, Prostaglandins & Other Lipid Mediators, 10.1016/j.prostaglandins.2018.09.005, 139, (10-18), Online publication date: 1-Nov-2018.

Sokoła-Wysoczańska E, Wysoczański T, Wagner J, Czyż K, Bodkowski R, Lochyński S and Patkowska-Sokoła B (2018) Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders—A Review, Nutrients, 10.3390/nu10101561, 10:10, (1561)

Sahebkar A, Simental-Mendía L, Mikhailidis D, Pirro M, Banach M, Sirtori C and Reiner Ž (2018) Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials, Annals of Medicine, 10.1080/07853890.2018.1511919, 50:7, (565-575), Online publication date: 3-Oct-2018.

De Caterina R and Madonna R (2018) Marine n-3 Fatty Acids and Vascular Disease, Journal of the American College of Cardiology, 10.1016/j.jacc.2018.07.044, 72:14, (1585-1588), Online publication date: 1-Oct-2018.

Al-Khatib S, Stevenson W, Ackerman M, Bryant W, Callans D, Curtis A, Deal B, Dickfeld T, Field M, Fonarow G, Gillis A, Granger C, Hammill S, Hlatky M, Joglar J, Kay G, Matlock D, Myerburg R and Page R (2018) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Journal of the American College of Cardiology, 10.1016/j.jacc.2017.10.054, 72:14, (e91-e220), Online publication date: 1-Oct-2018.

Al-Khatib S, Stevenson W, Ackerman M, Bryant W, Callans D, Curtis A, Deal B, Dickfeld T, Field M, Fonarow G, Gillis A, Granger C, Hammill S, Hlatky M, Joglar J, Kay G, Matlock D, Myerburg R and Page R (2018) 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, Heart Rhythm, 10.1016/j.hrthm.2017.10.036, 15:10, (e73-e189), Online publication date: 1-Oct-2018.

Alqarni A, Mcintyre K, Brown S, Meyer B and Mitchell T (2018) A High‐Throughput Method for the Analysis of Erythrocyte Fatty Acids and the Omega‐3 Index, Lipids, 10.1002/lipd.12108, 53:10, (1005-1015), Online publication date: 1-Oct-2018.

Al-Khatib S, Stevenson W, Ackerman M, Bryant W, Callans D, Curtis A, Deal B, Dickfeld T, Field M, Fonarow G, Gillis A, Granger C, Hammill S, Hlatky M, Joglar J, Kay G, Matlock D, Myerburg R and Page R (2018) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Circulation, 138:13, (e272-e391), Online publication date: 25-Sep-2018.

Shirooie S, Nabavi S, Dehpour A, Belwal T, Habtemariam S, Argüelles S, Sureda A, Daglia M, Tomczyk M, Sobarzo-Sanchez E, Xu S and Nabavi S (2018) Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?, Pharmacological Research, 10.1016/j.phrs.2018.07.004, 135, (37-48), Online publication date: 1-Sep-2018.

Schopfer F, Vitturi D, Jorkasky D and Freeman B (2018) Nitro-fatty acids: New drug candidates for chronic inflammatory and fibrotic diseases, Nitric Oxide, 10.1016/j.niox.2018.06.006, 79, (31-37), Online publication date: 1-Sep-2018.

Rantanen J, Schmidt E, Riahi S, Lundbye-Christensen S and Christensen J (2018) Marine n -3 PUFA, heart rate variability and ventricular arrhythmias in patients on chronic dialysis: a cross-sectional study , British Journal of Nutrition, 10.1017/S0007114518001010, 120:3, (317-325), Online publication date: 14-Aug-2018.

Abdelhamid A, Martin N, Bridges C, Brainard J, Wang X, Brown T, Hanson S, Jimoh O, Ajabnoor S, Deane K, Song F and Hooper L (2018) Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD012345.pub2

Abdelhamid A, Brown T, Brainard J, Biswas P, Thorpe G, Moore H, Deane K, AlAbdulghafoor F, Summerbell C, Worthington H, Song F and Hooper L (2018) Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003177.pub3

Desnoyers M, Gilbert K and Rousseau G (2018) Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids: Dichotomy between Experimental and Clinical Studies, Marine Drugs, 10.3390/md16070234, 16:7, (234)

Alfaidi M, Chamberlain J, Rothman A, Crossman D, Villa‐Uriol M, Hadoke P, Wu J, Schenkel T, Evans P and Francis S (2018) Dietary Docosahexaenoic Acid Reduces Oscillatory Wall Shear Stress, Atherosclerosis, and Hypertension, Most Likely Mediated via an IL‐1–Mediated Mechanism, Journal of the American Heart Association, 7:13, Online publication date: 3-Jul-2018.

Alfaddagh A, Elajami T, Saleh M, Elajami M, Bistrian B and Welty F (2018) The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial, Journal of Clinical Lipidology, 10.1016/j.jacl.2018.03.080, 12:4, (937-947.e2), Online publication date: 1-Jul-2018.

Mason R, Dawoud H, Jacob R, Sherratt S and Malinski T (2018) Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2018.04.118, 103, (1231-1237), Online publication date: 1-Jul-2018.

Hidayat K, Yang J, Zhang Z, Chen G, Qin L, Eggersdorfer M and Zhang W (2017) Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials, European Journal of Clinical Nutrition, 10.1038/s41430-017-0052-3, 72:6, (805-817), Online publication date: 1-Jun-2018.

Thomas S, Browne H, Mobasheri A and Rayman M (2018) What is the evidence for a role for diet and nutrition in osteoarthritis?, Rheumatology, 10.1093/rheumatology/key011, 57:suppl_4, (iv61-iv74), Online publication date: 1-May-2018.

Harris W, Tintle N, Etherton M and Vasan R (2018) Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study, Journal of Clinical Lipidology, 10.1016/j.jacl.2018.02.010, 12:3, (718-727.e6), Online publication date: 1-May-2018.

Hashimoto T, Ako J, Nakao K, Ozaki Y, Kimura K, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Ohshima S, Nakai M, Nishimura K, Miyamoto Y, Ogawa H and Ishihara M (2017) A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudy, Heart and Vessels, 10.1007/s00380-017-1084-2, 33:5, (481-488), Online publication date: 1-May-2018.

Scolaro B, Soo Jin Kim H and de Castro I (2017) Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention, Critical Reviews in Food Science and Nutrition, 10.1080/10408398.2016.1235546, 58:6, (958-971), Online publication date: 13-Apr-2018.

Sadler M (2017) A review of economic evaluations for beneficial health outcomes of micronutrient and long-chain omega-3 fatty acid supplementation, International Journal of Food Sciences and Nutrition, 10.1080/09637486.2017.1365825, 69:3, (262-282), Online publication date: 3-Apr-2018.

Zhang Z, Fulgoni V, Kris-Etherton P and Mitmesser S (2018) Dietary Intakes of EPA and DHA Omega-3 Fatty Acids among US Childbearing-Age and Pregnant Women: An Analysis of NHANES 2001–2014, Nutrients, 10.3390/nu10040416, 10:4, (416)

Schunck W, Konkel A, Fischer R and Weylandt K (2018) Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2017.10.016, 183, (177-204), Online publication date: 1-Mar-2018.

Calder P (2017) Very long-chain n -3 fatty acids and human health: fact, fiction and the future , Proceedings of the Nutrition Society, 10.1017/S0029665117003950, 77:1, (52-72), Online publication date: 1-Feb-2018.

Anagnostis P, Paschou S, Goulis D, Athyros V and Karagiannis A (2018) Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?, Maturitas, 10.1016/j.maturitas.2017.11.011, 108, (45-52), Online publication date: 1-Feb-2018.

Singh M, Kanoujia J, Parashar P, Arya M, Tripathi C, Sinha V, Saraf S and Saraf S (2017) Augmented bioavailability of felodipine through an α-linolenic acid-based microemulsion, Drug Delivery and Translational Research, 10.1007/s13346-017-0453-9, 8:1, (204-225), Online publication date: 1-Feb-2018.

Steffens W (2018) Fish: important source of essential fatty acids for human nutrition, Journal of Aquaculture & Marine Biology, 10.15406/jamb.2018.07.00223, 7:6, (223)

Mitrani R, Ilkhanoff L and Goldberger J (2018) Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death Cardiac Electrophysiology: From Cell to Bedside, 10.1016/B978-0-323-44733-1.00114-0, (1084-1091), .

Hussein A and Chung M (2018) Prevention of Sudden Cardiac Death Chronic Coronary Artery Disease, 10.1016/B978-0-323-42880-4.00022-4, (321-336), .

Capurso A, Crepaldi G and Capurso C (2018) Fish Benefits of the Mediterranean Diet in the Elderly Patient, 10.1007/978-3-319-78084-9_13, (325-352), .

Nakamura A and Kawaharada R (2018) Fish Oil and Cardiac Akt/mTOR-Mediated Insulin Resistance in Infants with Maternal Diabetes Nutrition and Diet in Maternal Diabetes, 10.1007/978-3-319-56440-1_14, (161-174), .

Ouchi S, Miyazaki T, Shimada K, Sugita Y, Shimizu M, Murata A, Kato T, Aikawa T, Suda S, Shiozawa T, Hiki M, Takahashi S, Kasai T, Miyauchi K and Daida H (2017) Decreased circulating dihomo-gamma-linolenic acid levels are associated with total mortality in patients with acute cardiovascular disease and acute decompensated heart failure, Lipids in Health and Disease, 10.1186/s12944-017-0542-2, 16:1, Online publication date: 1-Dec-2017.

Pirillo A, Norata G and Catapano A (2017) Strategies for the use of nonstatin therapies, Current Opinion in Lipidology, 10.1097/MOL.0000000000000459, 28:6, (458-464), Online publication date: 1-Dec-2017.

Wu B, Mottola G, Schaller M, Upchurch G and Conte M (2017) Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications, Molecular Aspects of Medicine, 10.1016/j.mam.2017.07.005, 58, (72-82), Online publication date: 1-Dec-2017.

Sultan S, Murarka S, Jahangir A, Mookadam F, Tajik A and Jahangir A (2017) Vitamins for Cardiovascular Diseases, Cardiology in Review, 10.1097/CRD.0000000000000150, 25:6, (298-308), Online publication date: 1-Nov-2017.

Jamieson K, Endo T, Darwesh A, Samokhvalov V and Seubert J (2017) Cytochrome P450-derived eicosanoids and heart function, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2017.05.005, 179, (47-83), Online publication date: 1-Nov-2017.

Chilton F, Dutta R, Reynolds L, Sergeant S, Mathias R and Seeds M (2017) Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized Supplementation Approaches for the Prevention and Management of Human Diseases, Nutrients, 10.3390/nu9111165, 9:11, (1165)

Tong M, Wang J, Ji Y, Chen X, Wang J, Wang S, Ruan L, Cui H, Zhou Y, Zhang Q and Watanabe E (2017)(2017) Effect of eicosapentaenoic acid and pitavastatin on electrophysiology and anticoagulant gene expression in mice with rapid atrial pacing, Experimental and Therapeutic Medicine, 10.3892/etm.2017.4741, 14:3, (2310-2316), Online publication date: 1-Sep-2017.

Maki K, Palacios O, Bell M and Toth P (2017) Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps, Journal of Clinical Lipidology, 10.1016/j.jacl.2017.07.010, 11:5, (1152-1160.e2), Online publication date: 1-Sep-2017.

Volpe M, Volpe R, Gallo G, Presta V, Tocci G, Folco E, Peracino A, Tremoli E and Trimarco B (2017) 2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document, High Blood Pressure & Cardiovascular Prevention, 10.1007/s40292-017-0211-6, 24:3, (313-329), Online publication date: 1-Sep-2017.

Weisman D, Beinart R, Erez A, Koren-Morag N, Goldenberg I, Eldar M, Glikson M and Luria D (2017) Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-017-0267-1, 49:3, (255-261), Online publication date: 1-Sep-2017.

Ouchi S, Miyazaki T, Shimada K, Sugita Y, Shimizu M, Murata A, Kato T, Aikawa T, Suda S, Shiozawa T, Hiki M, Takahashi S, Iwata H, Kasai T, Miyauchi K and Daida H (2017) Low Docosahexaenoic Acid, Dihomo-Gamma-Linolenic Acid, and Arachidonic Acid Levels Associated with Long-Term Mortality in Patients with Acute Decompensated Heart Failure in Different Nutritional Statuses, Nutrients, 10.3390/nu9090956, 9:9, (956)

Shetreat-Klein M (2017) 19 Neurology and Nutrition Integrating Nutrition Into Practice, 10.1201/9781315100913-20, (419-438), Online publication date: 26-Aug-2017.

Watanabe Y and Tatsuno I (2017) Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future, Expert Review of Clinical Pharmacology, 10.1080/17512433.2017.1333902, 10:8, (865-873), Online publication date: 3-Aug-2017.

Hall W (2017) The future for long chain n -3 PUFA in the prevention of coronary heart disease: do we need to target non-fish-eaters? , Proceedings of the Nutrition Society, 10.1017/S0029665117000428, 76:3, (408-418), Online publication date: 1-Aug-2017.

Coronel R (2017) The pro- or antiarrhythmic actions of polyunsaturated fatty acids and of cholesterol, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2017.02.004, 176, (40-47), Online publication date: 1-Aug-2017.

Rizos E and Elisaf M (2017) Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?, Current Cardiology Reports, 10.1007/s11886-017-0856-8, 19:6, Online publication date: 1-Jun-2017.

Fiordelisi A, Piscitelli P, Trimarco B, Coscioni E, Iaccarino G and Sorriento D (2017) The mechanisms of air pollution and particulate matter in cardiovascular diseases, Heart Failure Reviews, 10.1007/s10741-017-9606-7, 22:3, (337-347), Online publication date: 1-May-2017.

Siscovick D, Barringer T, Fretts A, Wu J, Lichtenstein A, Costello R, Kris-Etherton P, Jacobson T, Engler M, Alger H, Appel L and Mozaffarian D (2017) Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease, Circulation, 135:15, (e867-e884), Online publication date: 11-Apr-2017.

Elinder F and Liin S (2017) Actions and Mechanisms of Polyunsaturated Fatty Acids on Voltage-Gated Ion Channels, Frontiers in Physiology, 10.3389/fphys.2017.00043, 8

O'Connell T, Block R, Huang S and Shearer G (2017) ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4, Journal of Molecular and Cellular Cardiology, 10.1016/j.yjmcc.2016.12.003, 103, (74-92), Online publication date: 1-Feb-2017.

Sakamoto A, Saotome M, Hasan P, Satoh T, Ohtani H, Urushida T, Katoh H, Satoh H and Hayashi H (2017) Eicosapentaenoic acid ameliorates palmitate-induced lipotoxicity via the AMP kinase/dynamin-related protein-1 signaling pathway in differentiated H9c2 myocytes, Experimental Cell Research, 10.1016/j.yexcr.2017.01.004, 351:1, (109-120), Online publication date: 1-Feb-2017.

Takashima A and Sata M (2017) 4. Omega-3 Polyunsaturated Fatty Acid Reduces the Risk of Cardiovascular Events in the Patients with Ischemic Heart Disease 4．ω3系不飽和脂肪酸製剤による心血管二次予防のエビデンス, Nihon Naika Gakkai Zasshi, 10.2169/naika.106.226, 106:2, (226-231), .

Harris W, Luo J, Pottala J, Espeland M, Margolis K, Manson J, Wang L, Brasky T and Robinson J (2017) Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study, Journal of Clinical Lipidology, 10.1016/j.jacl.2016.12.013, 11:1, (250-259.e5), Online publication date: 1-Jan-2017.

Mason R and Jacob R (2017) Effects of Oxidative Stress, Hyperglycemia, and Hypercholesterolemia on Membrane Structural Organization and the Interactions of Omega-3 Fatty Acids Membrane Organization and Dynamics, 10.1007/978-3-319-66601-3_3, (31-47), .

Wong W and Cooke J (2017) Nutritional Impact on the Nitric Oxide Pathway Nitrite and Nitrate in Human Health and Disease, 10.1007/978-3-319-46189-2_9, (111-128), .

Liu X, Pang D, Yuan T, Li Z, Li Z, Zhang M, Ren W, Ouyang H and Tang X (2016) N-3 polyunsaturated fatty acids attenuates triglyceride and inflammatory factors level in hfat-1 transgenic pigs, Lipids in Health and Disease, 10.1186/s12944-016-0259-7, 15:1, Online publication date: 1-Dec-2016.

Nahab F, Pearson K, Frankel M, Ard J, Safford M, Kleindorfer D, Howard V and Judd S (2016) Dietary fried fish intake increases risk of CVD: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study, Public Health Nutrition, 10.1017/S136898001600152X, 19:18, (3327-3336), Online publication date: 1-Dec-2016.

Watanabe S, Yoshihisa A, Kanno Y, Takiguchi M, Yokokawa T, Sato A, Miura S, Shimizu T, Abe S, Sato T, Suzuki S, Oikawa M, Sakamoto N, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh S and Takeishi Y (2016) Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients, Journal of Cardiac Failure, 10.1016/j.cardfail.2016.04.017, 22:12, (962-969), Online publication date: 1-Dec-2016.

Mason R, Jacob R, Shrivastava S, Sherratt S and Chattopadhyay A (2016) Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes, Biochimica et Biophysica Acta (BBA) - Biomembranes, 10.1016/j.bbamem.2016.10.002, 1858:12, (3131-3140), Online publication date: 1-Dec-2016.

Nagai T, Honda Y, Sugano Y, Nishimura K, Nakai M, Honda S, Iwakami N, Okada A, Asaumi Y, Aiba T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T and Taniyama Y (2016) Circulating Omega-6, But Not Omega-3 Polyunsaturated Fatty Acids, Are Associated with Clinical Outcomes in Patients with Acute Decompensated Heart Failure, PLOS ONE, 10.1371/journal.pone.0165841, 11:11, (e0165841)

Kim J, Yin T, Shinozaki K, Lampe J and Becker L (2016) DHA-supplemented diet increases the survival of rats following asphyxia-induced cardiac arrest and cardiopulmonary bypass resuscitation, Scientific Reports, 10.1038/srep36545, 6:1

Asztalos I, Gleason J, Sever S, Gedik R, Asztalos B, Horvath K, Dansinger M, Lamon-Fava S and Schaefer E (2016) Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial, Metabolism, 10.1016/j.metabol.2016.07.010, 65:11, (1636-1645), Online publication date: 1-Nov-2016.

Jenkins N, Housh T, Miramonti A, McKay B, Yeo N, Smith C, Hill E, Cochrane K and Cramer J (2016) Effects of rumenic acid rich conjugated linoleic acid supplementation on cognitive function and handgrip performance in older men and women, Experimental Gerontology, 10.1016/j.exger.2016.08.004, 84, (1-11), Online publication date: 1-Nov-2016.

Takashima A, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Taketani Y, Shimabukuro M and Sata M (2016) Combination of n-3 polyunsaturated fatty acids reduces atherogenesis in apolipoprotein E-deficient mice by inhibiting macrophage activation, Atherosclerosis, 10.1016/j.atherosclerosis.2016.10.002, 254, (142-150), Online publication date: 1-Nov-2016.

Bowen K, Harris W and Kris-Etherton P (2016) Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-016-0487-1, 18:11, Online publication date: 1-Nov-2016.

Schaefer M, Schaefer C, Schifferings S, Kuhlmann C, Urban A, Benscheid U, Fischer T, Hecker M, Morty R, Vadasz I, Herold S, Witzenrath M, Seeger W, Erdogan A and Mayer K (2016) N-3 vs. n-6 fatty acids differentially influence calcium signalling and adhesion of inflammatory activated monocytes: impact of lipid rafts, Inflammation Research, 10.1007/s00011-016-0971-9, 65:11, (881-894), Online publication date: 1-Nov-2016.

Catapano A, Graham I, De Backer G, Wiklund O, Chapman M, Drexel H, Hoes A, Jennings C, Landmesser U, Pedersen T, Reiner Ž, Riccardi G, Taskinen M, Tokgozoglu L, Verschuren W, Vlachopoulos C, Wood D and Zamorano J (2016) 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias, European Heart Journal, 10.1093/eurheartj/ehw272, 37:39, (2999-3058), Online publication date: 14-Oct-2016.

Ruiz-Núñez B, Dijck-Brouwer D and Muskiet F (2016) The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease, The Journal of Nutritional Biochemistry, 10.1016/j.jnutbio.2015.12.007, 36, (1-20), Online publication date: 1-Oct-2016.

Morishita T, Uzui H, Ikeda H, Amaya N, Kaseno K, Ishida K, Fukuoka Y, Lee J and Tada H (2016) Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease, International Journal of Cardiology, 10.1016/j.ijcard.2016.07.079, 221, (1039-1042), Online publication date: 1-Oct-2016.

Catapano A, Graham I, De Backer G, Wiklund O, Chapman M, Drexel H, Hoes A, Jennings C, Landmesser U, Pedersen T, Reiner Ž, Riccardi G, Taskinen M, Tokgozoglu L, Verschuren W, Vlachopoulos C, Wood D and Zamorano J (2016) 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias, Atherosclerosis, 10.1016/j.atherosclerosis.2016.08.018, 253, (281-344), Online publication date: 1-Oct-2016.

Schunck W (2016) EPA and/or DHA? A test question on the principles and opportunities in utilizing the therapeutic potential of omega-3 fatty acids, Journal of Lipid Research, 10.1194/jlr.C071084, 57:9, (1608-1611), Online publication date: 1-Sep-2016.

Harris W, Masson S, Barlera S, Milani V, Pileggi S, Franzosi M, Marchioli R, Tognoni G, Tavazzi L and Latini R (2016) Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Heart Failure trial, Nutrition Research, 10.1016/j.nutres.2016.06.012, 36:9, (989-994), Online publication date: 1-Sep-2016.

Soran H, Schofield J, Adam S and Durrington P (2016) Diabetic dyslipidaemia, Current Opinion in Lipidology, 10.1097/MOL.0000000000000318, 27:4, (313-322), Online publication date: 1-Aug-2016.

Auger C, Said A, Nguyen P, Chabert P, Idris-Khodja N and Schini-Kerth V (2016) Potential of Food and Natural Products to Promote Endothelial and Vascular Health, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000382, 68:1, (11-18), Online publication date: 1-Jul-2016.

Glück T and Alter P (2016) Marine omega-3 highly unsaturated fatty acids: From mechanisms to clinical implications in heart failure and arrhythmias, Vascular Pharmacology, 10.1016/j.vph.2016.03.007, 82, (11-19), Online publication date: 1-Jul-2016.

Todoroki K, Ikeya Y, Fukui S, Tanaka C, Sekine K, Shizuma T, Fukuyama N and Mori H (2016) Nutrition-dependent eicosapentaenoic acid deficiency in care house residents, Nutrition, 10.1016/j.nut.2016.01.025, 32:7-8, (806-810), Online publication date: 1-Jul-2016.

Bonilla I, Nishijima Y, Vargas-Pinto P, Baine S, Sridhar A, Li C, Billman G and Carnes C (2016) Chronic Omega-3 Polyunsaturated Fatty Acid Treatment Variably Affects Cellular Repolarization in a Healed Post-MI Arrhythmia Model, Frontiers in Physiology, 10.3389/fphys.2016.00225, 7

Schofield J, Liu Y, Rao-Balakrishna P, Malik R and Soran H (2016) Diabetes Dyslipidemia, Diabetes Therapy, 10.1007/s13300-016-0167-x, 7:2, (203-219), Online publication date: 1-Jun-2016.

Steffens W (2015) Aquaculture produces wholesome food: cultured fish as a valuable source of n-3 fatty acids, Aquaculture International, 10.1007/s10499-015-9885-8, 24:3, (787-802), Online publication date: 1-Jun-2016.

Bernardi D, Bertol T, Pflanzer S, Sgarbieri V and Pollonio M (2016) ω-3 in meat products: benefits and effects on lipid oxidative stability, Journal of the Science of Food and Agriculture, 10.1002/jsfa.7559, 96:8, (2620-2634), Online publication date: 1-Jun-2016.

Krummen D, Ho G, Villongco C, Hayase J and Schricker A (2016) Ventricular fibrillation: triggers, mechanisms and therapies, Future Cardiology, 10.2217/fca-2016-0001, 12:3, (373-390), Online publication date: 1-May-2016.

Rice H, Bernasconi A, Maki K, Harris W, von Schacky C and Calder P (2016) Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2016.01.003, 107, (30-42), Online publication date: 1-Apr-2016.

Sun Y, Koh W, Yuan J, Choi H, Su J, Ong C and van Dam R (2016) Plasma α-Linolenic and Long-Chain ω-3 Fatty Acids Are Associated with a Lower Risk of Acute Myocardial Infarction in Singapore Chinese Adults, The Journal of Nutrition, 10.3945/jn.115.220418, 146:2, (275-282), Online publication date: 1-Feb-2016.

Sperling L and Nelson J (2015) History and future of omega-3 fatty acids in cardiovascular disease, Current Medical Research and Opinion, 10.1185/03007995.2015.1120190, 32:2, (301-311), Online publication date: 1-Feb-2016.

Greene S, Temporelli P, Campia U, Vaduganathan M, Esposti L, Buda S, Veronesi C, Butler J and Nodari S (2016) Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction, The American Journal of Cardiology, 10.1016/j.amjcard.2015.10.050, 117:3, (340-346), Online publication date: 1-Feb-2016.

Lomivorotov V, Efremov S, Pokushalov E and Karaskov A (2016) New-Onset Atrial Fibrillation After Cardiac Surgery: Pathophysiology, Prophylaxis, and Treatment, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/j.jvca.2015.08.003, 30:1, (200-216), Online publication date: 1-Jan-2016.

Harris W, Kennedy K, Maddox T, Kutty S and Spertus J (2016) Multiple differences between patients who initiate fish oil supplementation post–myocardial infarction and those who do not: the TRIUMPH Study, Nutrition Research, 10.1016/j.nutres.2015.11.006, 36:1, (65-71), Online publication date: 1-Jan-2016.

D'Avanzo N (2016) Lipid Regulation of Sodium Channels Na Channels from Phyla to Function, 10.1016/bs.ctm.2016.04.003, (353-407), .

Robinson V and Kowey P (2016) The Use of Omega-3 Polyunsaturated Fatty Acids ( n -3 PUFAs) in Atrial Fibrillation Handbook of Lipids in Human Function, 10.1016/B978-1-63067-036-8.00009-3, (181-206), .

Batchu S, Chaudhary K, Zlobine I, Pawa J and Seubert J (2016) Fatty Acids and Cardiac Ischemia Reperfusion Injury Handbook of Lipids in Human Function, 10.1016/B978-1-63067-036-8.00003-2, (39-83), .

(2016) Fish oils Meyler's Side Effects of Drugs, 10.1016/B978-0-444-53717-1.00746-0, (323-325), .

Harris W and von Schacky C (2016) Omega-3 Fatty Acids and Risk for Cardiovascular Disease Fish and Fish Oil in Health and Disease Prevention, 10.1016/B978-0-12-802844-5.00018-X, (199-205), .

Stanley J and Preetha G (2016) Pesticide Toxicity to Fishes: Exposure, Toxicity and Risk Assessment Methodologies Pesticide Toxicity to Non-target Organisms, 10.1007/978-94-017-7752-0_7, (411-497), .

Tamargo J and Tamargo M (2016) Pharmacokinetics and Safety Profile of Omega-3 Polyunsaturated Fatty Acids Omega-3 Fatty Acids, 10.1007/978-3-319-40458-5_39, (541-584), .

Peter S and Jacob J (2016) Role of Omega-3 Fatty Acids in Cardiovascular Disorders Omega-3 Fatty Acids, 10.1007/978-3-319-40458-5_37, (513-530), .

Lee S, Yi Y and Tak Y (2016) Effects of Omega-3 Fatty Acids in Myocardial Infarction Omega-3 Fatty Acids, 10.1007/978-3-319-40458-5_33, (465-473), .

Wen Y and Gao Q (2016) Role of Omega-3 Fatty Acid in Major Cardiovascular Events—A Current View Omega-3 Fatty Acids, 10.1007/978-3-319-40458-5_25, (301-305), .

Moyad M (2016) The Ideal 7-Step Breast Cancer Diet, Lifestyle, and Dietary Supplements Program for Prevention/Recurrence: Heart Healthy = Breast Healthy! Integrative Medicine for Breast Cancer, 10.1007/978-3-319-23422-9_3, (69-140), .

Dallongeville J (2015) Histoire critique des recommandations nutritionnelles : l’exemple des lipides et des maladies cardiovasculaires, Cahiers de Nutrition et de Diététique, 10.1016/S0007-9960(15)30017-1, 50:6, (6S42-6S49), Online publication date: 1-Dec-2015.

Alpers D and Cashman K (2015) General Nutritional Principles Yamada' s Textbook of Gastroenterology, 10.1002/9781118512074.ch27, (497-527), Online publication date: 27-Nov-2015.

Harris W (2015) Pushing the limits with omega-3 fatty acids, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2015.03.008, 25:8, (724-725), Online publication date: 1-Nov-2015.

Kiage J, Sampson U, Lipworth L, Fazio S, Mensah G, Yu Q, Munro H, Akwo E, Dai Q, Blot W and Kabagambe E (2015) Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2015.07.006, 25:11, (1016-1024), Online publication date: 1-Nov-2015.

Jacobson T, Maki K, Orringer C, Jones P, Kris-Etherton P, Sikand G, La Forge R, Daniels S, Wilson D, Morris P, Wild R, Grundy S, Daviglus M, Ferdinand K, Vijayaraghavan K, Deedwania P, Aberg J, Liao K, McKenney J, Ross J, Braun L, Ito M, Bays H and Brown W (2015) National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2, Journal of Clinical Lipidology, 10.1016/j.jacl.2015.09.002, 9:6, (S1-S122.e1), Online publication date: 1-Nov-2015.

Gomez-Candela C, Roldan Puchalt M, Palma Milla S, Lopez Plaza B and Bermejo L (2015) The Role of Omega-3 Fatty Acids in Diets, Journal of the American College of Nutrition, 10.1080/07315724.2015.1080111, 34:sup1, (42-47), Online publication date: 15-Sep-2015.

Athyros V, Tziomalos K and Karagiannis A (2015) Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy, Expert Review of Cardiovascular Therapy, 10.1586/14779072.2015.1072047, 13:9, (1059-1066), Online publication date: 2-Sep-2015.

Calder P (2015) Functional Roles of Fatty Acids and Their Effects on Human Health, Journal of Parenteral and Enteral Nutrition, 10.1177/0148607115595980, 39:1S, Online publication date: 1-Sep-2015.

Roy J, Oger C, Thireau J, Roussel J, Mercier-Touzet O, Faure D, Pinot E, Farah C, Taber D, Cristol J, Lee J, Lacampagne A, Galano J, Durand T and Le Guennec J (2015) Nonenzymatic lipid mediators, neuroprostanes, exert the antiarrhythmic properties of docosahexaenoic acid, Free Radical Biology and Medicine, 10.1016/j.freeradbiomed.2015.04.014, 86, (269-278), Online publication date: 1-Sep-2015.

Shetreat-Klein M (2015) Neurology and Nutrition Integrative Nutrition Therapy, 10.1201/b18833-20, (419-438), Online publication date: 26-Aug-2015.

Arakawa K, Himeno H, Kirigaya J, Otomo F, Matsushita K, Nakahashi H, Shimizu S, Nitta M, Yano H, Endo M, Kimura K and Umemura S (2015) Impact of n-3 polyunsaturated fatty acids in predicting ischemia/reperfusion injury and progression of myocardial damage after reperfusion in patients with ST-segment elevation acute myocardial infarction, Journal of Cardiology, 10.1016/j.jjcc.2015.03.009, 66:2, (101-107), Online publication date: 1-Aug-2015.

McLennan P and Pepe S (2015) Weighing Up Fish and Omega-3 PUFA Advice with Accurate, Balanced Scales: Stringent Controls and Measures Required for Clinical Trials, Heart, Lung and Circulation, 10.1016/j.hlc.2015.06.825, 24:8, (740-743), Online publication date: 1-Aug-2015.

Kones R and Rumana U (2015) Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs, Drugs, 10.1007/s40265-015-0429-3, 75:11, (1201-1228), Online publication date: 1-Jul-2015.

Savinova O, Fillaus K, Harris W and Shearer G (2015) Effects of niacin and omega-3 fatty acids on the apolipoproteins in overweight patients with elevated triglycerides and reduced HDL cholesterol, Atherosclerosis, 10.1016/j.atherosclerosis.2015.04.793, 240:2, (520-525), Online publication date: 1-Jun-2015.

Sikand G, Kris-Etherton P and Boulos N (2015) Impact of Functional Foods on Prevention of Cardiovascular Disease and Diabetes, Current Cardiology Reports, 10.1007/s11886-015-0593-9, 17:6, Online publication date: 1-Jun-2015.

Ruiz-Núñez B, van den Hurk G, de Vries J, Mariani M, de Jongste M, Dijck-Brouwer D and Muskiet F (2015) Patients undergoing elective coronary artery bypass grafting exhibit poor pre-operative intakes of fruit, vegetables, dietary fibre, fish and vitamin D, British Journal of Nutrition, 10.1017/S0007114515000434, 113:9, (1466-1476), Online publication date: 14-May-2015.

Derosa G and Maffioli P (2014) Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice, Expert Review of Endocrinology & Metabolism, 10.1586/17446651.2015.995630, 10:3, (297-304), Online publication date: 4-May-2015.

Cao Y, Lu L, Liang J, Liu M, Li X, Sun R, Zheng Y and Zhang P (2014) Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease, Cell Biochemistry and Biophysics, 10.1007/s12013-014-0407-5, 72:1, (77-81), Online publication date: 1-May-2015.

Scorza F, Cavalheiro E, de Almeida A, Scorza C, Nejm M and Cysneiros R (2015) Omega-3 Fatty Acids and Sudden Unexpected Death in Epilepsy: A Translational Approach Sudden Unexpected Death in Epilepsy, 10.1201/b18304-31, (269-274), Online publication date: 8-Apr-2015.

Serhan C, Dalli J, Colas R, Winkler J and Chiang N (2015) Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 10.1016/j.bbalip.2014.08.006, 1851:4, (397-413), Online publication date: 1-Apr-2015.

Oliver M (2014) Fatty acids and the risk of death during acute myocardial ischaemia, Clinical Science, 10.1042/CS20140404, 128:6, (349-355), Online publication date: 1-Mar-2015.

Moreno C, de la Cruz A, Oliveras A, Kharche S, Guizy M, Comes N, Starý T, Ronchi C, Rocchetti M, Baró I, Loussouarn G, Zaza A, Severi S, Felipe A and Valenzuela C (2014) Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains, Cardiovascular Research, 10.1093/cvr/cvu250, 105:2, (223-232), Online publication date: 1-Feb-2015., Online publication date: 1-Feb-2015.

Yamano T, Kubo T, Shiono Y, Shimamura K, Orii M, Tanimoto T, Matsuo Y, Ino Y, Kitabata H, Yamaguchi T, Hirata K, Tanaka A, Imanishi T and Akasaka T (2015) Impact of Eicosapentaenoic Acid Treatment on the Fibrous Cap Thickness in Patients with Coronary Atherosclerotic Plaque: An Optical Coherence Tomography Study, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.25593, 22:1, (52-61), .

Tsaregorodtsev D, Okisheva E, Gavva E, Grachev E, Sedov A and Sulimov V (2015) Effect of anti-arrhythmic drugs on non-invasive electrophysiologic indexes-predictors of sudden cardiac death, Kardiologiya i serdechno-sosudistaya khirurgiya, 10.17116/kardio20158157-64, 8:1, (57), .

Yessoufou A, Nekoua M, Gbankoto A, Mashalla Y and Moutairou K (2015) Beneficial Effects of Omega-3 Polyunsaturated Fatty Acids in Gestational Diabetes: Consequences in Macrosomia and Adulthood Obesity, Journal of Diabetes Research, 10.1155/2015/731434, 2015, (1-11), .

Vas Dias F (2015) Authorised EU health claims for DHA and EPA Foods, Nutrients and Food Ingredients with Authorised EU Health Claims: Volume 2, 10.1016/B978-1-78242-382-9.00013-X, (237-256), .

de Keizer L and Chow C (2015) Diet Modification After Acute Coronary Events Foods and Dietary Supplements in the Prevention and Treatment of Disease in Older Adults, 10.1016/B978-0-12-418680-4.00031-2, (323-334), .

Pounis G, Bonaccio M, Tuohy K, Donati M, de Gaetano G and Iacoviello L (2015) Population Level Divergence from the Mediterranean Diet and the Risk of Cancer and Metabolic Disease Diet-Microbe Interactions in the Gut, 10.1016/B978-0-12-407825-3.00014-9, (209-223), .

Maniar S and Bittner V (2015) Lifestyle Interventions for Primary and Secondary Prevention of Cardiovascular Disease PanVascular Medicine, 10.1007/978-3-642-37078-6_54, (1695-1718), .

Harris W (2015) n-3 and n-6 Fatty Acids Reduce Risk for Cardiovascular Disease Preventive Nutrition, 10.1007/978-3-319-22431-2_14, (255-271), .

Cipolletta L (2015) Sudden Cardiac Death Clinical Cases in Cardiology, 10.1007/978-3-319-19926-9_27, (311-324), .

Balogun K and Cheema S (2015) Cardioprotective Role of Omega-3 Polyunsaturated Fatty Acids Through the Regulation of Lipid Metabolism Pathophysiology and Pharmacotherapy of Cardiovascular Disease, 10.1007/978-3-319-15961-4_27, (563-588), .

Michael Allevato J and Allevato I (2015) The Effects of Diet in Hyperlipidemia Lipid Management, 10.1007/978-3-319-11161-2_7, (113-121), .

Goldberg S (2015) Non-Statin Treatment of Dyslipidemia Lipid Management, 10.1007/978-3-319-11161-2_12, (201-231), .

Schaefer E and Tani M (2015) Nutrition and Coronary Heart Disease Prevention Dyslipidemias, 10.1007/978-1-60761-424-1_19, (329-341), .

Florentin M, Kostapanos M, Kei A and Elisaf M (2014) Emerging drugs for hyperlipidaemia: an update, Expert Opinion on Emerging Drugs, 10.1517/14728214.2014.976553, 19:4, (471-488), Online publication date: 1-Dec-2014.

Laake K, Myhre P, Nordby L, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H and Solheim S (2014) Effects of omega 3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study, BMC Geriatrics, 10.1186/1471-2318-14-74, 14:1, Online publication date: 1-Dec-2014.

Dunbar B, Bosire R and Deckelbaum R (2014) Omega 3 and omega 6 fatty acids in human and animal health: An African perspective, Molecular and Cellular Endocrinology, 10.1016/j.mce.2014.10.009, 398:1-2, (69-77), Online publication date: 1-Dec-2014.

Fleming J and Kris-Etherton P (2014) The Evidence for α-Linolenic Acid and Cardiovascular Disease Benefits: Comparisons with Eicosapentaenoic Acid and Docosahexaenoic Acid, Advances in Nutrition, 10.3945/an.114.005850, 5:6, (863S-876S), Online publication date: 1-Nov-2014.

Wu S, Mayneris-Perxachs J, Lovegrove J, Todd S and Yaqoob P (2014) Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype, The American Journal of Clinical Nutrition, 10.3945/ajcn.114.088880, 100:5, (1232-1243), Online publication date: 1-Nov-2014.

Tatsuno I (2014) Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia, Expert Review of Cardiovascular Therapy, 10.1586/14779072.2014.971756, 12:11, (1261-1268), Online publication date: 1-Nov-2014.

Purcell R, Latham S, Botham K, Hall W and Wheeler-Jones C (2014) High-fat meals rich in EPA plus DHA compared with DHA only have differential effects on postprandial lipemia and plasma 8-isoprostane F2α concentrations relative to a control high–oleic acid meal: a randomized controlled trial, The American Journal of Clinical Nutrition, 10.3945/ajcn.114.091223, 100:4, (1019-1028), Online publication date: 1-Oct-2014.

Nigam A, Talajic M, Roy D, Nattel S, Lambert J, Nozza A, Jones P, Ramprasath V, O’Hara G, Kopecky S, Brophy J and Tardif J (2014) Fish Oil for the Reduction of Atrial Fibrillation Recurrence, Inflammation, and Oxidative Stress, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.07.956, 64:14, (1441-1448), Online publication date: 1-Oct-2014.

Doi M, Nosaka K, Miyoshi T, Iwamoto M, Kajiya M, Okawa K, Nakayama R, Takagi W, Takeda K, Hirohata S and Ito H (2014) Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study, International Journal of Cardiology, 10.1016/j.ijcard.2014.08.055, 176:3, (577-582), Online publication date: 1-Oct-2014.

Oh P, Koh K, Sakuma I, Lim S, Lee Y, Lee S, Lee K, Han S and Shin E (2014) Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia, International Journal of Cardiology, 10.1016/j.ijcard.2014.07.075, 176:3, (696-702), Online publication date: 1-Oct-2014.

Calder P (2014) Very long chain omega‐3 (n‐3) fatty acids and human health, European Journal of Lipid Science and Technology, 10.1002/ejlt.201400025, 116:10, (1280-1300), Online publication date: 1-Oct-2014.

Schrover I, Leiner T, Klomp D, Wijnen J, Uiterwaal C, Spiering W and Visseren F (2013) Feasibility and reproducibility of free fatty acid profiling in abdominal adipose tissue with 1 H‐magnetic resonance spectroscopy at 3 T: Differences between lean and obese individuals , Journal of Magnetic Resonance Imaging, 10.1002/jmri.24368, 40:2, (423-431), Online publication date: 1-Aug-2014.

Sanders T (2014) Plant compared with marine n–3 fatty acid effects on cardiovascular risk factors and outcomes: what is the verdict?, The American Journal of Clinical Nutrition, 10.3945/ajcn.113.071555, 100, (453S-458S), Online publication date: 1-Jul-2014.

Salakhutdinov N and Laev S (2014) Triglyceride-lowering agents, Bioorganic & Medicinal Chemistry, 10.1016/j.bmc.2014.05.008, 22:14, (3551-3564), Online publication date: 1-Jul-2014.

McLennan P (2014) Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids, European Journal of Applied Physiology, 10.1007/s00421-014-2876-z, 114:7, (1333-1356), Online publication date: 1-Jul-2014.

Fischer R, Konkel A, Mehling H, Blossey K, Gapelyuk A, Wessel N, von Schacky C, Dechend R, Muller D, Rothe M, Luft F, Weylandt K and Schunck W (2014) Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway, Journal of Lipid Research, 10.1194/jlr.M047357, 55:6, (1150-1164), Online publication date: 1-Jun-2014.

Kuratko C, Nolan C and Salem N (2014) Long-chain omega-3 fatty acids and cardiovascular health, Nutrafoods, 10.1007/s13749-014-0020-7, 13:2, (49-60), Online publication date: 1-Jun-2014.

Spindler S, Mote P and Flegal J (2014) Dietary supplementation with Lovaza and krill oil shortens the life span of long-lived F1 mice, AGE, 10.1007/s11357-014-9659-7, 36:3, Online publication date: 1-Jun-2014.

Wachira J, Larson M and Harris W (2014) n -3 Fatty acids affect haemostasis but do not increase the risk of bleeding: clinical observations and mechanistic insights , British Journal of Nutrition, 10.1017/S000711451300425X, 111:9, (1652-1662), Online publication date: 14-May-2014.

Roberts C (2014) Atherosclerosis Diet, Exercise, and Chronic Disease, 10.1201/b16783-5, (133-210), Online publication date: 14-Apr-2014.

(2014) Inflammation Diet, Exercise, and Chronic Disease, 10.1201/b16783-3, (15-99), Online publication date: 14-Apr-2014.

Bourre J (2014) À propos de l’effet additionnel des oméga 3 chez des patients cardiaques multimédiqués, Pratiques en nutrition, 10.1016/j.pranut.2014.03.010, 10:38, (40-43), Online publication date: 1-Apr-2014.

Skae M, Avatapalle H, Banerjee I, Rigby L, Vail A, Foster P, Charalambous C, Bowden L, Padidela R, Patel L, Ehtisham S, Cosgrove K, Dunne M and Clayton P (2014) Reduced Glycemic Variability in Diazoxide-Responsive Children with Congenital Hyperinsulinism Using Supplemental Omega-3-Polyunsaturated Fatty Acids; A Pilot Trial with MaxEPAR, Frontiers in Endocrinology, 10.3389/fendo.2014.00031, 5

Holdsworth C, Copp S, Hirai D, Ferguson S, Sims G, Hageman K, Stebbins C, Poole D and Musch T (2014) The effects of dietary fish oil on exercising skeletal muscle vascular and metabolic control in chronic heart failure rats, Applied Physiology, Nutrition, and Metabolism, 10.1139/apnm-2013-0301, 39:3, (299-307), Online publication date: 1-Mar-2014.

Brenyo A and Aktas M (2014) Review of Complementary and Alternative Medical Treatment of Arrhythmias, The American Journal of Cardiology, 10.1016/j.amjcard.2013.11.044, 113:5, (897-903), Online publication date: 1-Mar-2014.

von Schacky C (2014) Omega-3 Index and Cardiovascular Health, Nutrients, 10.3390/nu6020799, 6:2, (799-814)

Delmastro-Greenwood M, Freeman B and Wendell S (2014) Redox-Dependent Anti-Inflammatory Signaling Actions of Unsaturated Fatty Acids, Annual Review of Physiology, 10.1146/annurev-physiol-021113-170341, 76:1, (79-105), Online publication date: 10-Feb-2014.

Sanders T (2013) Protective effects of dietary PUFA against chronic disease: evidence from epidemiological studies and intervention trials, Proceedings of the Nutrition Society, 10.1017/S0029665113003789, 73:1, (73-79), Online publication date: 1-Feb-2014.

Augustine A, Lowenstein L, Harris W, Shearer G and Block R (2014) Treatment with omega-3 fatty acid ethyl-ester alters fatty acid composition of lipoproteins in overweight or obese adults with insulin resistance, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2013.12.003, 90:2-3, (69-75), Online publication date: 1-Feb-2014.

Ardashev A, Zhelyakov E and Kuzovlev O (2013) Antiarrhythmogenic effect of omega‐3 fatty acid ethyl esters in a patient treated with Omacor after a non‐Q‐wave myocardial infarction, Journal of Arrhythmia, 10.1016/j.joa.2013.04.008, 30:1, (71-74), Online publication date: 1-Feb-2014.

Fares H, Lavie C, DiNicolantonio J, O’Keefe J and Milani R (2014) Omega-3 Fatty Acids: A Growing Ocean of Choices, Current Atherosclerosis Reports, 10.1007/s11883-013-0389-6, 16:2, Online publication date: 1-Feb-2014.

NAGAOKA S (2014) Fat and Health, Oleoscience, 10.5650/oleoscience.14.237, 14:6, (237-242), .

Saita E, Kondo K and Momiyama Y (2015) Anti-Inflammatory Diet for Atherosclerosis and Coronary Artery Disease: Antioxidant Foods, Clinical Medicine Insights: Cardiology, 10.4137/CMC.S17071, 8s3, (CMC.S17071), Online publication date: 1-Jan-2014.

Kar S (2014) Omacor and Omega-3 Fatty Acids for Treatment of Coronary Artery Disease and the Pleiotropic Effects, American Journal of Therapeutics, 10.1097/MJT.0b013e31822b5603, 21:1, (56-66), Online publication date: 1-Jan-2014.

Monteiro J, Leslie M, Moghadasian M, Arendt B, Allard J and Ma D (2014) The role of n − 6 and n − 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease, Food & Function, 10.1039/c3fo60551e, 5:3, (426), .

Choque B, Catheline D, Rioux V and Legrand P (2014) Linoleic acid: Between doubts and certainties, Biochimie, 10.1016/j.biochi.2013.07.012, 96, (14-21), Online publication date: 1-Jan-2014.

Dai X, Zhang B, Wang P, Chen C, Chen Y and Su Y (2014) Erythrocyte membrane n-3 fatty acid levels and carotid atherosclerosis in Chinese men and women, Atherosclerosis, 10.1016/j.atherosclerosis.2013.10.028, 232:1, (79-85), Online publication date: 1-Jan-2014.

Kasper H (2014) Erkrankungen des Myokards Ernährungsmedizin und Diätetik, 10.1016/B978-3-437-42013-9.00007-5, (413-417), .

Kasper H (2014) Erkrankungen des Stoffwechsels ∗ ∗Überarbeitet und aktualisiert von Dr. Walter Burghardt Ernährungsmedizin und Diätetik, 10.1016/B978-3-437-42013-9.00004-X, (271-380), .

Ilkhanoff L, Kadish A and Goldberger J (2014) Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death Cardiac Electrophysiology: From Cell to Bedside, 10.1016/B978-1-4557-2856-5.00113-8, (1121-1128), .

Phang M and Garg M (2014) Combined Phytosterol and Fish Oil Therapy for Lipid Lowering and Cardiovascular Health Food Structures, Digestion and Health, 10.1016/B978-0-12-404610-8.00016-5, (437-463), .

Maniar S and Bittner V (2014) Lifestyle Interventions for Primary and Secondary Prevention of Cardiovascular Disease PanVascular Medicine, 10.1007/978-3-642-37393-0_54-1, (1-29), .

Mucsi I (2014) Non-statin Therapies for CKD with Dyslipidemia Dyslipidemias in Kidney Disease, 10.1007/978-1-4939-0515-7_9, (153-178), .

Moyad M (2014) Nutraceuticals for Fertility and Erectile Health: A Brief Overview of What Works and What Is Worthless Men's Sexual Health and Fertility, 10.1007/978-1-4939-0425-9_12, (183-228), .

Moyad M (2014) Complementary and Alternative Medicine Interventions for Male Infertility/Subfertility: First Do No Harm Complementary & Alternative Medicine for Prostate and Urologic Health, 10.1007/978-1-4614-8492-9_4, (67-87), .

Moyad M (2014) The Ideal Eight-Step Urologic Diet and Lifestyle Program: Heart Health = Urologic Health Complementary & Alternative Medicine for Prostate and Urologic Health, 10.1007/978-1-4614-8492-9_1, (1-29), .

Marchioli R and Levantesi G (2013) n−3 PUFAs in cardiovascular disease, International Journal of Cardiology, 10.1016/j.ijcard.2013.06.042, 170:2, (S33-S38), Online publication date: 1-Dec-2013.

Marchioli R and Levantesi G (2013) n-3 PUFAs and heart failure, International Journal of Cardiology, 10.1016/j.ijcard.2013.06.041, 170:2, (S28-S32), Online publication date: 1-Dec-2013.

Marangoni F and Poli A (2013) n−3 fatty acids: functional differences between food intake, oral supplementation and drug treatments, International Journal of Cardiology, 10.1016/j.ijcard.2013.06.039, 170:2, (S12-S15), Online publication date: 1-Dec-2013.

Mattila M, Boehm L, Burke S, Kashyap A, Holschbach L, Miller T and Vardeny O (2013) Nonprescription Medication Use in Patients With Heart Failure: Assessment Methods, Utilization Patterns, and Discrepancies With Medical Records, Journal of Cardiac Failure, 10.1016/j.cardfail.2013.10.009, 19:12, (811-815), Online publication date: 1-Dec-2013.

Harris W, Dayspring T and Moran T (2015) Omega-3 Fatty Acids and Cardiovascular Disease: New Developments and Applications, Postgraduate Medicine, 10.3810/pgm.2013.11.2717, 125:6, (100-113), Online publication date: 1-Nov-2013.

Firnhaber J and Kolasa K (2013) Fish Out of Water, Nutrition Today, 10.1097/NT.0000000000000003, 48:6, (245-250), Online publication date: 1-Nov-2013.

Scorza F, Cavalheiro E, Scorza C, Galduróz J, Tufik S and Andersen M (2013) Omega-3 intake in people with obstructive sleep apnea: Beauty sleep for the heart, Epilepsy & Behavior, 10.1016/j.yebeh.2013.07.029, 29:2, (424-426), Online publication date: 1-Nov-2013.

Fenton J, Hord N, Ghosh S and Gurzell E (2013) Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2013.09.011, 89:6, (379-390), Online publication date: 1-Nov-2013.

Tatsuno I, Saito Y, Kudou K and Ootake J (2013) Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized long-term (ORL) study, Journal of Clinical Lipidology, 10.1016/j.jacl.2013.09.002, 7:6, (615-625), Online publication date: 1-Nov-2013.

Flock M, Harris W and Kris-Etherton P (2013) Long-chain omega-3 fatty acids: time to establish a dietary reference intake, Nutrition Reviews, 10.1111/nure.12071, 71:10, (692-707), Online publication date: 1-Oct-2013.

Billman G (2013) The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: A critical reassessment, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2013.05.011, 140:1, (53-80), Online publication date: 1-Oct-2013.

Hall W, Hay G, Maniou Z, Seed P, Chowienczyk P and Sanders T (2013) Effect of low doses of long chain n-3 polyunsaturated fatty acids on sleep-time heart rate variability: A randomized, controlled trial, International Journal of Cardiology, 10.1016/j.ijcard.2013.06.153, 168:4, (4439-4442), Online publication date: 1-Oct-2013.

Yusof H, Cawood A, Ding R, Williams J, Napper F, Shearman C, Grimble R, Payne S and Calder P (2013) Limited Impact of 2 g/day Omega-3 Fatty Acid Ethyl Esters (Omacor®) on Plasma Lipids and Inflammatory Markers in Patients Awaiting Carotid Endarterectomy, Marine Drugs, 10.3390/md11093569, 11:9, (3569-3581)

Greene J, Ashburn S, Razzouk L and Smith D (2013) Fish Oils, Coronary Heart Disease, and the Environment, American Journal of Public Health, 10.2105/AJPH.2012.300959, 103:9, (1568-1576), Online publication date: 1-Sep-2013.

Harris W, Kennedy K, O'Keefe J and Spertus J (2013) Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction, International Journal of Cardiology, 10.1016/j.ijcard.2012.09.076, 168:1, (53-59), Online publication date: 1-Sep-2013.

Stevenson J (2013) What constitutes healthy eating for the heart?, Maturitas, 10.1016/j.maturitas.2013.05.014, 75:4, (303-304), Online publication date: 1-Aug-2013.

Casula M, Soranna D, Catapano A and Corrao G (2013) Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials, Atherosclerosis Supplements, 10.1016/S1567-5688(13)70005-9, 14:2, (243-251), Online publication date: 1-Aug-2013.

Bilato C (2013) n-3 Fatty acids and cardiovascular disease: the story is not over yet, Aging Clinical and Experimental Research, 10.1007/s40520-013-0077-y, 25:4, (357-363), Online publication date: 1-Aug-2013.

Fetter J, Brunette M and Green A (2013) N-3 Fatty Acids for Hypertriglyceridemia in Patients Taking Second-Generation Antipsychotics, Clinical Schizophrenia & Related Psychoses, 10.3371/CSRP.FEBR.012513, 7:2, (73-77A), Online publication date: 1-Jul-2013.

Levantesi G, Marfisi R, Franzosi M, Maggioni A, Nicolosi G, Schweiger C, Silletta M, Tavazzi L, Tognoni G and Marchioli R (2013) Uric acid: A cardiovascular risk factor in patients with recent myocardial infarction, International Journal of Cardiology, 10.1016/j.ijcard.2011.12.110, 167:1, (262-269), Online publication date: 1-Jul-2013.

Khoueiry G, Abi Rafeh N, Sullivan E, Saiful F, Jaffery Z, Kenigsberg D, Krishnan S, Khanal S, Bekheit S and Kowalski M (2013) Do omega-3 polyunsaturated fatty acids reduce risk of sudden cardiac death and ventricular arrhythmias? A meta-analysis of randomized trials, Heart & Lung, 10.1016/j.hrtlng.2013.03.006, 42:4, (251-256), Online publication date: 1-Jul-2013.

Alla V, Agrawal V, DeNazareth A, Mohiuddin S, Ravilla S and Rendell M (2013) A Reappraisal of the Risks and Benefits of Treating to Target with Cholesterol Lowering Drugs, Drugs, 10.1007/s40265-013-0072-9, 73:10, (1025-1054), Online publication date: 1-Jul-2013.

Halcox J (2017) Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega–3 polyunsaturated fatty acid ethyl esters, Clinical Lipidology, 10.2217/clp.13.16, 8:3, (329-344), Online publication date: 1-Jun-2013.

Shah M, Critchley W, Yonan N, Williams S and Shaw S (2013) Second Line Options for Hyperlipidemia Management after Cardiac Transplantation, Cardiovascular Therapeutics, 10.1111/j.1755-5922.2012.00315.x, 31:3, (138-146), Online publication date: 1-Jun-2013.

Smith S, Trushenski J and Hill H (2013) Testing Nutritional Value and Consumer Acceptability of Hybrid Striped Bass Raised on Sustainable Feeds, Journal of Culinary Science & Technology, 10.1080/15428052.2013.769864, 11:2, (131-154), Online publication date: 1-Jun-2013.

(2013) n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors, New England Journal of Medicine, 10.1056/NEJMoa1205409, 368:19, (1800-1808), Online publication date: 9-May-2013.

Macchia A, Romero M, D’Ettorre A, Tognoni G, Mariani J and Marchioli R (2013) Exploratory Analysis on the Use of Statins with or without n-3 PUFA and Major Events in Patients Discharged for Acute Myocardial Infarction: An Observational Retrospective Study, PLoS ONE, 10.1371/journal.pone.0062772, 8:5, (e62772)

Xin W, Wei W and Li X (2013) Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials, The American Journal of Clinical Nutrition, 10.3945/ajcn.112.049833, 97:5, (926-935), Online publication date: 1-May-2013.

Mutoh A and Ueda S (2013) Peroxidized unsaturated fatty acids stimulate Toll-like receptor 4 signaling in endothelial cells, Life Sciences, 10.1016/j.lfs.2013.03.019, 92:20-21, (984-992), Online publication date: 1-May-2013.

Tatsuno I, Saito Y, Kudou K and Ootake J (2013) Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) study, Journal of Clinical Lipidology, 10.1016/j.jacl.2013.01.006, 7:3, (199-207), Online publication date: 1-May-2013.

Surette M (2013) Dietary omega-3 PUFA and health: Stearidonic acid-containing seed oils as effective and sustainable alternatives to traditional marine oils, Molecular Nutrition & Food Research, 10.1002/mnfr.201200706, 57:5, (748-759), Online publication date: 1-May-2013.

de Leiris J, Tanguy S and Boucher F (2013) Alcohol and Heart Health Cardiovascular Diseases, 10.1201/b14663-23, (365-374), Online publication date: 16-Apr-2013.

Khan R, Chokshi A, Drosatos K, Jiang H, Yu S, Harris C, Schulze P, Homma S, Blaner W, Shulman G, Huang L and Goldberg I (2013) Fish Oil Selectively Improves Heart Function in a Mouse Model of Lipid-induced Cardiomyopathy, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e318283d845, 61:4, (345-354), Online publication date: 1-Apr-2013.

Bourre J (2013) Oméga 3 : toute méta-analyse n’est pas bonne à vanter, Pratiques en nutrition, 10.1016/j.pranut.2013.03.008, 9:34, (34-38), Online publication date: 1-Apr-2013.

Harris W, Pottala J, Varvel S, Borowski J, Ward J and McConnell J (2013) Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: Observations from 160,000 patients, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2012.12.004, 88:4, (257-263), Online publication date: 1-Apr-2013.

Nasu-Kawaharada R, Nakamura A, Kakarla S, Blough E, Kohama K and Kohama T (2013) A maternal diet rich in fish oil may improve cardiac Akt-related signaling in the offspring of diabetic mother rats, Nutrition, 10.1016/j.nut.2012.11.017, 29:4, (688-692), Online publication date: 1-Apr-2013.

Rizos E and Elisaf M (2013) Current evidence and future perspectives of omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease, European Journal of Pharmacology, 10.1016/j.ejphar.2013.02.050, 706:1-3, (1-3), Online publication date: 1-Apr-2013.

Standl E (2012) Statins and beyond: Concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes, Diabetes and Vascular Disease Research, 10.1177/1479164112448876, 10:2, (99-114), Online publication date: 1-Mar-2013.

Harris W (2013) Are n-3 fatty acids still cardioprotective?, Current Opinion in Clinical Nutrition and Metabolic Care, 10.1097/MCO.0b013e32835bf380, 16:2, (141-149), Online publication date: 1-Mar-2013.

Suematsu Y, Miura S, Zhang B, Uehara Y, Tokunaga M, Yonemoto N, Nonogi H, Nagao K, Kimura T and Saku K (2013) Associations between the consumption of different kinds of seafood and out-of-hospital cardiac arrests of cardiac origin in Japan, IJC Heart & Vessels, 10.1016/j.ijchv.2013.11.002, 2, (8-14), Online publication date: 1-Mar-2013.

Levantesi G, Marfisi R, Mozaffarian D, Franzosi M, Maggioni A, Nicolosi G, Schweiger C, Silletta M, Tavazzi L, Tognoni G and Marchioli R (2013) Wine consumption and risk of cardiovascular events after myocardial infarction: Results from the GISSI-Prevenzione trial, International Journal of Cardiology, 10.1016/j.ijcard.2011.06.053, 163:3, (282-287), Online publication date: 1-Mar-2013.

Capra V, Bäck M, Barbieri S, Camera M, Tremoli E and Rovati G (2012) Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke, Medicinal Research Reviews, 10.1002/med.21251, 33:2, (364-438), Online publication date: 1-Mar-2013.

Moyad M (2013) Nutraceuticals in fertility preservation Fertility Preservation in Male Cancer Patients, 10.1017/CBO9780511997761.023, (195-202)

(2013) Preservation strategies Fertility Preservation in Male Cancer Patients, 10.1017/CBO9780511997761.020, (172-281)

Larson M, Tormoen G, Weaver L, Luepke K, Patel I, Hjelmen C, Ensz N, McComas L and McCarty O (2013) Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation, American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.00174.2012, 304:3, (C273-C279), Online publication date: 1-Feb-2013.

Kiecolt-Glaser J, Epel E, Belury M, Andridge R, Lin J, Glaser R, Malarkey W, Hwang B and Blackburn E (2013) Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial, Brain, Behavior, and Immunity, 10.1016/j.bbi.2012.09.004, 28, (16-24), Online publication date: 1-Feb-2013.

Gao L, Cao J, Mao Q, Lu X, Zhou X and Fan L (2013) Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: A meta-analysis of randomized controlled trials, Atherosclerosis, 10.1016/j.atherosclerosis.2012.10.056, 226:2, (328-334), Online publication date: 1-Feb-2013.

Mariani J, Doval H, Nul D, Varini S, Grancelli H, Ferrante D, Tognoni G and Macchia A (2013) N‐3 Polyunsaturated Fatty Acids to Prevent Atrial Fibrillation: Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials, Journal of the American Heart Association, 2:1, Online publication date: 23-Jan-2013.

Grand B (2013) Effects of omacor<sup>® </sup>on left ventricular remodelling consecutive to post myocardial infarction special issue-myocardial infarction, World Journal of Cardiovascular Diseases, 10.4236/wjcd.2013.35A007, 03:05, (40-44), .

Kimmig L and Karalis D (2013) Do Omega-3 Polyunsaturated Fatty Acids Prevent Cardiovascular Disease? A Review of the Randomized Clinical Trials, Lipid Insights, 10.4137/LPI.S10846, 6, (LPI.S10846), Online publication date: 1-Jan-2013.

Calder P (2013) Nutritional benefits of omega-3 fatty acids Food Enrichment with Omega-3 Fatty Acids, 10.1533/9780857098863.1.3, (3-26), .

Kim C (2013) Management of Hypertriglyceridemia for Prevention of Cardiovascular Diseases, Journal of Lipid and Atherosclerosis, 10.12997/jla.2013.2.2.53, 2:2, (53), .

Yazdi P (2014) A review of the biologic and pharmacologic role of docosapentaenoic acid n-3, F1000Research, 10.12688/f1000research.2-256.v2, 2, (256)

Yazdi P (2013) A review of the biologic and pharmacological role of docosapentaenoic acid, F1000Research, 10.12688/f1000research.2-256.v1, 2, (256)

Brinton E, Ballantyne C, Bays H, Kastelein J, Braeckman R and Soni P (2013) Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study, Cardiovascular Diabetology, 10.1186/1475-2840-12-100, 12:1, (100), .

Rupp T, Rupp K, Alter P and Rupp H (2013) Replacement of Reduced Highly Unsaturated Fatty Acids (HUFA Deficiency) in Dilative Heart Failure: Dosage of EPA/DHA and Variability of Adverse Peroxides and Aldehydes in Dietary Supplement Fish Oils, Cardiology, 10.1159/000350656, 125:4, (223-231), .

Murru E, Banni S and Carta G (2013) Nutritional Properties of Dietary Omega-3-Enriched Phospholipids, BioMed Research International, 10.1155/2013/965417, 2013, (1-13), .

Albert B, Cameron-Smith D, Hofman P and Cutfield W (2013) Oxidation of Marine Omega-3 Supplements and Human Health, BioMed Research International, 10.1155/2013/464921, 2013, (1-8), .

Rodrigo R, Prieto J and Castillo R (2012) Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n −3 fatty acids: molecular mechanisms and potential clinical applications , Clinical Science, 10.1042/CS20110663, 124:1, (1-15), Online publication date: 1-Jan-2013.

Lindberg M, Åsberg A, Midthjell K and Bjerve K (2013) Plasma phospholipid EPA and DHA are divergently associated with overall mortality in newly diagnosed diabetic patients: results from a follow-up of the Nord-Trøndelag Health (HUNT) Study, Norway, Journal of Nutritional Science, 10.1017/jns.2013.30, 2, .

Sakaguchi S and Li H (2013) Syncope and Driving, Flying and Vocational Concerns, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2012.11.010, 55:4, (454-463), Online publication date: 1-Jan-2013.

Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G and Doval H (2013) Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation, Journal of the American College of Cardiology, 10.1016/j.jacc.2012.11.021, 61:4, (463-468), Online publication date: 1-Jan-2013.

Haberka M, Mizia-Stec K, Mizia M, Gieszczyk K, Chmiel A, Sitnik-Warchulska K and Gąsior Z (2013) Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction, Pharmacological Reports, 10.1016/S1734-1140(13)70964-2, 65:1, (59-68), Online publication date: 1-Jan-2013.

Pizzorno J, Paul C and Schauss A (2013) Fish Oils (Omega-3 Fatty Acids, Docosahexaenoic Acid, Eicosapentaenoic Acid, Dietary Fish, and Fish Oils) Textbook of Natural Medicine, 10.1016/B978-1-4377-2333-5.00091-2, (745-771), .

Moreillon J, Bowden R and Shelmadine B (2013) Fish Oil and C-Reactive Protein Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases, 10.1016/B978-0-12-397156-2.00028-4, (393-404), .

Sharma R, Moffatt R, Singh R and Katz J (2013) Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans Bioactive Food as Dietary Interventions for Cardiovascular Disease, 10.1016/B978-0-12-396485-4.00277-2, (1-28), .

Sharma R and Moffatt R (2013) Herbal Supplements or Herbs in Heart Disease Bioactive Food as Dietary Interventions for Cardiovascular Disease, 10.1016/B978-0-12-396485-4.00178-X, (491-523), .

Sharma R (2013) Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans Bioactive Food as Dietary Interventions for Cardiovascular Disease, 10.1016/B978-0-12-396485-4.00028-1, (465-489), .

Batchu S, Chaudhary K, Wiebe G and Seubert J (2013) Bioactive Compounds in Heart Disease Bioactive Food as Dietary Interventions for Cardiovascular Disease, 10.1016/B978-0-12-396485-4.00026-8, (431-442), .

Haller D and Hörmannsperger G (2013) Immunfunktion und Entzündungsprävention Biofunktionalität der Lebensmittelinhaltsstoffe, 10.1007/978-3-642-29374-0_5, (43-66), .

Barthel K, Harvey P and Leinwand L (2013) Diet and Exercise Are Potent Modulators of Cardiovascular Disease in Women Integrative Biology of Women’s Health, 10.1007/978-1-4614-8630-5_10, (175-204), .

Ilkhanoff L, Kadish A and Jacobson J (2013) Non-antiarrhythmic Drugs in Sudden Death Prevention Electrical Diseases of the Heart, 10.1007/978-1-4471-4978-1_34, (525-541), .

Nounou H, Deif M and Shalaby M (2012) Effect of flaxseed supplementation and exercise training on lipid profile, oxidative stress and inflammation in rats with myocardial ischemia, Lipids in Health and Disease, 10.1186/1476-511X-11-129, 11:1, Online publication date: 1-Dec-2012.

Siegel G and Ermilov E (2012) Omega-3 fatty acids: Benefits for cardio-cerebro-vascular diseases, Atherosclerosis, 10.1016/j.atherosclerosis.2012.09.006, 225:2, (291-295), Online publication date: 1-Dec-2012.

Donati M and de Gaetano G (2012) Bio-medical research and search for personhood: a 40-year project, Journal of Medicine and the Person, 10.1007/s12682-012-0130-1, 10:3, (114-125), Online publication date: 1-Dec-2012.

Trimarco B (2012) Omega-3 in Antiarrhythmic Therapy, High Blood Pressure & Cardiovascular Prevention, 10.1007/BF03297631, 19:4, (201-205), Online publication date: 1-Dec-2012.

Shearer G, Pottala J, Hansen S, Brandenburg V and Harris W (2012) Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial, Journal of Lipid Research, 10.1194/jlr.P022392, 53:11, (2429-2435), Online publication date: 1-Nov-2012.

Block R, Kakinami L, Jonovich M, Antonetti I, Lawrence P, Meednu N, CalderonArtero P, Mousa S, Thomas Brenna J and Georas S (2012) The combination of EPA+DHA and low-dose aspirin ingestion reduces platelet function acutely whereas each alone may not in healthy humans, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2012.08.007, 87:4-5, (143-151), Online publication date: 1-Oct-2012.

Ling P, Puder M and Bistrian B (2012) Purified fish oil eliminating linoleic and alpha linolenic acid meets essential fatty acid requirements in rats, Metabolism, 10.1016/j.metabol.2012.03.007, 61:10, (1443-1451), Online publication date: 1-Oct-2012.

Nieva R, Safavynia S, Lee Bishop K and Laurence S (2012) Herbal, Vitamin, and Mineral Supplement Use in Patients Enrolled in a Cardiac Rehabilitation Program, Journal of Cardiopulmonary Rehabilitation and Prevention, 10.1097/HCR.0b013e31825f78f0, 32:5, (270-277), Online publication date: 1-Sep-2012.

Dalal J, Kasliwal R, Dutta A, Sawhney J, Iyengar S, Dani S, Desai N, Sathyamurthy I, Rao D, Menon A, Dasbiswas A, Wander G, Chadha M, Hiremath M, Roy D, Gupta V and Shivakadaksham N (2012) Role of omega-3 ethyl ester concentrate in reducing sudden cardiac death following myocardial infarction and in management of hypertriglyceridemia: An Indian consensus statement, Indian Heart Journal, 10.1016/j.ihj.2012.08.004, 64:5, (503-507), Online publication date: 1-Sep-2012.

(2012) Weight Loss and Diet Metabolic Syndrome and Cardiovascular Disease, 10.1002/9781118480045.ch11, (266-302), Online publication date: 29-Aug-2012.

McLennan P, Abeywardena M, Dallimore J and Raederstorff D (2011) Dietary fish oil preserves cardiac function in the hypertrophied rat heart, British Journal of Nutrition, 10.1017/S0007114511005915, 108:4, (645-654), Online publication date: 28-Aug-2012.

Kiecolt-Glaser J, Belury M, Andridge R, Malarkey W, Hwang B and Glaser R (2012) Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial, Brain, Behavior, and Immunity, 10.1016/j.bbi.2012.05.011, 26:6, (988-995), Online publication date: 1-Aug-2012.

Silverberg D and Schwartz D (2012) The Role of Iron, Omega-3 Fatty Acids, and Vitamins in Heart Failure, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-012-0188-3, 14:4, (328-341), Online publication date: 1-Aug-2012.

Doenyas-Barak K, Berman S, Abu-Hamad R, Golik A, Rahimi-Levene N and Efrati S (2012) N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients’ daytime blood pressure, and improves inflammatory status, European Journal of Clinical Pharmacology, 10.1007/s00228-012-1235-4, 68:8, (1139-1146), Online publication date: 1-Aug-2012.

Claudia F, Marcelo B and Giselle H (2012) Dyslipidemia: evidence of efficacy of the pharmacological and non-pharmacological treatment in the elderly, Journal of Geriatric Cardiology, 10.3724/SP.J.1263.2011.12292, 9:2, (83-90), Online publication date: 20-Jul-2012.

Harris W, Pottala J, Vasan R, Larson M and Robins S (2012) Changes in Erythrocyte Membrane Trans and Marine Fatty Acids between 1999 and 2006 in Older Americans, The Journal of Nutrition, 10.3945/jn.112.158295, 142:7, (1297-1303), Online publication date: 1-Jul-2012.

Calder P and Yaqoob P (2012) Marine omega-3 fatty acids and coronary heart disease, Current Opinion in Cardiology, 10.1097/HCO.0b013e328353febd, 27:4, (412-419), Online publication date: 1-Jul-2012.

Hileman C, Carman T, Storer N, Labbato D, White C and McComsey G (2012) Omega-3 Fatty Acids Do Not Improve Endothelial Function In Virologically Suppressed HIV-Infected Men: A Randomized Placebo-Controlled Trial, AIDS Research and Human Retroviruses, 10.1089/aid.2011.0088, 28:7, (649-655), Online publication date: 1-Jul-2012.

Ramadeen A, Connelly K, Leong-Poi H, Hu X, Fujii H, Van Krieken R, Laurent G, Holub B, Bazinet R and Dorian P (2012) N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atria, Heart Rhythm, 10.1016/j.hrthm.2012.02.013, 9:7, (1115-1122.e4), Online publication date: 1-Jul-2012.

Albert C (2012) Omega-3 Fatty Acids, Ventricular Arrhythmias, and Sudden Cardiac Death, Circulation: Arrhythmia and Electrophysiology, 5:3, (456-459), Online publication date: 1-Jun-2012.

Billman G, Carnes C, Adamson P, Vanoli E and Schwartz P (2012) Dietary Omega-3 Fatty Acids and Susceptibility to Ventricular Fibrillation, Circulation: Arrhythmia and Electrophysiology, 5:3, (553-560), Online publication date: 1-Jun-2012.

Kuipers R, Joordens J and Muskiet F (2012) A multidisciplinary reconstruction of Palaeolithic nutrition that holds promise for the prevention and treatment of diseases of civilisation, Nutrition Research Reviews, 10.1017/S0954422412000017, 25:1, (96-129), Online publication date: 1-Jun-2012.

Barringer T and Harris W (2012) Omega-3 Fatty Acids and Cardiovascular Disease Prevention, Current Nutrition Reports, 10.1007/s13668-012-0011-5, 1:2, (115-122), Online publication date: 1-Jun-2012.

Lopez H (2012) Nutritional Interventions to Prevent and Treat Osteoarthritis. Part I: Focus on Fatty Acids and Macronutrients, PM&R, 10.1016/j.pmrj.2012.02.022, 4:5S, Online publication date: 1-May-2012.

Ohlow M, Geller J, Richter S, Farah A, Müller S, Fuhrmann J and Lauer B (2012) Incidence and predictors of ventricular arrhythmias after ST-segment elevation myocardial infarction, The American Journal of Emergency Medicine, 10.1016/j.ajem.2011.02.029, 30:4, (580-586), Online publication date: 1-May-2012.

Lin Y, Salem N, Wells E, Zhou W, Loewke J, Brown J, Lands W, Goldman L and Hibbeln J (2012) Automated High‐Throughput Fatty Acid Analysis of Umbilical Cord Serum and Application to an Epidemiological Study, Lipids, 10.1007/s11745-012-3661-6, 47:5, (527-539), Online publication date: 1-May-2012.

Kirkegaard E, Svensson M, Strandhave C, Schmidt E, Jørgensen K and Christensen J (2011) Marine n -3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients , British Journal of Nutrition, 10.1017/S0007114511003771, 107:6, (903-909), Online publication date: 28-Mar-2012.

Calder P (2012) Mechanisms of Action of (n-3) Fatty Acids,, The Journal of Nutrition, 10.3945/jn.111.155259, 142:3, (592S-599S), Online publication date: 1-Mar-2012.

Deckelbaum R and Torrejon C (2012) The Omega-3 Fatty Acid Nutritional Landscape: Health Benefits and Sources, The Journal of Nutrition, 10.3945/jn.111.148080, 142:3, (587S-591S), Online publication date: 1-Mar-2012.

Harris W (2012) Stearidonic Acid–Enhanced Soybean Oil: A Plant-Based Source of (n-3) Fatty Acids for Foods, The Journal of Nutrition, 10.3945/jn.111.146613, 142:3, (600S-604S), Online publication date: 1-Mar-2012.

Lardizabal J and Deedwania P (2012) Lipid-lowering therapy Advances in Acute Coronary Syndrome Management, 10.2217/ebo.11.259, (68-77), Online publication date: 1-Mar-2012.

Shearer G, Carrero J, Heimbürger O, Barany P and Stenvinkel P (2012) Plasma Fatty Acids in Chronic Kidney Disease: Nervonic Acid Predicts Mortality, Journal of Renal Nutrition, 10.1053/j.jrn.2011.05.005, 22:2, (277-283), Online publication date: 1-Mar-2012.

Khawaja O, Gaziano J and Djoussé L (2012) A Meta-Analysis of Omega-3 Fatty Acids and Incidence of Atrial Fibrillation, Journal of the American College of Nutrition, 10.1080/07315724.2012.10720003, 31:1, (4-13), Online publication date: 1-Feb-2012.

Moyad M (2012) The Optimal Male Health Diet and Dietary Supplement Program, Urologic Clinics of North America, 10.1016/j.ucl.2011.09.006, 39:1, (89-107), Online publication date: 1-Feb-2012.

Koh K, Quon M, Shin K, Lim S, Lee Y, Sakuma I, Lee K, Han S and Shin E (2012) Significant differential effects of omega-3 fatty acids and fenofibrate in patients with hypertriglyceridemia, Atherosclerosis, 10.1016/j.atherosclerosis.2011.11.018, 220:2, (537-544), Online publication date: 1-Feb-2012.

Telle‐Hansen V, Larsen L, Høstmark A, Molin M, Dahl L, Almendingen K and Ulven S (2011) Daily Intake of Cod or Salmon for 2 Weeks Decreases the 18:1n‐9/18:0 Ratio and Serum Triacylglycerols in Healthy Subjects, Lipids, 10.1007/s11745-011-3637-y, 47:2, (151-160), Online publication date: 1-Feb-2012.

Norata G (2012) Established and Emerging Approaches for the Management of Dyslipidaemia, Scientifica, 10.6064/2012/482423, 2012, (1-14), .

Swanson D, Block R and Mousa S (2012) Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life, Advances in Nutrition, 10.3945/an.111.000893, 3:1, (1-7), Online publication date: 1-Jan-2012.

Turyk M, Bhavsar S, Bowerman W, Boysen E, Clark M, Diamond M, Mergler D, Pantazopoulos P, Schantz S and Carpenter D (2012) Risks and Benefits of Consumption of Great Lakes Fish, Environmental Health Perspectives, 10.1289/ehp.1003396, 120:1, (11-18), Online publication date: 1-Jan-2012.

Ramadeen A and Dorian P (2012) How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease, Cardiology Research and Practice, 10.1155/2012/746709, 2012, (1-8), .

Aarsetoey H, Grundt H, Nygaard O and Nilsen D (2012) The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease, Cardiology Research and Practice, 10.1155/2012/303456, 2012, (1-15), .

Rupp H, Rupp T, Alter P and Maisch B (2012) Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in “HUFA deficiency”, Canadian Journal of Physiology and Pharmacology, 10.1139/y11-101, 90:1, (55-73), Online publication date: 1-Jan-2012.

Deedwania P and Lardizabal J (2012) Non-antiarrhythmic Therapies for Cardiac Arrhythmias Electrophysiological Disorders of the Heart, 10.1016/B978-1-4377-0285-9.00084-3, (1167-1174), .

Singh S (2012) Evaluation and Management of Arrhythmias Associated with Congestive Heart Failure Electrophysiological Disorders of the Heart, 10.1016/B978-1-4377-0285-9.00058-2, (819-822), .

Siriwardhana N, Kalupahana N and Moustaid-Moussa N (2012) Health Benefits of n-3 Polyunsaturated Fatty Acids Marine Medicinal Foods - Implications and Applications - Animals and Microbes, 10.1016/B978-0-12-416003-3.00013-5, (211-222), .

Abel R, Francisco L, Korinek J, Somers V and Kottke T (2012) Secondary Prevention Strategies Coronary Artery Disease, 10.1007/978-1-84628-712-1_14, (169-182), .

Moyad M (2012) Rational Herbal and Complementary Interventions for Prevention and Treatment of Urological Disorders in Men Urological Men’s Health, 10.1007/978-1-61779-900-6_8, (77-88), .

McEvoy C, Young I and Woodside J (2012) Fish, n-3 Polyunsaturated Fatty Acids, and Cardiovascular Disease Nutritional Health, 10.1007/978-1-61779-894-8_10, (221-246), .

Stanley J (2012) Does fish oil prevent cardiac arrhythmias?, Lipid Technology, 10.1002/lite.201200166, 24:1, (15-16), Online publication date: 1-Jan-2012.

Serini S, Fasano E, Piccioni E, Cittadini A and Calviello G (2011) Dietary n-3 Polyunsaturated Fatty Acids and the Paradox of Their Health Benefits and Potential Harmful Effects, Chemical Research in Toxicology, 10.1021/tx200314p, 24:12, (2093-2105), Online publication date: 19-Dec-2011.

Davidson M, Kling D and Maki K (2011) Novel developments in omega-3 fatty acid-based strategies, Current Opinion in Lipidology, 10.1097/MOL.0b013e32834bd642, 22:6, (437-444), Online publication date: 1-Dec-2011.

Reiner Ž, Catapano A, De Backer G, Graham I, Taskinen M, Wiklund O, Agewall S, Alegría E, John Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey R and Wood D (2011) Guía de la ESC/EAS sobre el manejo de las dislipemias, Revista Española de Cardiología, 10.1016/j.recesp.2011.09.014, 64:12, (1168.e1-1168.e60), Online publication date: 1-Dec-2011.

Harris K, Fleming J and Kris-Etherton P (2011) Challenges in estimating omega-3 fatty acid content of seafood from US nutrient databases: A salmon case study, Journal of Food Composition and Analysis, 10.1016/j.jfca.2011.03.019, 24:8, (1168-1173), Online publication date: 1-Dec-2011.

Carpentier Y and Komsa-Penkova R (2011) Clinical Nutrition University. The place of nutrition in the prevention of cardiovascular diseases (CVDs), e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, 10.1016/j.eclnm.2011.10.002, 6:6, (e272-e282), Online publication date: 1-Dec-2011.

Thomazella M, Góes M, Andrade C, Debbas V, Barbeiro D, Correia R, Marie S, Cardounel A, daLuz P and Laurindo F (2011) Effects of High Adherence to Mediterranean or Low-Fat Diets in Medicated Secondary Prevention Patients, The American Journal of Cardiology, 10.1016/j.amjcard.2011.07.008, 108:11, (1523-1529), Online publication date: 1-Dec-2011.

Park Y and Kim M (2011) Serum 25-hydroxyvitamin D concentrations are associated with erythrocyte levels of n -3 PUFA but not risk of CVD , British Journal of Nutrition, 10.1017/S0007114511001930, 106:10, (1529-1534), Online publication date: 28-Nov-2011.

Westphal C, Konkel A and Schunck W (2011) CYP-eicosanoids—A new link between omega-3 fatty acids and cardiac disease?, Prostaglandins & Other Lipid Mediators, 10.1016/j.prostaglandins.2011.09.001, 96:1-4, (99-108), Online publication date: 1-Nov-2011.

von Schacky C (2011) The Omega-3 Index as a risk factor for cardiovascular diseases, Prostaglandins & Other Lipid Mediators, 10.1016/j.prostaglandins.2011.06.008, 96:1-4, (94-98), Online publication date: 1-Nov-2011.

Kuipers R, Luxwolda M, Janneke Dijck-Brouwer D and Muskiet F (2011) Intrauterine, postpartum and adult relationships between arachidonic acid (AA) and docosahexaenoic acid (DHA), Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 10.1016/j.plefa.2011.04.015, 85:5, (245-252), Online publication date: 1-Nov-2011.

Thireau J, Pasquié J, Martel E, Le Guennec J and Richard S (2011) New drugs vs. old concepts: A fresh look at antiarrhythmics, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2011.03.003, 132:2, (125-145), Online publication date: 1-Nov-2011.

Brown W, Bays H, Harris W and Miller M (2011) Using omega-3 fatty acids in the practice of clinical lipidology, Journal of Clinical Lipidology, 10.1016/j.jacl.2011.09.006, 5:6, (424-433), Online publication date: 1-Nov-2011.

Jiménez Jiménez F, Cervera Montes M and Blesa Malpica A (2011) Recomendaciones para el soporte nutricional y metabólico especializado del paciente crítico. Actualización. Consenso SEMICYUC-SENPE: Paciente cardíaco, Medicina Intensiva, 10.1016/S0210-5691(11)70017-1, 35, (81-85), Online publication date: 1-Nov-2011.

Hoffman R and Gerber M (2011) Cardiovascular Diseases The Mediterranean Diet, 10.1002/9781118785027.ch11, (258-292), Online publication date: 21-Oct-2011.

Yadav V, Shinto L and Bourdette D (2011) Complementary and alternative treatments in multiple sclerosis Multiple Sclerosis Therapeutics, 10.1017/CBO9781139023986.052, (562-573)

(2011) Clinical trials of multiple sclerosis therapies Multiple Sclerosis Therapeutics, 10.1017/CBO9781139023986.028, (300-582)

Sanders T, Hall W, Maniou Z, Lewis F, Seed P and Chowienczyk P (2011) Effect of low doses of long-chain n−3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial, The American Journal of Clinical Nutrition, 10.3945/ajcn.111.018036, 94:4, (973-980), Online publication date: 1-Oct-2011.

Jeppe H, Erik B and My S (2017) n-3 polyunsaturated fatty acids, lipids and lipoproteins in end-stage renal disease, Clinical Lipidology, 10.2217/clp.11.50, 6:5, (563-576), Online publication date: 1-Oct-2011.

Deutch-Kolevzon R, Aserin A and Garti N (2011) Synergistic cosolubilization of omega-3 fatty acid esters and CoQ10 in dilutable microemulsions, Chemistry and Physics of Lipids, 10.1016/j.chemphyslip.2011.06.010, 164:7, (654-663), Online publication date: 1-Oct-2011.

Hill A, Roussell M and Kris-Etherton P (2011) The Role of Nutrition in Secondary Prevention of Coronary Artery Disease, Current Cardiovascular Risk Reports, 10.1007/s12170-011-0188-y, 5:5, (383-390), Online publication date: 1-Oct-2011.

Kremmyda L, Tvrzicka E, Stankova B and Zak A (2011) FATTY ACIDS AS BIOCOMPOUNDS: THEIR ROLE IN HUMAN METABOLISM, HEALTH AND DISEASE - A REVIEW. PART 2: FATTY ACID PHYSIOLOGICAL ROLES AND APPLICATIONS IN HUMAN HEALTH AND DISEASE, Biomedical Papers, 10.5507/bp.2011.052, 155:3, (195-218), Online publication date: 1-Sep-2011.

Larsen R, Eilertsen K and Elvevoll E (2011) Health benefits of marine foods and ingredients, Biotechnology Advances, 10.1016/j.biotechadv.2011.05.017, 29:5, (508-518), Online publication date: 1-Sep-2011.

Millán Núñez-Cortés J, Pedro-Botet Montoya J and Pintó Sala X (2011) Riesgo residual vascular de origen lipídico. Estrategias para el tratamiento del riesgo residual por dislipidemia aterogénica, Clínica e Investigación en Arteriosclerosis, 10.1016/j.arteri.2011.07.003, 23:5, (230-239), Online publication date: 1-Sep-2011.

Djoussé L, Biggs M, Lemaitre R, King I, Song X, Ix J, Mukamal K, Siscovick D and Mozaffarian D (2011) Plasma omega-3 fatty acids and incident diabetes in older adults, The American Journal of Clinical Nutrition, 10.3945/ajcn.111.013334, 94:2, (527-533), Online publication date: 1-Aug-2011.

Moyad M (2011) Heart Health = Urologic Health and Heart Unhealthy = Urologic Unhealthy: Rapid Review of Lifestyle Changes and Dietary Supplements, Urologic Clinics of North America, 10.1016/j.ucl.2011.05.004, 38:3, (359-367), Online publication date: 1-Aug-2011.

Fredman G and Serhan C (2011) Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution, Biochemical Journal, 10.1042/BJ20110327, 437:2, (185-197), Online publication date: 15-Jul-2011.

Thomas D, Yousef Z and Anderson R (2011) Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion, ISRN Cardiology, 10.5402/2011/176834, 2011, (1-7), Online publication date: 12-Jul-2011.

Reiner Z, Catapano A, De Backer G, Graham I, Taskinen M, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi P, Riccardi G, Storey R, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hobbs R, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu B, Reiner Z, Sechtem U, Sirnes P, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Reviewers: D, Funck-Brentano C, Poldermans D, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida G, Gulec S, Henkin Y, Huber K, Kesaniemi Y, Lekakis J, Manolis A, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek M and Zamorano J (2011) ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), European Heart Journal, 10.1093/eurheartj/ehr158, 32:14, (1769-1818), Online publication date: 2-Jul-2011.

Balanzá-Martínez V, Fries G, Colpo G, Silveira P, Portella A, Tabarés-Seisdedos R and Kapczinski F (2014) Therapeutic use of omega-3 fatty acids in bipolar disorder, Expert Review of Neurotherapeutics, 10.1586/ern.11.42, 11:7, (1029-1047), Online publication date: 1-Jul-2011.

Fox K and Ferrari R (2011) Heart rate: a forgotten link in coronary artery disease?, Nature Reviews Cardiology, 10.1038/nrcardio.2011.58, 8:7, (369-379), Online publication date: 1-Jul-2011.

Catapano A, Reiner Ž, De Backer G, Graham I, Taskinen M, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey R and Wood D (2011) ESC/EAS Guidelines for the management of dyslipidaemias, Atherosclerosis, 10.1016/j.atherosclerosis.2011.06.028, 217:1, (3-46), Online publication date: 1-Jul-2011.

Catapano A, Reiner Ž, De Backer G, Graham I, Taskinen M, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Perrone Filardi P, Riccardi G, Storey R and Wood D (2011) ESC/EAS Guidelines for the management of dyslipidaemias, Atherosclerosis, 10.1016/j.atherosclerosis.2011.06.012, 217, (1-44), Online publication date: 1-Jul-2011.

De Caterina R (2011) n–3 Fatty Acids in Cardiovascular Disease, New England Journal of Medicine, 10.1056/NEJMra1008153, 364:25, (2439-2450), Online publication date: 23-Jun-2011.

Falck J, Wallukat G, Puli N, Goli M, Arnold C, Konkel A, Rothe M, Fischer R, Müller D and Schunck W (2011) 17( R ),18( S )-Epoxyeicosatetraenoic Acid, a Potent Eicosapentaenoic Acid (EPA) Derived Regulator of Cardiomyocyte Contraction: Structure–Activity Relationships and Stable Analogues , Journal of Medicinal Chemistry, 10.1021/jm200132q, 54:12, (4109-4118), Online publication date: 23-Jun-2011.

Yang Y, Chan S, Hu M, Walden R and Tomlinson B (2011) Effects of Some Common Food Constituents on Cardiovascular Disease, ISRN Cardiology, 10.5402/2011/397136, 2011, (1-16), Online publication date: 16-Jun-2011.

Fang Y, Favre J, Vercauteren M, Laillet B, Remy‐Jouet I, Skiba M, Lallemand F, Dehaudt C, Monteil C, Thuillez C and Mulder P (2011) Reduced cardiac remodelling and prevention of glutathione deficiency after omega‐3 supplementation in chronic heart failure, Fundamental & Clinical Pharmacology, 10.1111/j.1472-8206.2010.00839.x, 25:3, (323-332), Online publication date: 1-Jun-2011.

Chen Q, Cheng L, Xiao T, Zhang Y, Zhu M, Zhang R, Li K, Wang Y and Li Y (2011) Effects of Omega-3 Fatty Acid for Sudden Cardiac Death Prevention in Patients with Cardiovascular Disease: A Contemporary Meta-Analysis of Randomized, Controlled Trials, Cardiovascular Drugs and Therapy, 10.1007/s10557-011-6306-8, 25:3, (259-265), Online publication date: 1-Jun-2011.

Salm P, Taylor P and Kostner K (2010) Simultaneous quantification of total eicosapentaenoic acid, docosahexaenoic acid and arachidonic acid in plasma by high‐performance liquid chromatography–tandem mass spectrometry, Biomedical Chromatography, 10.1002/bmc.1496, 25:6, (652-659), Online publication date: 1-Jun-2011.

Chelazzi C, Villa G and De Gaudio A (2011) Postoperative Atrial Fibrillation, ISRN Cardiology, 10.5402/2011/203179, 2011, (1-10), Online publication date: 22-May-2011.

Wang J and Shahidi F (2011) Effect of Enzymatic Randomization on Positional Distribution and Stability of Seal Blubber and Menhaden Oils, Journal of Agricultural and Food Chemistry, 10.1021/jf200039j, 59:8, (4232-4237), Online publication date: 27-Apr-2011.

Dawczynski C and Jahreis G (2011) Benefits of Fish Oil for Rheumatoid Arthritis Arthritis, 10.1201/b10852-30, (349-384), Online publication date: 5-Apr-2011.

Benedetto U, Melina G, di Bartolomeo R, Angeloni E, Sansone D, Falaschi G, Capuano F, Comito C, Roscitano A and Sinatra R (2011) n-3 Polyunsaturated Fatty Acids After Coronary Artery Bypass Grafting, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2010.11.068, 91:4, (1169-1175), Online publication date: 1-Apr-2011.

Malhotra S and Das M (2011) Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death, Future Cardiology, 10.2217/fca.11.3, 7:2, (203-217), Online publication date: 1-Mar-2011.

Valera B, Dewailly E, Anassour-Laouan-Sidi E and Poirier P (2016) Influence of n-3 fatty acids on cardiac autonomic activity among Nunavik Inuit adults, International Journal of Circumpolar Health, 10.3402/ijch.v70i1.17800, 70:1, (6-18), Online publication date: 18-Feb-2011.

Guthrie R (2015) Use of Omega-3 Fish Oil Supplementation to Reduce Recurrent Cardiovascular Events, The Physician and Sportsmedicine, 10.3810/psm.2011.02.1853, 39:1, (166-168), Online publication date: 1-Feb-2011.

Savelieva I and Camm A (2011) Polyunsaturated fatty acids for prevention of atrial fibrillation: a 'fishy' story, Europace, 10.1093/europace/euq520, 13:2, (149-152), Online publication date: 1-Feb-2011.

Tanaka T (2010) Contribution of Diet and Genes to Polyunsaturated Fatty Acid Composition, Current Cardiovascular Risk Reports, 10.1007/s12170-010-0140-6, 5:1, (45-51), Online publication date: 1-Feb-2011.

Dujovne C, Williams C and Ito M (2010) What Combination Therapy with a Statin, If Any, Would You Recommend?, Current Atherosclerosis Reports, 10.1007/s11883-010-0150-3, 13:1, (12-22), Online publication date: 1-Feb-2011.

Nahab F, Le A, Judd S, Frankel M, Ard J, Newby P and Howard V (2011) Racial and geographic differences in fish consumption, Neurology, 10.1212/WNL.0b013e3182061afb, 76:2, (154-158), Online publication date: 11-Jan-2011.

Nikolić M (2011) The importance of nutrition in secondary prevention and rehabilitation of coronary artery disease, Srce i krvni sudovi, 10.5937/siks1104206N, 30:4, (206-209), .

Itakura H, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K and Matsuzawa Y (2011) Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease, Journal of Atherosclerosis and Thrombosis, 10.5551/jat.5876, 18:2, (99-107), .

Djoussé L, Gaziano J, Buring J and Lee I (2011) Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes, The American Journal of Clinical Nutrition, 10.3945/ajcn.110.005603, 93:1, (143-150), Online publication date: 1-Jan-2011.

Madsen T, Christensen J, Toft E, Aardestrup I, Lundbye‐Christensen S and Schmidt E (2011) Effect of Intravenous ω‐3 Fatty Acid Infusion and Hemodialysis on Fatty Acid Composition of Free Fatty Acids and Phospholipids in Patients With End‐Stage Renal Disease, Journal of Parenteral and Enteral Nutrition, 10.1177/0148607110371807, 35:1, (97-106), Online publication date: 1-Jan-2011.

Toth P (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia, Yearbook of Endocrinology, 10.1016/j.yend.2011.06.058, 2011, (51-54), Online publication date: 1-Jan-2011.

Toth P (2011) Dietary intake of n–3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease, Yearbook of Endocrinology, 10.1016/j.yend.2011.06.026, 2011, (41-46), Online publication date: 1-Jan-2011.

Konkel A and Schunck W (2011) Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 10.1016/j.bbapap.2010.09.009, 1814:1, (210-222), Online publication date: 1-Jan-2011.

Toth P (2011) Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia, Yearbook of Medicine, 10.1016/S0084-3873(11)00362-2, 2011, (522-525), Online publication date: 1-Jan-2011.

Serhan C and Godson C (2011) Endogenous Anti-inflammatory and Proresolving Lipid Mediators in Renal Disease Regenerative Nephrology, 10.1016/B978-0-12-380928-5.10004-1, (69-92), .

Moyad M (2011) Nutriceuticals in Sexual Health Cancer and Sexual Health, 10.1007/978-1-60761-916-1_39, (603-626), .

Wong W and Cooke J (2011) Nutritional Impact on the Nitric Oxide Pathway Nitrite and Nitrate in Human Health and Disease, 10.1007/978-1-60761-616-0_7, (97-122), .

Toth P (2011) Management of Dyslipidemia Comprehensive Cardiovascular Medicine in the Primary Care Setting, 10.1007/978-1-60327-963-5_3, (59-89), .

Kuipers R, Luxwolda M, Janneke Dijck-Brouwer D, Eaton S, Crawford M, Cordain L and Muskiet F (2010) Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet, British Journal of Nutrition, 10.1017/S0007114510002679, 104:11, (1666-1687), Online publication date: 14-Dec-2010.

Abate E, Sartor R, Ceconi C and Boffa G (2010) Pharmacological treatment of chronic systolic heart failure: are we scraping the bottom of the barrel?, Journal of Cardiovascular Medicine, 10.2459/JCM.0b013e328339d884, 11:12, (893-905), Online publication date: 1-Dec-2010.

(2010) Efficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice, Trials, 10.1186/1745-6215-11-68, 11:1, Online publication date: 1-Dec-2010.

Palomäki A, Pohjantähti-Maaroos H, Wallenius M, Kankkunen P, Aro H, Husgafvel S, Pihlava J and Oksanen K (2010) Effects of dietary cold-pressed turnip rapeseed oil and butter on serum lipids, oxidized LDL and arterial elasticity in men with metabolic syndrome, Lipids in Health and Disease, 10.1186/1476-511X-9-137, 9:1, Online publication date: 1-Dec-2010.

Kong W, Yen J, Vassiliou E, Adhikary S, Toscano M and Ganea D (2010) Docosahexaenoic acid prevents dendritic cell maturation and in vitro and in vivo expression of the IL-12 cytokine family, Lipids in Health and Disease, 10.1186/1476-511X-9-12, 9:1, Online publication date: 1-Dec-2010.

Filion K, El Khoury F, Bielinski M, Schiller I, Dendukuri N and Brophy J (2010) Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials, BMC Cardiovascular Disorders, 10.1186/1471-2261-10-24, 10:1, Online publication date: 1-Dec-2010.

Ghio S, Scelsi L, Latini R, Masson S, Eleuteri E, Palvarini M, Vriz O, Pasotti M, Gorini M, Marchioli R, Maggioni A and Tavazzi L (2014) Effects of n ‐3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI‐HF trial , European Journal of Heart Failure, 10.1093/eurjhf/hfq172, 12:12, (1345-1353), Online publication date: 1-Dec-2010.

Gerber M (2010) Les effets de la nutrition sur la longévité, Médecine & Longévité, 10.1016/j.mlong.2010.07.001, 2:4, (168-181), Online publication date: 1-Dec-2010.

Scorza F, Cavalheiro E, Arida R, Terra V, Scorza C, Sonoda E and Cysneiros R (2010) Omega-3 Fatty Acids in Sudden Unexpected Death in Epilepsy Sudden Death in Epilepsy, 10.1201/b10317-4, Online publication date: 8-Nov-2010.

Harris W (2010) The Omega-3 Index: Clinical Utility for Therapeutic Intervention, Current Cardiology Reports, 10.1007/s11886-010-0141-6, 12:6, (503-508), Online publication date: 1-Nov-2010.

Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A, von Schacky C, Luft F, Muller D, Rothe M and Schunck W (2010) Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids*, Journal of Biological Chemistry, 10.1074/jbc.M110.118406, 285:43, (32720-32733), Online publication date: 1-Oct-2010.

Dawczynski C, Martin L, Wagner A and Jahreis G (2010) n−3 LC-PUFA-enriched dairy products are able to reduce cardiovascular risk factors: A double-blind, cross-over study, Clinical Nutrition, 10.1016/j.clnu.2010.02.008, 29:5, (592-599), Online publication date: 1-Oct-2010.

Musa-Veloso K and Poon T (2010) Author's reply: Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering, Nutrition Reviews, 10.1111/j.1753-4887.2010.00318.x, 68:9, (569-570)

Maki K and Rains T (2010) Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering, Nutrition Reviews, 10.1111/j.1753-4887.2010.00317.x, 68:9, (567-568)

Bouzidi N, Mekki K, Boukaddoum A, Dida N, Kaddous A and Bouchenak M (2010) Effects of Omega-3 Polyunsaturated Fatty-Acid Supplementation on Redox Status in Chronic Renal Failure Patients With Dyslipidemia, Journal of Renal Nutrition, 10.1053/j.jrn.2010.01.002, 20:5, (321-328), Online publication date: 1-Sep-2010.

Cawood A, Ding R, Napper F, Young R, Williams J, Ward M, Gudmundsen O, Vige R, Payne S, Ye S, Shearman C, Gallagher P, Grimble R and Calder P (2010) Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability, Atherosclerosis, 10.1016/j.atherosclerosis.2010.05.022, 212:1, (252-259), Online publication date: 1-Sep-2010.

Wang J, Reyes Suárez E, Kralovec J and Shahidi F (2010) Effect of Chemical Randomization on Positional Distribution and Stability of Omega-3 Oil Triacylglycerols, Journal of Agricultural and Food Chemistry, 10.1021/jf101582u, 58:15, (8842-8847), Online publication date: 11-Aug-2010.

Shearer G, Harris W, Pedersen T and Newman J (2010) Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters, Journal of Lipid Research, 10.1194/jlr.M900193-JLR200, 51:8, (2074-2081), Online publication date: 1-Aug-2010.

Saravanan P, Davidson N, Schmidt E and Calder P (2010) Cardiovascular effects of marine omega-3 fatty acids, The Lancet, 10.1016/S0140-6736(10)60445-X, 376:9740, (540-550), Online publication date: 1-Aug-2010.

Toth P (2010) Drug Treatment of Hyperlipidaemia, Drugs, 10.2165/10898610-000000000-00000, 70:11, (1363-1379), Online publication date: 1-Jul-2010.

Slee E, McLennan P, Owen A and Theiss M (2010) Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats, Journal of Lipid Research, 10.1194/jlr.M004069, 51:7, (1841-1848), Online publication date: 1-Jul-2010.

McEwen B, Morel-Kopp M, Tofler G and Ward C (2010) Effect of Omega-3 Fish Oil on Cardiovascular Risk in Diabetes, The Diabetes Educator, 10.1177/0145721710372675, 36:4, (565-584), Online publication date: 1-Jul-2010.

Pottala J, Garg S, Cohen B, Whooley M and Harris W (2010) Blood Eicosapentaenoic and Docosahexaenoic Acids Predict All-Cause Mortality in Patients With Stable Coronary Heart Disease, Circulation: Cardiovascular Quality and Outcomes, 3:4, (406-412), Online publication date: 1-Jul-2010.

Dallongeville J, Marecaux N and Amouyel P (2010) Acides gras oméga-3 et risque cardiovasculaire, Oléagineux, Corps gras, Lipides, 10.1051/ocl.2010.0317, 17:4, (232-235), Online publication date: 1-Jul-2010.

Lee S and Chung S (2010) A review of the effects of vitamins and other dietary supplements on seizure activity, Epilepsy & Behavior, 10.1016/j.yebeh.2010.04.013, 18:3, (139-150), Online publication date: 1-Jul-2010.

Ren H, Collins V, Fernandez F, Quinlan S, Griffiths L and Choo K (2010) Shorter Telomere Length in Peripheral Blood Cells Associated With Migraine in Women, Headache: The Journal of Head and Face Pain, 10.1111/j.1526-4610.2010.01693.x, 50:6, (965-972), Online publication date: 1-Jun-2010.

Alvaro A, Rosales R, Masana L and Vallvé J (2010) Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids, The Journal of Nutritional Biochemistry, 10.1016/j.jnutbio.2009.02.010, 21:6, (518-525), Online publication date: 1-Jun-2010.

Gupta A, Guyomard V, Zaman M, Rehman H and Myint P (2010) Systematic review on evidence of the effectiveness of cholesterol-lowering drugs, Advances in Therapy, 10.1007/s12325-010-0033-6, 27:6, (348-364), Online publication date: 1-Jun-2010.

Shukla S, Gupta S, Ojha S and Sharma S (2010) Cardiovascular friendly natural products: a promising approach in the management of CVD, Natural Product Research, 10.1080/14786410903417378, 24:9, (873-898), Online publication date: 20-May-2010.

Ekstein D and Schachter S (2010) Natural Products in Epilepsy—the Present Situation and Perspectives for the Future, Pharmaceuticals, 10.3390/ph3051426, 3:5, (1426-1445)

Bajpai V, Kang S, Kim H and Hou C (2010) Potential Approach of Microbial Conversion to Develop New Antifungal Products of Omega‐3 Fatty Acids Biocatalysis and Biomolecular Engineering, 10.1002/9780470608524.ch30, (459-472), Online publication date: 10-May-2010.

Alessandra Manerba, Enrico Vizzardi, Marco Metra, Livio Dei (2010) n-3 PUFAs and cardiovascular disease prevention, Future Cardiology, 10.2217/fca.10.19, 6:3, (343-350), Online publication date: 1-May-2010.

Rudolph T, Rudolph V, Edreira M, Cole M, Bonacci G, Schopfer F, Woodcock S, Franek A, Pekarova M, Khoo N, Hasty A, Baldus S and Freeman B (2010) Nitro–Fatty Acids Reduce Atherosclerosis in Apolipoprotein E–Deficient Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, 30:5, (938-945), Online publication date: 1-May-2010.

PIRESTANI S, SAHARI M, BARZEGAR M and NIKOOPOUR H LIPID, CHOLESTEROL AND FATTY ACID PROFILE OF SOME COMMERCIALLY IMPORTANT FISH SPECIES FROM SOUTH CASPIAN SEA, Journal of Food Biochemistry, 10.1111/j.1745-4514.2010.00343.x, (no-no)

Das M and Zipes D (2010) Antiarrhythmic and Nonantiarrhythmic Drugs for Sudden Cardiac Death Prevention, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0b013e3181d64dde, 55:5, (438-449), Online publication date: 1-May-2010.

Arnold C, Konkel A, Fischer R and Schunck W (2010) Cytochrome P450–dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids, Pharmacological Reports, 10.1016/S1734-1140(10)70311-X, 62:3, (536-547), Online publication date: 1-May-2010.

Fruchart J, Sacks F, Hermans M, Assmann G, Brown W, Ceska R, Chapman M, Dodson P, Fioretto P, Ginsberg H, Kadowaki T, Lablanche J, Marx N, Plutzky J, Reiner Z, Rosenson R, Staels B, Stock J, Sy R, Wanner C, Zambon A and Zimmet P (2010) Residual Risk Reduction Initiative: výzva ke snížení reziduálního vaskulárního rizika u pacientů s dyslipidemií, Cor et Vasa, 10.33678/cor.2010.056, 52:4, (212-228), Online publication date: 1-Apr-2010.

Billman G, Nishijima Y, Belevych A, Terentyev D, Xu Y, Haizlip K, Monasky M, Hiranandani N, Harris W, Gyorke S, Carnes C and Janssen P (2010) Effects of dietary omega–3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.01065.2009, 298:4, (H1219-H1228), Online publication date: 1-Apr-2010.

(2013) Stroke prevention - other nutrients, Arbor Clinical Nutrition Updates, 10.1017/S144654500000004X, 319, (1-6), Online publication date: 1-Apr-2010.

Le Guennec J, Jude S, Besson P, Martel E and Champeroux P (2010) Cardioprotection by omega-3 fatty acids: Involvement of PKCs?, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 10.1016/j.plefa.2010.02.024, 82:4-6, (173-177), Online publication date: 1-Apr-2010.

Solfrizzi V, Frisardi V, Capurso C, D’Introno A, Colacicco A, Vendemiale G, Capurso A and Panza F (2010) Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms, Ageing Research Reviews, 10.1016/j.arr.2009.07.005, 9:2, (184-199), Online publication date: 1-Apr-2010.

Von Schacky C (2010) Omega-3 Index and Sudden Cardiac Death, Nutrients, 10.3390/nu2030375, 2:3, (375-388)

Volkova E and Tantsyreva I (2010) Contribution of traditional risk factors to 10-year survival in elderly male patients with coronary heart disease, CardioSomatics, 10.26442/CS44974, 1:1, (70-74)

Stirban A, Nandrean S, Götting C, Tamler R, Pop A, Negrean M, Gawlowski T, Stratmann B and Tschoepe D (2010) Effects of n–3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus, The American Journal of Clinical Nutrition, 10.3945/ajcn.2009.28374, 91:3, (808-813), Online publication date: 1-Mar-2010.

Perez-Martinez P, Perez-Jimenez F and Lopez-Miranda J (2010) n-3 PUFA and lipotoxicity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 10.1016/j.bbalip.2009.09.010, 1801:3, (362-366), Online publication date: 1-Mar-2010.

Viviani Anselmi C, Ferreri C, Novelli V, Roncarati R, Bronzini R, Marchese G, Somalvico F, Condorelli G, Montenero A and Puca A (2010) Fatty acid percentage in erythrocyte membranes of atrial flutter/fibrillation patients and controls, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-009-9466-8, 27:2, (95-99), Online publication date: 1-Mar-2010.

Stanley J (2010) How good is the evidence for a favourable effect of very long chain n‐3 polyunsaturated fatty acids on cardiovascular disease?, Lipid Technology, 10.1002/lite.201000006, 22:3, (62-64), Online publication date: 1-Mar-2010.

Joensen A, Schmidt E, Dethlefsen C, Johnsen S, Tjønneland A, Rasmussen L and Overvad K (2009) Dietary intake of total marine n -3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome – a cohort study , British Journal of Nutrition, 10.1017/S0007114509992170, 103:4, (602-607), Online publication date: 28-Feb-2010.

Buhr G and Bales C (2010) Nutritional Supplements for Older Adults: Review and Recommendations—Part II, Journal of Nutrition For the Elderly, 10.1080/01639360903586464, 29:1, (42-71), Online publication date: 24-Feb-2010.

McKeown P, Logan K, McKinley M, Young I and Woodside J (2009) Session 4: CVD, diabetes and cancer Evidence for the use of the Mediterranean diet in patients with CHD, Proceedings of the Nutrition Society, 10.1017/S0029665109991856, 69:1, (45-60), Online publication date: 1-Feb-2010.

Calder P (2010) The 2008 ESPEN Sir David Cuthbertson lecture: Fatty acids and inflammation – From the membrane to the nucleus and from the laboratory bench to the clinic, Clinical Nutrition, 10.1016/j.clnu.2009.11.003, 29:1, (5-12), Online publication date: 1-Feb-2010.

Cho K and Park Y (2010) Cardiovascular Disease and Health Functional Foods, Korean Journal of Family Medicine, 10.4082/kjfm.2010.31.8.587, 31:8, (587), .

Bushkin-Bedient S and Carpenter D Benefits versus Risks Associated with Consumption of Fish and other Seafood, Reviews on Environmental Health, 10.1515/REVEH.2010.25.3.161, 25:3

Wong C, Yiu K, Li S, Lee S, Tam S, Lau C and Tse H (2010) Fish‐oil supplement has neutral effects on vascular and metabolic function but improves renal function in patients with Type 2 diabetes mellitus, Diabetic Medicine, 10.1111/j.1464-5491.2009.02869.x, 27:1, (54-60), Online publication date: 1-Jan-2010.

Kralovec J, Wang W and Barrow C (2010) Production of Omega-3 Triacylglycerol Concentrates using a New Food Grade Immobilized Candida antarctica Lipase B, Australian Journal of Chemistry, 10.1071/CH10087, 63:6, (922), .

Huang T, Wahlqvist M and Li D (2010) Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism, Nutrition, 10.1016/j.nut.2009.05.015, 26:1, (112-119), Online publication date: 1-Jan-2010.

Ambrose J and Srikanth S (2010) Vulnerable Plaques and Patients: Improving Prediction of Future Coronary Events, The American Journal of Medicine, 10.1016/j.amjmed.2009.07.019, 123:1, (10-16), Online publication date: 1-Jan-2010.

Bannenberg G and Serhan C (2010) A Novel Genus of Specialized Anti-Inflammatory and Pro-Resolution Lipid Mediators The Brain and Host Defense, 10.1016/S1567-7443(10)70009-0, (37-57), .

Farnier M (2010) Dyslipidémies et risque cardiovasculaire : données des études de prévention cardiovasculaire, EMC - Endocrinologie - Nutrition, 10.1016/S1155-1941(10)51267-8, 7:4, (1-13), Online publication date: 1-Jan-2010.

Man J, Tymchak W and Jugdutt B (2010) Adjunctive Pharmacologic Therapies in Acute Myocardial Infarction Cardiac Intensive Care, 10.1016/B978-1-4160-3773-6.10013-8, (145-182), .

Roth E and Harris W (2009) Fish Oil for Primary and Secondary Prevention of Coronary Heart Disease, Current Atherosclerosis Reports, 10.1007/s11883-009-0079-6, 12:1, (66-72), Online publication date: 1-Jan-2010.

Weiner S and Rabbani L (2009) Secondary prevention strategies for coronary heart disease, Journal of Thrombosis and Thrombolysis, 10.1007/s11239-009-0381-8, 29:1, (8-24), Online publication date: 1-Jan-2010.

Connor W and Connor S (2010) N-3 Fatty Acids from Fish and Plants: Primary and Secondary Prevention of Cardiovascular Disease Preventive Nutrition, 10.1007/978-1-60327-542-2_10, (249-271), .

Coronel R, Dun W, Boyden P and de Bakker J (2009) Arrhythmia Mechanisms in Ischemia and Infarction Novel Therapeutic Targets for Antiarrhythmic Drugs, 10.1002/9780470561416.ch4, (101-153), Online publication date: 16-Dec-2009.

London B and Frangiskakis J (2009) Dietary Omega‐3 Fatty Acids as a Nonpharmacological Antiarrhythmic Intervention Novel Therapeutic Targets for Antiarrhythmic Drugs, 10.1002/9780470561416.ch21, (543-566), Online publication date: 16-Dec-2009.

Gowani S, Shoukat S, Taqui A, Hanif H, Rawasia W, Qadri Z and Dhakam S (2009) Secondary prevention of heart disease – knowledge among cardiologists and Ω-3 (Omega-3) fatty acid prescribing behaviors in Karachi, Pakistan, BMC Cardiovascular Disorders, 10.1186/1471-2261-9-4, 9:1, Online publication date: 1-Dec-2009.

Lee J, O'Keefe J, Lavie C and Harris W (2009) Omega-3 fatty acids: cardiovascular benefits, sources and sustainability, Nature Reviews Cardiology, 10.1038/nrcardio.2009.188, 6:12, (753-758), Online publication date: 1-Dec-2009.

Tuleta I, Bauriedel G, Hasenbank I, Andrié R, Pabst S, Nickenig G and Skowasch D (2009) Antiplatelet effects of n-3 polyunsaturated fatty acids compared with aspirin: A pilot study with whole-blood aggregometry, Thrombosis Research, 10.1016/j.thromres.2009.04.014, 124:6, (724-726), Online publication date: 1-Dec-2009.

Park Y, Park S, Yi H, Kim H, Kang S, Kim J and Ahn H (2009) Low level of n-3 polyunsaturated fatty acids in erythrocytes is a risk factor for both acute ischemic and hemorrhagic stroke in Koreans, Nutrition Research, 10.1016/j.nutres.2009.10.018, 29:12, (825-830), Online publication date: 1-Dec-2009.

Micallef M and Garg M (2009) Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia, The Journal of Nutritional Biochemistry, 10.1016/j.jnutbio.2009.06.009, 20:12, (927-939), Online publication date: 1-Dec-2009.

Park Y, Lim J, Lee J and Kim S (2009) Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction, British Journal of Nutrition, 10.1017/S0007114509990298, 102:9, (1355-1361), Online publication date: 14-Nov-2009.

Sánchez P and Fernández‐Avilés F (2009) An Integrated Approach to the Management of Patients after the Early Phase of ST Segment Elevation Myocardial Infarction Evidence‐Based Cardiology, 10.1002/9781444309768.ch34, (516-527), Online publication date: 13-Nov-2009.

Calder P and Yaqoob P (2015) Understanding Omega-3 Polyunsaturated Fatty Acids, Postgraduate Medicine, 10.3810/pgm.2009.11.2083, 121:6, (148-157), Online publication date: 1-Nov-2009.

Bitzur R, Cohen H, Kamari Y, Shaish A and Harats D (2009) Triglycerides and HDL Cholesterol, Diabetes Care, 10.2337/dc09-S343, 32:suppl_2, (S373-S377), Online publication date: 1-Nov-2009.

Poppitt S, Howe C, Lithander F, Silvers K, Lin R, Croft J, Ratnasabapathy Y, Gibson R and Anderson C (2009) Effects of Moderate-Dose Omega-3 Fish Oil on Cardiovascular Risk Factors and Mood After Ischemic Stroke, Stroke, 40:11, (3485-3492), Online publication date: 1-Nov-2009.

Tai C, Chen C, Lee H, Wang Y, Li T, Mersamm H, Ding S and Wang P (2009) Docosahexaenoic Acid Enhances Hepatic Serum Amyloid A Expression via Protein Kinase A-dependent Mechanism, Journal of Biological Chemistry, 10.1074/jbc.M109.024661, 284:47, (32239-32247), Online publication date: 1-Nov-2009.

Dallongeville J (2009) Acides gras oméga-3 et risque cardiovasculaire, Médecine des Maladies Métaboliques, 10.1016/S1957-2557(09)73296-1, 3:5, (491-495), Online publication date: 1-Nov-2009.

Harris W (2009) Substudies of the Japan EPA lipid intervention study (JELIS), Current Atherosclerosis Reports, 10.1007/s11883-009-0071-1, 11:6, (399-400), Online publication date: 1-Nov-2009.

Marchioli R, Silletta M, Levantesi G and Pioggiarella R (2009) Omega-3 fatty acids and heart failure, Current Atherosclerosis Reports, 10.1007/s11883-009-0066-y, 11:6, (440-447), Online publication date: 1-Nov-2009.

Harris W (2009) The omega-3 index: From biomarker to risk marker to risk factor, Current Atherosclerosis Reports, 10.1007/s11883-009-0062-2, 11:6, (411-417), Online publication date: 1-Nov-2009.

Kohli P and Levy B (2009) Resolvins and protectins: mediating solutions to inflammation, British Journal of Pharmacology, 10.1111/j.1476-5381.2009.00290.x, 158:4, (960-971), Online publication date: 1-Oct-2009.

Scorza F, Cysneiros R, Terra V, Scorza C, Cavalheiro E, Ribeiro M and Gattaz W (2009) Omega-3 consumption and sudden cardiac death in schizophrenia, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2009.06.008, 81:4, (241-245), Online publication date: 1-Oct-2009.

Verkerk A, den Ruijter H, Bourier J, Boukens B, Brouwer I, Wilders R and Coronel R (2009) Dietary fish oil reduces pacemaker current and heart rate in rabbit, Heart Rhythm, 10.1016/j.hrthm.2009.07.024, 6:10, (1485-1492), Online publication date: 1-Oct-2009.

Chang J, Chen Y and Su K (2009) Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Cardiovascular Diseases (CVDs) and Depression: The Missing Link?, Cardiovascular Psychiatry and Neurology, 10.1155/2009/725310, 2009, (1-6), Online publication date: 27-Sep-2009.

Cysneiros R, Terra V, Machado H, Arida R, Schwartzman J, Cavalheiro E and Scorza F (2009) May the best friend be an enemy if not recognized early: possible role of omega-3 against cardiovascular abnormalities due antipsychotics in the treatment of autism, Arquivos de Neuro-Psiquiatria, 10.1590/S0004-282X2009000500031, 67:3b, (922-926), Online publication date: 1-Sep-2009.

Ambrose J and Srikanth S (2009) Preventing future acute coronary events: is the target the so-called vulnerable plaque or the high-risk or vulnerable patient?, Current Opinion in Cardiology, 10.1097/HCO.0b013e32832ec379, 24:5, (483-489), Online publication date: 1-Sep-2009.

He K (2009) Fish, Long-Chain Omega-3 Polyunsaturated Fatty Acids and Prevention of Cardiovascular Disease—Eat Fish or Take Fish Oil Supplement?, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2009.06.003, 52:2, (95-114), Online publication date: 1-Sep-2009.

Houston M, Fazio S, Chilton F, Wise D, Jones K, Barringer T and Bramlet D (2009) Nonpharmacologic Treatment of Dyslipidemia, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2009.02.002, 52:2, (61-94), Online publication date: 1-Sep-2009.

Rodriguez-Leyva D, McCullough R and Pierce G (2009) Nutrition as a Vehicle for Cardiovascular Translational Research, Journal of Cardiovascular Translational Research, 10.1007/s12265-009-9116-7, 2:3, (328-334), Online publication date: 1-Sep-2009.

Maki1 K, Dicklin M, Lawless A and Reeves M (2017) Omega-3 fatty acids for the treatment of elevated triglycerides, Clinical Lipidology, 10.2217/clp.09.34, 4:4, (425-437), Online publication date: 1-Aug-2009.

Kris-Etherton P, Grieger J and Etherton T (2009) Dietary reference intakes for DHA and EPA, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2009.05.011, 81:2-3, (99-104), Online publication date: 1-Aug-2009.

von Schacky C (2009) Cardiovascular disease prevention and treatment, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2009.05.009, 81:2-3, (193-198), Online publication date: 1-Aug-2009.

Lavie C, Milani R, Mehra M and Ventura H (2009) Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases, Journal of the American College of Cardiology, 10.1016/j.jacc.2009.02.084, 54:7, (585-594), Online publication date: 1-Aug-2009.

Farzaneh-Far R, Harris W, Garg S, Na B and Whooley M (2009) Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study, Atherosclerosis, 10.1016/j.atherosclerosis.2008.12.013, 205:2, (538-543), Online publication date: 1-Aug-2009.

Hirsch A, Verouden N, Koch K, Baan J, Henriques J, Piek J, Rohling W, van der Schaaf R, Tijssen J, Vis M and de Winter R (2009) Comparison of Long-Term Mortality After Percutaneous Coronary Intervention in Patients Treated for Acute ST-Elevation Myocardial Infarction Versus Those With Unstable and Stable Angina Pectoris, The American Journal of Cardiology, 10.1016/j.amjcard.2009.03.052, 104:3, (333-337), Online publication date: 1-Aug-2009.

Pratt C, Reiffel J, Ellenbogen K, Naccarelli G and Kowey P (2009) Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: A prospective study, American Heart Journal, 10.1016/j.ahj.2009.05.024, 158:2, (163-169.e3), Online publication date: 1-Aug-2009.

Hussein N, Fedorova I, Moriguchi T, Hamazaki K, Kim H, Hoshiba J and Salem N (2009) Artificial Rearing of Infant Mice Leads to n‐3 Fatty Acid Deficiency in Cardiac, Neural and Peripheral Tissues, Lipids, 10.1007/s11745-009-3318-2, 44:8, (685-702), Online publication date: 1-Aug-2009.

Den Ruijter H and Coronel R (2009) The Response to Fish Oil in Patients with Heart Disease Depends on the Predominant Arrhythmia Mechanism, Cardiovascular Drugs and Therapy, 10.1007/s10557-009-6172-9, 23:4, (333-334), Online publication date: 1-Aug-2009.

Serhan C and Aliberti J (2014) Novel Anti-Inflammatory and Proresolution Lipid Mediators in Induction and Modulation of Phagocyte Function Phagocyte-Pathogen Interactions, 10.1128/9781555816650.ch17, (265-280)

Kris-Etherton P (2009) Adherence to dietary guidelines: benefits on atherosclerosis progression, The American Journal of Clinical Nutrition, 10.3945/ajcn.2009.28074, 90:1, (13-14), Online publication date: 1-Jul-2009.

Marchioli R, Levantesi G, Silletta M, Barlera S, Bernardinangeli M, Carbonieri E, Cosmi F, Franzosi M, Latini R, Lucci D, Maggioni A, Moretti L, Nicolosi G, Porcu M, Rossi M, Tognoni G and Tavazzi L (2014) Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial, Expert Review of Cardiovascular Therapy, 10.1586/erc.09.70, 7:7, (735-748), Online publication date: 1-Jul-2009.

Kryzhanovskii S and Vititnova M (2009) ω-3 polyunsaturated fatty acids and the cardiovascular system, Human Physiology, 10.1134/S036211970904015X, 35:4, (491-501), Online publication date: 1-Jul-2009.

Rupp H (2009) Omacor® (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia, Advances in Therapy, 10.1007/s12325-009-0045-2, 26:7, (675-690), Online publication date: 1-Jul-2009.

Hu F (2009) Diet and lifestyle influences on risk of coronary heart disease, Current Atherosclerosis Reports, 10.1007/s11883-009-0040-8, 11:4, (257-263), Online publication date: 1-Jul-2009.

McClements D, Decker E, Park Y and Weiss J (2009) Structural Design Principles for Delivery of Bioactive Components in Nutraceuticals and Functional Foods, Critical Reviews in Food Science and Nutrition, 10.1080/10408390902841529, 49:6, (577-606), Online publication date: 16-Jun-2009.

Lavie C, O'Keefe J, Milani R, Ventura H and Mehra M (2015) New Data on the Clinical Impact of Exercise Training, Fish Oils, and Statins in Heart Failure, The Physician and Sportsmedicine, 10.3810/psm.2009.06.1706, 37:2, (22-28), Online publication date: 1-Jun-2009.

Hoy S and Keating G (2009) Omega-3 Ethylester Concentrate, Drugs, 10.2165/00003495-200969080-00008, 69:8, (1077-1105), Online publication date: 1-Jun-2009.

Preiss D and Sattar N (2009) Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence, Clinical Endocrinology, 10.1111/j.1365-2265.2008.03490.x, 70:6, (815-828), Online publication date: 1-Jun-2009.

Park Y, Lim J, Kwon Y and Lee J (2009) Correlation of erythrocyte fatty acid composition and dietary intakes with markers of atherosclerosis in patients with myocardial infarction, Nutrition Research, 10.1016/j.nutres.2009.05.010, 29:6, (391-396), Online publication date: 1-Jun-2009.

Rahman M, Al-Belushi R, Guizani N, Al-Saidi G and Soussi B (2009) Fat oxidation in freeze-dried grouper during storage at different temperatures and moisture contents, Food Chemistry, 10.1016/j.foodchem.2008.11.002, 114:4, (1257-1264), Online publication date: 1-Jun-2009.

Micallef M and Garg M (2009) Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals, Atherosclerosis, 10.1016/j.atherosclerosis.2008.09.020, 204:2, (476-482), Online publication date: 1-Jun-2009.

Shearer G, Pottala J, Spertus J, Harris W and Tomé D (2009) Red Blood Cell Fatty Acid Patterns and Acute Coronary Syndrome, PLoS ONE, 10.1371/journal.pone.0005444, 4:5, (e5444)

Smith P, Blumenthal J, Babyak M, Georgiades A, Sherwood A, Sketch M and Watkins L (2009) Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction, The American Journal of Clinical Nutrition, 10.3945/ajcn.2008.26829, 89:5, (1315-1320), Online publication date: 1-May-2009.

Lecerf J (2009) Fatty acids and cardiovascular disease, Nutrition Reviews, 10.1111/j.1753-4887.2009.00194.x, 67:5, (273-283), Online publication date: 1-May-2009.

Calder P, Albers R, Antoine J, Blum S, Bourdet-Sicard R, Ferns G, Folkerts G, Friedmann P, Frost G, Guarner F, Løvik M, Macfarlane S, Meyer P, M'Rabet L, Serafini M, van Eden W, van Loo J, Vas Dias W, Vidry S, Winklhofer-Roob B and Zhao J (2009) Inflammatory Disease Processes and Interactions with Nutrition, British Journal of Nutrition, 10.1017/S0007114509377867, 101:S1, (1-45), Online publication date: 1-May-2009.

Madden J, Shearman C, Dunn R, Dastur N, Tan R, Nash G, Rainger G, Brunner A, Calder P and Grimble R (2009) Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2008.06.011, 19:4, (247-252), Online publication date: 1-May-2009.

Harris W, Mozaffarian D, Lefevre M, Toner C, Colombo J, Cunnane S, Holden J, Klurfeld D, Morris M and Whelan J (2009) Towards Establishing Dietary Reference Intakes for Eicosapentaenoic and Docosahexaenoic Acids, The Journal of Nutrition, 10.3945/jn.108.101329, 139:4, (804S-819S), Online publication date: 1-Apr-2009.

Musolino A, Panebianco M, Zendri E, Santini M, Di Nuzzo S and Ardizzoni A (2009) Hypertriglyceridaemia with bexarotene in cutaneous T cell lymphoma: the role of omega‐3 fatty acids, British Journal of Haematology, 10.1111/j.1365-2141.2009.07596.x, 145:1, (84-86), Online publication date: 1-Apr-2009.

CLIFTON P (2009) Dietary fatty acids and inflammation, Nutrition & Dietetics, 10.1111/j.1747-0080.2008.01311.x, 66:1, (7-11), Online publication date: 1-Mar-2009.

Majmudar M, Tompkins C, Bachmann J, Blumenthal R and Marine J (2009) Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death, Cardiology in Review, 10.1097/CRD.0b013e3181861be8, 17:2, (60-69), Online publication date: 1-Mar-2009.

Fotuhi M, Mohassel P and Yaffe K (2009) Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association, Nature Reviews Neurology, 10.1038/ncpneuro1044, 5:3, (140-152), Online publication date: 1-Mar-2009.

Katcher H, Hill A, Lanford J, Yoo J and Kris-Etherton P (2009) Lifestyle Approaches and Dietary Strategies to Lower LDL-Cholesterol and Triglycerides and Raise HDL-Cholesterol, Endocrinology and Metabolism Clinics of North America, 10.1016/j.ecl.2008.11.010, 38:1, (45-78), Online publication date: 1-Mar-2009.

Nair A and Darrow B (2009) Lipid Management in the Geriatric Patient, Endocrinology and Metabolism Clinics of North America, 10.1016/j.ecl.2008.11.003, 38:1, (185-206), Online publication date: 1-Mar-2009.

Russo G (2009) Dietary n−6 and n−3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention, Biochemical Pharmacology, 10.1016/j.bcp.2008.10.020, 77:6, (937-946), Online publication date: 1-Mar-2009.

Polsani V, Virani S and Nambi V (2009) Lipid management: Considerations in acute coronary syndrome, Current Atherosclerosis Reports, 10.1007/s11883-009-0024-8, 11:2, (149-156), Online publication date: 1-Mar-2009.

Meiss D and Olmstead S (2009) Cardiac Arrhythmias Food and Nutrients in Disease Management, 10.1201/9781420067637.ch7, Online publication date: 2-Feb-2009.

von Schacky C (2009) Use of red blood cell fatty-acid profiles as biomarkers in cardiac disease, Biomarkers in Medicine, 10.2217/17520363.3.1.25, 3:1, (25-32), Online publication date: 1-Feb-2009.

Pavy B (2009) L’alimentation du cardiaque, Archives des Maladies du Coeur et des Vaisseaux - Pratique, 10.1016/S1261-694X(09)71537-8, 2009:175, (28-29), Online publication date: 1-Feb-2009.

Howlett J, McKelvie R, Arnold J, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz J, Giannetti N, Haddad H, Heckman G, Herd A, Isaac D, Jong P, Kouz S, Liu P, Mann E, Moe G, Tsuyuki R, Ross H and White M (2009) Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials, Canadian Journal of Cardiology, 10.1016/S0828-282X(09)70477-5, 25:2, (85-105), Online publication date: 1-Feb-2009.

Raitt M (2008) Are n-3 Polyunsaturated Fatty Acids Antiarrhythmic in the Absence of Ischemia?, Cardiovascular Drugs and Therapy, 10.1007/s10557-008-6151-6, 23:1, (1-3), Online publication date: 1-Feb-2009.

Freije A (2009) Fatty Acid Profile of the Erythrocyte Membranes of Healthy Bahraini Citizens in Comparison with Coronary Heart Disease Patients, Journal of Oleo Science, 10.5650/jos.58.379, 58:7, (379-388), .

Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y and The JELIS Investigators (2009) Incremental Effects of Eicosapentaenoic Acid on Cardiovascular Events in Statin-Treated Patients With Coronary Artery Disease Secondary Prevention Analysis From JELIS, Circulation Journal, 10.1253/circj.CJ-08-1197, 73:7, (1283-1290), .

Zhao Y, Chen Q, Sun Y, Li X, Zhang P, Xu Y and Guo J (2009) Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trials, Annals of Medicine, 10.1080/07853890802698834, 41:4, (301-310), Online publication date: 1-Jan-2009.

Taha A, Ciobanu F, Saxena A and McIntyre Burnham W (2009) Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy, Epilepsy & Behavior, 10.1016/j.yebeh.2008.10.012, 14:1, (27-31), Online publication date: 1-Jan-2009.

Harris W and Jacobson T (2009) Omega-3 Fatty Acids Clinical Lipidology, 10.1016/B978-141605469-6.50031-7, (326-338), .

Darbar D and Roden D (2009) RHYTHM DISORDERS Pharmacology and Therapeutics, 10.1016/B978-1-4160-3291-5.50029-9, (367-387), .

Murphy M and O'Brien T (2009) DYSLIPIDEMIAS Pharmacology and Therapeutics, 10.1016/B978-1-4160-3291-5.50027-5, (303-320), .

(2009) ADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS MeylerÃ¢Â€Â™s Side Effects of Cardiovascular Drugs, 10.1016/B978-0-444-53268-8.50009-0, (557-820), .

Guthrie R (2008) Should we treat all primary prevention patients with statins?, Current Atherosclerosis Reports, 10.1007/s11883-009-0006-x, 11:1, (36-42), Online publication date: 1-Jan-2009.

(2009) Literatur Kompendium der kardiologischen Prävention und Rehabilitation, 10.1007/978-3-211-69390-2_48, (425-429), .

Kasuga K, Yang R, Porter T, Agrawal N, Petasis N, Irimia D, Toner M and Serhan C (2008) Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution, The Journal of Immunology, 10.4049/jimmunol.181.12.8677, 181:12, (8677-8687), Online publication date: 15-Dec-2008.

Tziomalos K, Athyros V, Karagiannis A and Mikhailidis D (2008) Omega-3 fatty acids: How can they be used in secondary prevention?, Current Atherosclerosis Reports, 10.1007/s11883-008-0079-y, 10:6, (510-517), Online publication date: 1-Dec-2008.

Harris W, Kris-Etherton P and Harris K (2008) Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults, Current Atherosclerosis Reports, 10.1007/s11883-008-0078-z, 10:6, (503-509), Online publication date: 1-Dec-2008.

Müller P, Rosenkranz S, Adam O, Custodis F and Böhm M (2008) Clinical trial updates and hotline sessions presented at the European Society of Cardiology Congress 2008, Clinical Research in Cardiology, 10.1007/s00392-008-0729-7, 97:12, (851-864), Online publication date: 1-Dec-2008.

Estrada J and Darbar D (2008) Clinical use of and future perspectives on antiarrhythmic drugs, European Journal of Clinical Pharmacology, 10.1007/s00228-008-0555-x, 64:12, (1139-1146), Online publication date: 1-Dec-2008.

Fruchart J, Sacks F, Hermans M, Assmann G, Brown W, Ceska R, Chapman M, Dodson P, Fioretto P, Ginsberg H, Kadowaki T, Lablanche J, Marx N, Plutzky J, Reiner Z, Rosenson R, Staels B, Stock J, Sy R, Wanner C, Zambon A and Zimmet P (2008) The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients, Diabetes and Vascular Disease Research, 10.3132/dvdr.2008.046, 5:4, (319-335), Online publication date: 1-Nov-2008.

MacFadyen R (2014) Evolution in cardiovascular care: highlights and observations from the ESC Congress 2008, Expert Review of Cardiovascular Therapy, 10.1586/14779072.6.10.1339, 6:10, (1339-1341), Online publication date: 1-Nov-2008.

DeGiorgio C and Miller P (2008) n-3 fatty acids (eicosapentanoic and docosahexanoic acids) in epilepsy and for the prevention of sudden unexpected death in epilepsy, Epilepsy & Behavior, 10.1016/j.yebeh.2008.06.017, 13:4, (712-713), Online publication date: 1-Nov-2008.

Fruchart J, Sacks F, Hermans M, Assmann G, Brown W, Ceska R, Chapman M, Dodson P, Fioretto P, Ginsberg H, Kadowaki T, Lablanche J, Marx N, Plutzky J, Reiner Ž, Rosenson R, Staels B, Stock J, Sy R, Wanner C, Zambon A and Zimmet P (2008) The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia, The American Journal of Cardiology, 10.1016/j.amjcard.2008.10.002, 102:10, (1K-34K), Online publication date: 1-Nov-2008.

Widlicka A (2008) Enteral Nutrition in the Cardiothoracic Intensive Care Unit: Challenges and Considerations, Nutrition in Clinical Practice, 10.1177/0884533608323422, 23:5, (510-520), Online publication date: 1-Oct-2008.

Anderson P and Delgado M (2008) Endogenous anti‐inflammatory neuropeptides and pro‐resolving lipid mediators: a new therapeutic approach for immune disorders, Journal of Cellular and Molecular Medicine, 10.1111/j.1582-4934.2008.00387.x, 12:5b, (1830-1847), Online publication date: 1-Oct-2008.

Amin A, Menon R, Reid K, Harris W and Spertus J (2008) Acute Coronary Syndrome Patients With Depression Have Low Blood Cell Membrane Omega-3 Fatty Acid Levels, Psychosomatic Medicine, 10.1097/PSY.0b013e318188a01e, 70:8, (856-862), Online publication date: 1-Oct-2008.

Abdukeyum G, Owen A and McLennan P (2008) Dietary (n-3) Long-Chain Polyunsaturated Fatty Acids Inhibit Ischemia and Reperfusion Arrhythmias and Infarction in Rat Heart Not Enhanced by Ischemic Preconditioning, The Journal of Nutrition, 10.1093/jn/138.10.1902, 138:10, (1902-1909), Online publication date: 1-Oct-2008.

Cheng J and Santoni F (2008) Omega-3 Fatty Acid: A Role in the Management of Cardiac Arrhythmias?, The Journal of Alternative and Complementary Medicine, 10.1089/acm.2007.0765, 14:8, (965-974), Online publication date: 1-Oct-2008.

Álvaro A, Rosales R, Masana L and Carles Vallvé J (2008) Los ácidos grasos poliinsaturados disminuyen la expresión in vitro de la proteína NPC1L1, clave en la absorción intestinal de colesterol, Clínica e Investigación en Arteriosclerosis, 10.1016/S0214-9168(08)75907-2, 20:5, (200-206), Online publication date: 1-Oct-2008.

lvarez-Sala Walther L, Torres Do Rego A, del Castillo Rueda A and Recarte Garca-Andrade C (2008) Tratamiento de las hiperlipidemias. Estilos de vida: factores diet?ticos y actividad f?sica. Medicaci?n. Grupos farmacol?gicos: clasificaci?n, indicaciones, contraindicaciones, posolog?a, efectos secundarios e interacciones farmacol?gicas, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 10.1016/S0211-3449(08)73237-5, 10:19, (1246-1252), Online publication date: 1-Oct-2008.

GISSI-HF investigators (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial, The Lancet, 10.1016/S0140-6736(08)61239-8, 372:9645, (1223-1230), Online publication date: 1-Oct-2008.

Chung M (2008) Omega-3 fatty acid supplementation for the prevention of arrhythmias, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-008-0031-z, 10:5, (398-407), Online publication date: 1-Oct-2008.

Schunck W and Schmidt C (2008) Cytochrome P450‐Dependent Eicosanoids Cardiovascular Hormone Systems, 10.1002/9783527626236.ch14, (333-372), Online publication date: 10-Sep-2008.

Messinger-Rapport B, Thomas D, Gammack J and Morley J (2008) Clinical Update on Nursing Home Medicine: 2008, Journal of the American Medical Directors Association, 10.1016/j.jamda.2008.07.006, 9:7, (460-475), Online publication date: 1-Sep-2008.

Erkkilä A, Schwab U, de Mello V, Lappalainen T, Mussalo H, Lehto S, Kemi V, Lamberg-Allardt C and Uusitupa M (2008) Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications, European Journal of Nutrition, 10.1007/s00394-008-0728-5, 47:6, (319-328), Online publication date: 1-Sep-2008.

Dona M, Fredman G, Schwab J, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian U and Serhan C (2008) Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets, Blood, 10.1182/blood-2007-11-122598, 112:3, (848-855), Online publication date: 1-Aug-2008.

BORAN G, BORAN M and KARAÇAM H (2008) SEASONAL CHANGES IN PROXIMATE COMPOSITION OF ANCHOVY AND STORAGE STABILITY OF ANCHOVY OIL, Journal of Food Quality, 10.1111/j.1745-4557.2008.00215.x, 31:4, (503-513), Online publication date: 1-Aug-2008.

Wierzbicki A (2008) A fishy business: omega-3 fatty acids and cardiovascular disease, International Journal of Clinical Practice, 10.1111/j.1742-1241.2008.01781.x, 62:8, (1142-1146)

Ong H and Cheah J (2008) Statin alternatives or just placebo: an objective review of omega-3, red yeast rice and garlic in cardiovascular therapeutics, Chinese Medical Journal, 10.1097/00029330-200808020-00017, 121:16, (1588-1594), Online publication date: 1-Aug-2008.

Scorza F, Cysneiros R, Arida R, Terra-Bustamante V, de Albuquerque M and Cavalheiro E (2008) The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy, Epilepsy & Behavior, 10.1016/j.yebeh.2008.04.011, 13:2, (279-283), Online publication date: 1-Aug-2008.

Harris W (2008) Omega-3 Fatty Acids: The “Japanese” Factor?, Journal of the American College of Cardiology, 10.1016/j.jacc.2008.04.018, 52:6, (425-427), Online publication date: 1-Aug-2008.

Mazza A (2008) Insulin Resistance Syndrome and Glucose Dysregulation in the Elderly, Clinics in Geriatric Medicine, 10.1016/j.cger.2008.03.006, 24:3, (437-454), Online publication date: 1-Aug-2008.

Celik S, Doesch A, Erbel C, Blessing E, Ammon K, Koch A, Katus H and Dengler T (2008) Beneficial Effect of Omega-3 Fatty Acids on Sirolimus- or Everolimus-Induced Hypertriglyceridemia in Heart Transplant Recipients, Transplantation, 10.1097/TP.0b013e318177281e, 86:2, (245-250), Online publication date: 27-Jul-2008.

Becker D, Gordon R, Morris P, Yorko J, Gordon Y, Li M and Iqbal N (2008) Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial, Mayo Clinic Proceedings, 10.4065/83.7.758, 83:7, (758-764), Online publication date: 1-Jul-2008.

Tanaka K, Ishikawa Y, Yokoyama M, Origasa H, Matsuzaki M, Saito Y, Matsuzawa Y, Sasaki J, Oikawa S, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K and Shirato K (2008) Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients, Stroke, 39:7, (2052-2058), Online publication date: 1-Jul-2008.

Bertisch S, Wee C and McCarthy E (2012) Use of Complementary and Alternative Therapies by Overweight and Obese Adults, Obesity, 10.1038/oby.2008.239, 16:7, (1610-1615), Online publication date: 1-Jul-2008.

Polsani V, Virani S and Nambi V (2008) Lipid management: Considerations in acute coronary syndrome, Current Cardiology Reports, 10.1007/s11886-008-0053-x, 10:4, (334-341), Online publication date: 1-Jul-2008.

Solfrizzi V, Capurs C, D'Introno A, Colacicco A, Frisardi V, Santamato A, Ranieri M, Fiore R, Vendemiale G, Seripa D, Pilotto A, Capurso A and Panza F (2008) Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment, The Journal of nutrition, health and aging, 10.1007/BF02982670, 12:6, (382-386), Online publication date: 1-Jul-2008.

O'Keefe J, Lee J, Marchioli R, Lavie C and Harris W (2008) Are All Fish Equally Close to the Heart?–Reply, Mayo Clinic Proceedings, 10.4065/83.6.724-a, 83:6, (724-725), Online publication date: 1-Jun-2008.

Jew S, Vanstone C, Antoine J and Jones P (2008) Generic and Product-Specific Health Claim Processes for Functional Foods across Global Jurisdictions3, The Journal of Nutrition, 10.1093/jn/138.6.1228S, 138:6, (1228S-1236S), Online publication date: 1-Jun-2008.

Cohen B, Garg S, Ali S, Harris W and Whooley M (2008) Red Blood Cell Docosahexaenoic Acid and Eicosapentaenoic Acid Concentrations Are Positively Associated with Socioeconomic Status in Patients with Established Coronary Artery Disease: Data from the Heart and Soul Study, The Journal of Nutrition, 10.1093/jn/138.6.1135, 138:6, (1135-1140), Online publication date: 1-Jun-2008.

Jung U, Torrejon C, Tighe A and Deckelbaum R (2008) n−3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects, The American Journal of Clinical Nutrition, 10.1093/ajcn/87.6.2003S, 87:6, (2003S-2009S), Online publication date: 1-Jun-2008.

Harris W (2008) The omega-3 index as a risk factor for coronary heart disease, The American Journal of Clinical Nutrition, 10.1093/ajcn/87.6.1997S, 87:6, (1997S-2002S), Online publication date: 1-Jun-2008.

Mozaffarian D (2008) Fish and n−3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death, The American Journal of Clinical Nutrition, 10.1093/ajcn/87.6.1991S, 87:6, (1991S-1996S), Online publication date: 1-Jun-2008.

Jacobson T (2008) Role of n−3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease, The American Journal of Clinical Nutrition, 10.1093/ajcn/87.6.1981S, 87:6, (1981S-1990S), Online publication date: 1-Jun-2008.

Albert C (2008) Omega-3 fatty acids and ventricular arrhythmias: Nothing is simple, American Heart Journal, 10.1016/j.ahj.2008.02.001, 155:6, (967-970), Online publication date: 1-Jun-2008.

O'Keefe J, Lee J, Marchioli R, Lavie C and Harris W (2008) Are All Fish Equally Close to the Heart?–Reply, Mayo Clinic Proceedings, 10.1016/S0025-6196(11)60903-8, 83:6, (724-725), Online publication date: 1-Jun-2008.

Macchia A, Monte S, Pellegrini F, Romero M, Ferrante D, Doval H, D’Ettorre A, Maggioni A and Tognoni G (2008) Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction, European Journal of Clinical Pharmacology, 10.1007/s00228-008-0464-z, 64:6, (627-634), Online publication date: 1-Jun-2008.

Hansen H and Artmann A (2008) Endocannabinoids and Nutrition, Journal of Neuroendocrinology, 10.1111/j.1365-2826.2008.01687.x, 20:s1, (94-99), Online publication date: 1-May-2008.

Vaseghi M and Shivkumar K (2008) The Role of the Autonomic Nervous System in Sudden Cardiac Death, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2008.01.003, 50:6, (404-419), Online publication date: 1-May-2008.

Arshad A, Mandava A, Kamath G and Musat D (2008) Sudden Cardiac Death and the Role of Medical Therapy, Progress in Cardiovascular Diseases, 10.1016/j.pcad.2007.12.003, 50:6, (420-438), Online publication date: 1-May-2008.

Panov A, Gordeev M, Nilk R, Korzhenevskaya K and Usova E (2008) Omega3-fatty acid (Omacor) therapy for atrial fibrillation prevention after surgical myocardial revascularization (AXIOMA Study), "Arterial’naya Gipertenziya" ("Arterial Hypertension"), 10.18705/1607-419X-2008-14-2-162-164, 14:2, (162-164)

Cannon C (2008) Combination therapy in the management of mixed dyslipidaemia, Journal of Internal Medicine, 10.1111/j.1365-2796.2008.01933.x, 263:4, (353-365), Online publication date: 1-Apr-2008.

Goldberg R and Sabharwal A (2008) Fish oil in the treatment of dyslipidemia, Current Opinion in Endocrinology, Diabetes & Obesity, 10.1097/MED.0b013e3282f76728, 15:2, (167-174), Online publication date: 1-Apr-2008.

Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K and Aoyama T (2008) Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis, Journal of Clinical Gastroenterology, 10.1097/MCG.0b013e31815591aa, 42:4, (413-418), Online publication date: 1-Apr-2008.

Schaefer M, Wenzel A, Fischer T, Braun-Dullaeus R, Renner F, Dietrich H, Schaefer C, Seeger W and Mayer K (2008) Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: Impact on adhesion and apoptosis, Atherosclerosis, 10.1016/j.atherosclerosis.2007.09.004, 197:2, (630-637), Online publication date: 1-Apr-2008.

Block R, Harris W, Reid K, Sands S and Spertus J (2008) EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls, Atherosclerosis, 10.1016/j.atherosclerosis.2007.07.042, 197:2, (821-828), Online publication date: 1-Apr-2008.

Martin C (2010) Omega-3 Fatty Acids: Proven Benefit or Just a "Fish Story"?, The Consultant Pharmacist, 10.4140/TCP.n.2008.210, 23:3, (210-221), Online publication date: 1-Mar-2008.

Lee J, O'Keefe J, Lavie C, Marchioli R and Harris W (2008) Omega-3 Fatty Acids for Cardioprotection, Mayo Clinic Proceedings, 10.4065/83.3.324, 83:3, (324-332), Online publication date: 1-Mar-2008.

Tannock L (2014) Advances in the management of hyperlipidemia-induced atherosclerosis, Expert Review of Cardiovascular Therapy, 10.1586/14779072.6.3.369, 6:3, (369-383), Online publication date: 1-Mar-2008.

Anand R, Alkadri M, Lavie C and Milani R (2008) The Role of Fish Oil in Arrhythmia Prevention, Journal of Cardiopulmonary Rehabilitation and Prevention, 10.1097/01.HCR.0000314202.09676.f0, 28:2, (92-98), Online publication date: 1-Mar-2008.

Serhan C and Chiang N (2009) Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus, British Journal of Pharmacology, 10.1038/sj.bjp.0707489, 153:S1, Online publication date: 1-Mar-2008.

Harris W and von Schacky C (2008) Omega-3 fatty acids, acute coronary syndrome, and sudden death, Current Cardiovascular Risk Reports, 10.1007/s12170-008-0029-9, 2:2, (161-166), Online publication date: 1-Mar-2008.

Fernandes G (2008) Progress in nutritional immunology, Immunologic Research, 10.1007/s12026-007-0021-3, 40:3, (244-261), Online publication date: 1-Mar-2008.

Smith C, Freeman L, Meurs K, Rush J and Lamb A Plasma fatty acid concentrations in Boxers and Doberman Pinschers, American Journal of Veterinary Research, 10.2460/ajvr.69.2.195, 69:2, (195-198)

Fischer R, Dechend R, Qadri F, Markovic M, Feldt S, Herse F, Park J, Gapelyuk A, Schwarz I, Zacharzowsky U, Plehm R, Safak E, Heuser A, Schirdewan A, Luft F, Schunck W and Muller D (2007) Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension, Hypertension, 51:2, (540-546), Online publication date: 1-Feb-2008.

Serhan C, Yacoubian S and Yang R (2008) Anti-Inflammatory and Proresolving Lipid Mediators, Annual Review of Pathology: Mechanisms of Disease, 10.1146/annurev.pathmechdis.3.121806.151409, 3:1, (279-312), Online publication date: 1-Feb-2008.

Knollmann B and Roden D (2008) A genetic framework for improving arrhythmia therapy, Nature, 10.1038/nature06799, 451:7181, (929-936), Online publication date: 1-Feb-2008.

Brock T (2007) Capturing Proteins that Bind Polyunsaturated Fatty Acids: Demonstration Using Arachidonic Acid and Eicosanoids, Lipids, 10.1007/s11745-007-3136-3, 43:2, (161-169), Online publication date: 1-Feb-2008.

Masood M and Salem N (2007) High‐Throughput Analysis of Plasma Fatty Acid Methyl Esters Employing Robotic Transesterification and Fast Gas Chromatography, Lipids, 10.1007/s11745-007-3130-9, 43:2, Online publication date: 1-Feb-2008.

Versari D, Daghini E, Salvetti G and Salvetti A (2008) Omega 3, High Blood Pressure & Cardiovascular Prevention, 10.2165/0151642-200815040-00002, 15:4, (225-230), .

Solfrizzi V, Capurso C, D’Introno A, Colacicco A, Santamato A, Ranieri M, Fiore P, Capurso A and Panza F (2014) Lifestyle-related factors in predementia and dementia syndromes, Expert Review of Neurotherapeutics, 10.1586/14737175.8.1.133, 8:1, (133-158), Online publication date: 1-Jan-2008.

George C, Barberini-Jammaers S and Muller C (2008) Refocussing therapeutic strategies for cardiac arrhythmias: defining viable molecular targets to restore cardiac ion flux, Expert Opinion on Therapeutic Patents, 10.1517/13543776.18.1.1, 18:1, (1-19), Online publication date: 1-Jan-2008.

Kabagambe E, Tsai M, Hopkins P, Ordovas J, Peacock J, Borecki I and Arnett D (2008) Erythrocyte Fatty Acid Composition and the Metabolic Syndrome: A National Heart, Lung, and Blood Institute GOLDN Study, Clinical Chemistry, 10.1373/clinchem.2007.095059, 54:1, (154-162), Online publication date: 1-Jan-2008.

Harbottle L and Schonfelder N (2009) Nutrition and depression: A review of the evidence, Journal of Mental Health, 10.1080/09638230701677746, 17:6, (576-587), Online publication date: 1-Jan-2008.

Stricker H, Duchini F, Facchini M and Mombelli G (2008) Canola oil decreases cholesterol and improves endothelial function in patients with peripheral arterial occlusive disease – a pilot study☆, Artery Research, 10.1016/j.artres.2008.02.001, 2:2, (67)

Aursnes I (2008) Drugs that affect lipid metabolism A worldwide yearly survey of new data and trends in adverse drug reactions and interactions, 10.1016/S0378-6080(08)00044-5, (515-519), .

Kakar P, Watson T and Lip G (2008) New approaches to therapy with omega-3 fatty acids, Current Atherosclerosis Reports, 10.1007/s11883-008-0012-4, 10:1, (79-87), Online publication date: 1-Jan-2008.

Serhan C Novel lipid mediators in resolution and their aspirin triggered epimers: Lipoxins, resolvins, and protectins The Resolution of Inflammation, 10.1007/978-3-7643-7506-5_6, (93-117)

de Ferranti S (2008) Drug Therapy for Hypercholesterolemia and Dyslipidemia Handbook of Pediatric Cardiovascular Drugs, 10.1007/978-1-84628-953-8_13, (318-333), .

Kadish A and Reddy V Nonantiarrhythmic Drugs in Sudden Death Prevention Electrical Diseases of the Heart, 10.1007/978-1-84628-854-8_54, (760-771)

Dobs A and Edelstein D (2008) Evaluating the Biological Activity and Effects on Human Health of Fish Oil and Its Omega-3 Fatty Acids Wild-Type Food in Health Promotion and Disease Prevention, 10.1007/978-1-59745-330-1_15, (195-214), .

De Meester F (2008) Wild-Type Land-Based Food in Health Promotion and Disease Prevention Wild-Type Food in Health Promotion and Disease Prevention, 10.1007/978-1-59745-330-1_1, (3-20), .

Bell J and Waagbø R (2008) Safe and Nutritious Aquaculture Produce: Benefits and Risks of Alternative Sustainable Aquafeeds Aquaculture in the Ecosystem, 10.1007/978-1-4020-6810-2_6, (185-225), .

Jones S (2008) Therapeutic Foods Hyperlipidemia Management for Primary Care, 10.1007/978-0-387-76606-5_4, (73-111), .

Block G, Jensen C, Norkus E, Dalvi T, Wong L, McManus J and Hudes M (2007) Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study, Nutrition Journal, 10.1186/1475-2891-6-30, 6:1, Online publication date: 1-Dec-2007.

Getz G and Reardon C (2007) Nutrition and Cardiovascular Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 27:12, (2499-2506), Online publication date: 1-Dec-2007.

Luu N, Madden J, Calder P, Grimble R, Shearman C, Chan T, Dastur N, Howell W, Rainger G and Nash G (2007) Dietary Supplementation with Fish Oil Modifies the Ability of Human Monocytes to Induce an Inflammatory Response ,, The Journal of Nutrition, 10.1093/jn/137.12.2769, 137:12, (2769-2774), Online publication date: 1-Dec-2007.

Santini V, Ciampittiello G, Gigli F, Bracaglia D, Baroni A, Cicconetti E, Verri C, Gambardella S and Frontoni S (2007) QTc and autonomic neuropathy in diabetes: Effects of acute hyperglycaemia and n-3 PUFA, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2006.09.006, 17:10, (712-718), Online publication date: 1-Dec-2007.

Pignier C, Revenaz C, Rauly-Lestienne I, Cussac D, Delhon A, Gardette J and Grand B (2007) Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current, Basic Research in Cardiology, 10.1007/s00395-007-0676-x, 102:6, (553-564), Online publication date: 1-Nov-2007.

Brohet C (2014) WHAT’S NEW IN CARDIOVASCULAR PREVENTION?, Acta Clinica Belgica, 10.1179/acb.2007.048, 62:5, (317-322), Online publication date: 1-Oct-2007.

McClements D, Decker E and Weiss J (2007) Emulsion‐Based Delivery Systems for Lipophilic Bioactive Components, Journal of Food Science, 10.1111/j.1750-3841.2007.00507.x, 72:8, Online publication date: 1-Oct-2007.

Zhang W, Wang R, Han S, Bu L, Wang S, Ma H and Jia G (2007) α-Linolenic acid attenuates high glucose-induced apoptosis in cultured human umbilical vein endothelial cells via PI3K/Akt/eNOS pathway, Nutrition, 10.1016/j.nut.2007.07.003, 23:10, (762-770), Online publication date: 1-Oct-2007.

Marchioli R and Mozaffarian D (2007) Foreword, Journal of Cardiovascular Medicine, 10.2459/01.JCM.0000289278.18298.8b, 8:Suppl 1, (S1-S3), Online publication date: 1-Sep-2007.

Garattini S (2007) Long-chain n-3 fatty acids in lipid rafts: implications for anti-inflammatory effects, Journal of Cardiovascular Medicine, 10.2459/01.JCM.0000289277.10675.e8, 8:Suppl 1, (S30-S33), Online publication date: 1-Sep-2007.

McLennan P, Owen A, Slee E and Theiss M (2007) Myocardial function, ischaemia and n-3 polyunsaturated fatty acids: a membrane basis, Journal of Cardiovascular Medicine, 10.2459/01.JCM.0000289272.87803.ce, 8:Suppl 1, (S15-S18), Online publication date: 1-Sep-2007.

Marchioli R, Marfisi R, Borrelli G, Chieffo C, Franzosi M, Levantesi G, Maggioni A, Nicolosi G, Scarano M, Silletta M, Schweiger C, Tavazzi L and Tognoni G (2007) Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial, Journal of Cardiovascular Medicine, 10.2459/01.JCM.0000289271.80180.b6, 8:Suppl 1, (S34-S37), Online publication date: 1-Sep-2007.

Prabodh Shah A, Ichiuji A, Han J, Traina M, El-Bialy A, Kamal Meymandi S and Yvonne Wachsner R (2016) Cardiovascular and Endothelial Effects of Fish Oil Supplementation in Healthy Volunteers, Journal of Cardiovascular Pharmacology and Therapeutics, 10.1177/1074248407304749, 12:3, (213-219), Online publication date: 1-Sep-2007.

Le P, Fraser C, Gardner G, Liang W, Kralovec J, Cunnane S and Windust A (2007) Biosynthetic production of universally 13C-labelled polyunsaturated fatty acids as reference materials for natural health product research, Analytical and Bioanalytical Chemistry, 10.1007/s00216-007-1305-0, 389:1, (241-249), Online publication date: 22-Aug-2007.

Zivkovic A, German J and Sanyal A (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease, The American Journal of Clinical Nutrition, 10.1093/ajcn/86.2.285, 86:2, (285-300), Online publication date: 1-Aug-2007.

Wittwer J and Hersberger M (2007) The two faces of the 15-lipoxygenase in atherosclerosis, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2007.08.001, 77:2, (67-77), Online publication date: 1-Aug-2007.

Mozaffarian D, Marfisi R, Levantesi G, Silletta M, Tavazzi L, Tognoni G, Valagussa F and Marchioli R (2007) Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors, The Lancet, 10.1016/S0140-6736(07)61343-9, 370:9588, (667-675), Online publication date: 1-Aug-2007.

Simopoulos A (2007) Omega-3 fatty acids and athletics, Current Sports Medicine Reports, 10.1007/s11932-007-0037-4, 6:4, (230-236), Online publication date: 1-Aug-2007.

(2007) Common hyperlipidaemia Hyperlipidaemia 3Ed, 10.1201/b13464-6, (125-168), Online publication date: 27-Jul-2007.

(2007) Lipid-modifying therapy Hyperlipidaemia 3Ed, 10.1201/b13464-10, (258-291), Online publication date: 27-Jul-2007.

Svensson M, Schmidt E, Jørgensen K and Christensen J (2007) The Effect of n-3 Fatty Acids on Heart Rate Variability in Patients Treated With Chronic Hemodialysis, Journal of Renal Nutrition, 10.1053/j.jrn.2007.02.004, 17:4, (243-249), Online publication date: 1-Jul-2007.

Harris W, Poston W and Haddock C (2007) Tissue n−3 and n−6 fatty acids and risk for coronary heart disease events, Atherosclerosis, 10.1016/j.atherosclerosis.2007.03.018, 193:1, (1-10), Online publication date: 1-Jul-2007.

Bjarnason-Wehrens B, Held K, Hoberg E, Karoff M and Rauch B (2007) Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha), Clinical Research in Cardiology Supplements, 10.1007/s11789-007-0001-0, 2:3, (1-54), Online publication date: 1-Jul-2007.

Saldanha T and Bragagnolo N (2007) Cholesterol Oxidation is Increased and PUFA Decreased by Frozen Storage and Grilling of Atlantic Hake Fillets ( Merluccius hubbsi ) , Lipids, 10.1007/s11745-007-3062-4, 42:7, (671-678), Online publication date: 1-Jul-2007.

Dubois V, Breton S, Linder M, Fanni J and Parmentier M (2007) Fatty acid profiles of 80 vegetable oils with regard to their nutritional potential, European Journal of Lipid Science and Technology, 10.1002/ejlt.200700040, 109:7, (710-732), Online publication date: 1-Jul-2007.

Nykamp D, Kavanaugh E and Wenker A (2009) <b>Vitamins: The Wise Choice for Women with Cardiovascular Disease</b>, The Consultant Pharmacist, 10.4140/TCP.n.2007.490, 22:6, (490-502), Online publication date: 1-Jun-2007.

Faintuch J, Horie L, Schmidt V, Barbeiro H, Barbeiro D, Soriano F and Cecconello I (2007) OBESITY, INFLAMMATION, VASCULAR REACTIVITY, AND CARDIOCIRCULATORY EVENTS, Clinics, 10.1590/S1807-59322007000300023, 62:3, (357-358), Online publication date: 1-Jun-2007.

Thomas N, Cooper S, Graham M, Boobier W, Baker J and Davies B (2016) Dietary habits of Welsh 12—13 year olds, European Physical Education Review, 10.1177/1356336X07076881, 13:2, (247-257), Online publication date: 1-Jun-2007.

Moyad M (2007) Lifestyle Changes, Nutritional Supplements, and General Preventive Medicine Recommendations That Can Simultaneously Improve Heart and Urologic Health: Part II. What Do I Tell Patients?, Seminars in Preventive and Alternative Medicine, 10.1016/j.spre.2007.10.002, 3:2, (88-100), Online publication date: 1-Jun-2007.

Madden J, Brunner A, Dastur N, Tan R, Nash G, Ed Rainger G, Shearman C, Calder P and Grimble R (2007) Fish oil induced increase in walking distance, but not ankle brachial pressure index, in peripheral arterial disease is dependent on both body mass index and inflammatory genotype, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2007.04.003, 76:6, (331-340), Online publication date: 1-Jun-2007.

Monassier J and Monassier L (2007) Prise en charge du post-infarctus, La Presse Médicale, 10.1016/j.lpm.2007.02.029, 36:6, (999-1006), Online publication date: 1-Jun-2007.

Chrysohoou C, Panagiotakos D, Pitsavos C, Skoumas J, Krinos X, Chloptsios Y, Nikolaou V and Stefanadis C (2007) Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region—the ATTICA study, The American Journal of Clinical Nutrition, 10.1093/ajcn/85.5.1385, 85:5, (1385-1391), Online publication date: 1-May-2007.

Metcalf R, James M, Gibson R, Edwards J, Stubberfield J, Stuklis R, Roberts-Thomson K, Young G and Cleland L (2007) Effects of fish-oil supplementation on myocardial fatty acids in humans, The American Journal of Clinical Nutrition, 10.1093/ajcn/85.5.1222, 85:5, (1222-1228), Online publication date: 1-May-2007.

von Schacky C (2007) n -3 PUFA in CVD: influence of cytokine polymorphism , Proceedings of the Nutrition Society, 10.1017/S0029665107005411, 66:2, (166-170), Online publication date: 1-May-2007.

Cundiff D, Lanou A and Nigg C (2007) Relation of Omega-3 Fatty Acid Intake to Other Dietary Factors Known to Reduce Coronary Heart Disease Risk, The American Journal of Cardiology, 10.1016/j.amjcard.2006.12.032, 99:9, (1230-1233), Online publication date: 1-May-2007.

Karpov Y and Talitsky K (2007) ω3-polyunsaturated fatti acids as a tool for cardiovascular prevention, "Arterial’naya Gipertenziya" ("Arterial Hypertension"), 10.18705/1607-419X-2007-13-2-160-168, 13:2, (160-168)

Baker W and White C (2016) Cardiology: Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies, Annals of Pharmacotherapy, 10.1345/aph.1H594, 41:4, (587-598), Online publication date: 1-Apr-2007.

Serhan C (2007) Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways, Annual Review of Immunology, 10.1146/annurev.immunol.25.022106.141647, 25:1, (101-137), Online publication date: 1-Apr-2007.

Ariel A and Serhan C (2007) Resolvins and protectins in the termination program of acute inflammation, Trends in Immunology, 10.1016/j.it.2007.02.007, 28:4, (176-183), Online publication date: 1-Apr-2007.

Jacobson T (2007) Beyond lipids: The role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease, Current Atherosclerosis Reports, 10.1007/s11883-007-0011-x, 9:2, (145-153), Online publication date: 1-Apr-2007.

Harris W, DiRienzo M, Sands S, George C, Jones P and Eapen A (2007) Stearidonic Acid Increases the Red Blood Cell and Heart Eicosapentaenoic Acid Content in Dogs, Lipids, 10.1007/s11745-007-3036-6, 42:4, Online publication date: 1-Apr-2007.

McKenney J and Sica D (2007) Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia, American Journal of Health-System Pharmacy, 10.2146/ajhp060164, 64:6, (595-605), Online publication date: 15-Mar-2007.

Smith C, Freeman L, Rush J, Cunningham S and Biourge V (2008) Omega‐3 Fatty Acids in Boxer Dogs with Arrhythmogenic Right Ventricular Cardiomyopathy, Journal of Veterinary Internal Medicine, 10.1111/j.1939-1676.2007.tb02959.x, 21:2, (265-273), Online publication date: 1-Mar-2007.

Aligeti V, Gandhi M, Elam M, Braden R and Rezk A (2007) Effect of Combination Lipid-Modifying Therapy on the Triglyceride Lowering Effect of Fish Oil, The American Journal of the Medical Sciences, 10.1097/MAJ.0b013e3180312ebf, 333:3, (168-172), Online publication date: 1-Mar-2007.

Lip G, Barnett A, Bradbury A, Cappuccio F, Gill P, Hughes E, Imray C, Jolly K and Patel K (2007) Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management, Journal of Human Hypertension, 10.1038/sj.jhh.1002126, 21:3, (183-211), Online publication date: 1-Mar-2007.

da Cunha D, Hamlin R, Billman G and Carnes C (2009) n‐3 (omega‐3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling, British Journal of Pharmacology, 10.1038/sj.bjp.0706977, 150:3, (281-285), Online publication date: 1-Feb-2007.

Burr M (2007) Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel, Proceedings of the Nutrition Society, 10.1017/S0029665107005241, 66:1, (9-15), Online publication date: 1-Feb-2007.

Albert C (2008) Dietary n-3 fatty acid intake and risk of sudden death and coronary artery disease, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-007-0053-y, 9:1, (71-77), Online publication date: 1-Feb-2007.

McClaskey E and Michalets E (2012) Subdural Hematoma After a Fall in an Elderly Patient Taking High‐Dose Omega‐3 Fatty Acids with Warfarin and Aspirin: Case Report and Review of the Literature, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 10.1592/phco.27.1.152, 27:1, (152-160), Online publication date: 1-Jan-2007.

Tamai T, Murota I, Maruyama K, Baba T, Toyama T, Watanabe N, Kudo N and Kawashima Y (2007) Effects of Supplemented Diacylglycerol Rich in Docosahexaenoic Acid on Serum Triacylglycerol in a Diet-Induced Hyperlipidemic Model of Rats Are Essentially Equivalent to Those of Triacylglycerol Rich in Docosahexaenoic Acid, Biological & Pharmaceutical BulletinBiological and Pharmaceutical Bulletin, 10.1248/bpb.30.2381, 30:12, (2381-2388), .

Mazza A and Morley J (2009) Metabolic syndrome and the older male population, The Aging Male, 10.1080/13685530701249592, 10:1, (3-8), Online publication date: 1-Jan-2007.

Harris W, Reid K, Sands S and Spertus J (2007) Blood Omega-3 and Trans Fatty Acids in Middle-Aged Acute Coronary Syndrome Patients, The American Journal of Cardiology, 10.1016/j.amjcard.2006.08.013, 99:2, (154-158), Online publication date: 1-Jan-2007.

Arora R, Frisch D and Kadish A (2007) The Role of Implantable Cardioverter-Defibrillators in Primary and Secondary Prevention of Sudden Cardiac Death Cardiovascular Therapeutics, 10.1016/B978-1-4160-3358-5.50027-9, (459-471), .

Mori T, Burke V and Beilin L (2007) Dietary Fats and Blood Pressure Comprehensive Hypertension, 10.1016/B978-0-323-03961-1.50010-6, (77-88), .

Nodari S, Metra M, Manerba A, Frattini S, Seresini G and dei Cas L (2007) The Prevention of Sudden Death: New Perspectives Current News in Cardiology, 10.1007/978-88-470-0636-2_27, (205-213), .

Zecchin M, Vitrella G and Sinagra G (2007) Sudden Death in Heart Failure: Risk Stratification and Treatment Strategies Perioperative Critical Care Cardiology, 10.1007/978-88-470-0558-7_1, (1-20), .

Hasselmann M, Boncompain-Gérard M and Guérin C Pharmaconutriments lipidiques Traité de nutrition artificielle de l’adulte, 10.1007/978-2-287-33475-7_54, (733-744)

Madjid M, Casscells S and Willerson J (2007) Atherosclerotic Vulnerable Plaques: Pathophysiology, Detection, and Treatment Cardiovascular Medicine, 10.1007/978-1-84628-715-2_27, (621-639), .

Labossiere R and Goldberg I (2007) Management of Hypertriglyceridemia Therapeutic Lipidology, 10.1007/978-1-59745-533-6_10, (201-220), .

Griffin M, Sanders T, Davies I, Morgan L, Millward D, Lewis F, Slaughter S, Cooper J, Miller G and Griffin B (2006) Effects of altering the ratio of dietary n−6 to n−3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP Study, The American Journal of Clinical Nutrition, 10.1093/ajcn/84.6.1290, 84:6, (1290-1298), Online publication date: 1-Dec-2006.

Serhan C (2016) Resolvins and protectins: novel lipid mediators in anti-inflammation and resolution, Scandinavian Journal of Food and Nutrition, 10.1080/17482970601066298, 50:sup2, (68-78), Online publication date: 1-Dec-2006.

Catta-Preta M, Oliveira D, Mandarim-de-Lacerda C and Aguila M (2006) Adult cardiorenal benefits from postnatal fish oil supplement in rat offspring of low-protein pregnancies, Life Sciences, 10.1016/j.lfs.2006.09.004, 80:3, (219-229), Online publication date: 1-Dec-2006.

Basu H, Pernecky S, Sengupta A and Liepa G (2006) Coronary heart disease: How do the benefits of ω‐3 fatty acids compare with those of aspirin, alcohol/red wine, and statin drugs?, Journal of the American Oil Chemists' Society, 10.1007/s11746-006-5153-4, 83:12, (985-997), Online publication date: 1-Dec-2006.

Garg M, Leitch J, Blake R and Garg R (2006) Long‐chain n−3 polyunsaturated fatty acid incorporation into human atrium following fish oil supplementation, Lipids, 10.1007/s11745-006-5062-1, 41:12, (1127-1132), Online publication date: 1-Dec-2006.

Harris W, Gonzales M, Laney N, Sastre A and Borkon A (2006) Effects of Omega-3 Fatty Acids on Heart Rate in Cardiac Transplant Recipients††Disclaimer: Saint Luke’s Hospital holds a minority interest in OmegaMetrix, LLC, Kansas City, Missouri, a company offering blood omega-3 fatty acid testing., The American Journal of Cardiology, 10.1016/j.amjcard.2006.06.033, 98:10, (1393-1395), Online publication date: 1-Nov-2006.

Riedel M, Baczkó I, Searle G, Webster N, Fercho M, Jones L, Lang J, Lytton J, Dyck J and Light P (2006) Metabolic regulation of sodium–calcium exchange by intracellular acyl CoAs, The EMBO Journal, 10.1038/sj.emboj.7601321, 25:19, (4605-4614), Online publication date: 4-Oct-2006.

Toth P and Gotto A (2006) High-Density Lipoprotein Cholesterol Comprehensive Management of High Risk Cardiovascular Patients, 10.3109/9781420019667.008, (295-340), Online publication date: 1-Oct-2006.

Hoskins M and Jacobson T (2017) Combination use of statins and omega-3 fatty acids: an emerging therapy for combined hyperlipidemia, Future Lipidology, 10.2217/17460875.1.5.579, 1:5, (579-591), Online publication date: 1-Oct-2006.

Quiles J, Barja G, Battino M, Mataix J and Solfrizzi V (2006) Role of Olive Oil and Monounsaturated Fatty Acids in Mitochondrial Oxidative Stress and Aging, Nutrition Reviews, 10.1111/j.1753-4887.2006.tb00261.x, 64, (S31-S39), Online publication date: 1-Oct-2006.

Moore C, Bryant S, Mishra G, Krebs J, Browning L, Miller G and Jebb S (2006) Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women, Nutrition, 10.1016/j.nut.2006.07.005, 22:10, (1012-1024), Online publication date: 1-Oct-2006.

Floras J and Bagai A (2006) Polyunsaturated Fatty Acids and the Post-Infarct Patient, Journal of the American College of Cardiology, 10.1016/j.jacc.2006.07.029, 48:8, (1607-1609), Online publication date: 1-Oct-2006.

Rauch B, Schiele R, Schneider S, Gohlke H, Diller F, Gottwik M, Steinbeck G, Heer T, Katus H, Zimmer R, Erdogan A, Pfafferott C and Senges for the OMEGA-Study Group J (2006) Highly Purified Omega-3 Fatty Acids for Secondary Prevention of Sudden Cardiac Death After Myocardial Infarction—Aims and Methods of the OMEGA-Study, Cardiovascular Drugs and Therapy, 10.1007/s10557-006-0495-6, 20:5, (365-375), Online publication date: 1-Oct-2006.

Hamaad A, Kaeng Lee W, Lip G and MacFadyen R (2006) Oral Omega n3-PUFA Therapy (Omacor) Has No Impact on Indices of Heart Rate Variability in Stable Post Myocardial Infarction Patients, Cardiovascular Drugs and Therapy, 10.1007/s10557-006-0295-z, 20:5, (359-364), Online publication date: 1-Oct-2006.

Zipes D, Camm A, Borggrefe M, Buxton A, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss A, Myerburg R, Priori S, Quinones M, Roden D, Silka M and Tracy C (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Circulation, 114:10, (e385-e484), Online publication date: 5-Sep-2006.

Mori T (2006) OMEGA‐3 FATTY ACIDS AND HYPERTENSION IN HUMANS, Clinical and Experimental Pharmacology and Physiology, 10.1111/j.1440-1681.2006.04451.x, 33:9, (842-846), Online publication date: 1-Sep-2006.

Schmidt E, Rasmussen L, Rasmussen J, Joensen A, Madsen M and Christensen J (2006) Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: A minireview with focus on clinical trial data, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2006.05.008, 75:3, (191-195), Online publication date: 1-Sep-2006.

Trevisan M and Stranges S (2006) Cholesterol lowering and mortality: A great success story!, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2006.05.008, 16:6, (391-394), Online publication date: 1-Sep-2006.

Zipes D, Camm A, Borggrefe M, Buxton A, Chaitman B, Fromer M, Gregoratos G, Klein G, Myerburg R, Quinones M, Roden D, Silka M, Tracy C, Smith S, Jacobs A, Adams C, Antman E, Anderson J, Hunt S, Halperin J, Nishimura R, Ornato J, Page R, Riegel B, Priori S, Moss A, Priori S, Blanc J, Budaj A, Camm A, Dean V, Deckers J, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J and Zamorano J (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, Journal of the American College of Cardiology, 10.1016/j.jacc.2006.07.010, 48:5, (e247-e346), Online publication date: 1-Sep-2006.

Wirth A (2006) Metabolisches Syndrom und kardiovaskuläre Komplikationen Metabolic syndrome and cardiovascular complications, Clinical Research in Cardiology Supplements, 10.1007/s11789-006-0005-1, 1:1, (55-67), Online publication date: 1-Sep-2006.

Rupp H (2006) Omega-3-Fettsäuren in der Sekundärprävention nach Myokardinfarkt Omega-3 fatty acids in secondary prevention after myocardial infarct, Clinical Research in Cardiology, 10.1007/s00392-006-1803-7, 95:S6, (vi12-vi16), Online publication date: 1-Sep-2006.

Schacky C (2006) A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels, Vascular Health and Risk Management, 10.2147/vhrm.2006.2.3.251, 2:3, (251-262), Online publication date: 1-Aug-2006.

Lee S, Gura K, Kim S, Arsenault D, Bistrian B and Puder M (2006) Current Clinical Applications of Ω‐6 and Ω‐3 Fatty Acids, Nutrition in Clinical Practice, 10.1177/0115426506021004323, 21:4, (323-341), Online publication date: 1-Aug-2006.

QUILICI S, MARTIN M, MCGUIRE A and ZOELLNER Y (2006) A cost-effectiveness analysis of n-3 PUFA (Omacor®) treatment in post-MI patients, International Journal of Clinical Practice, 10.1111/j.1742-1241.2006.01009.x, 60:8, (922-932)

Benito P, Caballero J, Moreno J, Gutiérrez-Alcántara C, Muñoz C, Rojo G, Garcia S and Soriguer F (2006) Effects of milk enriched with ω-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome, Clinical Nutrition, 10.1016/j.clnu.2005.12.006, 25:4, (581-587), Online publication date: 1-Aug-2006.

Jacobson T (2006) Secondary Prevention of Coronary Artery Disease with Omega-3 Fatty Acids, The American Journal of Cardiology, 10.1016/j.amjcard.2005.12.028, 98:4, (61-70), Online publication date: 1-Aug-2006.

Reiffel J and McDonald A (2006) Antiarrhythmic Effects of Omega-3 Fatty Acids, The American Journal of Cardiology, 10.1016/j.amjcard.2005.12.027, 98:4, (50-60), Online publication date: 1-Aug-2006.

Robinson J and Stone N (2006) Antiatherosclerotic and Antithrombotic Effects of Omega-3 Fatty Acids, The American Journal of Cardiology, 10.1016/j.amjcard.2005.12.026, 98:4, (39-49), Online publication date: 1-Aug-2006.

Adams S and Standridge J (2006) What Should We Eat? Evidence from Observational Studies, Southern Medical Journal, 10.1097/01.smj.0000220887.52952.f0, 99:7, (744-748), Online publication date: 1-Jul-2006.

Darbar D and Roden D (2006) Future of antiarrhythmic drugs, Current Opinion in Cardiology, 10.1097/01.hco.0000231407.61683.05, 21:4, (361-367), Online publication date: 1-Jul-2006.

Zaloga G, Ruzmetov N, Harvey K, Terry C, Patel N, Stillwell W and Siddiqui R (2006) (n-3) Long-Chain Polyunsaturated Fatty Acids Prolong Survival following Myocardial Infarction in Rats, The Journal of Nutrition, 10.1093/jn/136.7.1874, 136:7, (1874-1878), Online publication date: 1-Jul-2006.

Wang C, Harris W, Chung M, Lichtenstein A, Balk E, Kupelnick B, Jordan H and Lau J (2006) n−3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review, The American Journal of Clinical Nutrition, 10.1093/ajcn/84.1.5, 84:1, (5-17), Online publication date: 1-Jul-2006.

Brouwer I, Geelen A and Katan M (2006) n−3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease, Progress in Lipid Research, 10.1016/j.plipres.2006.02.004, 45:4, (357-367), Online publication date: 1-Jul-2006.

Bryhn M, Hansteen H, Schanche T and Aakre S (2006) The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2006.04.003, 75:1, (19-24), Online publication date: 1-Jul-2006.

Breslow J (2006) n−3 Fatty acids and cardiovascular disease, The American Journal of Clinical Nutrition, 10.1093/ajcn/83.6.1477S, 83:6, (1477S-1482S), Online publication date: 1-Jun-2006.

Serhan C (2006) Novel Chemical Mediators in the Resolution of Inflammation: Resolvins and Protectins, Anesthesiology Clinics of North America, 10.1016/j.atc.2006.01.003, 24:2, (341-364), Online publication date: 1-Jun-2006.

Raitt M (2006) Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?, Future Cardiology, 10.2217/14796678.2.3.273, 2:3, (273-279), Online publication date: 1-May-2006.

Paoletti R, Poli A and Cignarella A (2014) The emerging link between nutrition, inflammation and atherosclerosis, Expert Review of Cardiovascular Therapy, 10.1586/14779072.4.3.385, 4:3, (385-393), Online publication date: 1-May-2006.

Mccallum R and Fisher M (2016) Review: Comparing cardiovascular outcomes in diabetes studies, The British Journal of Diabetes & Vascular Disease, 10.1177/14746514060060030301, 6:3, (111-118), Online publication date: 1-May-2006.

Jenkins N, Davidson N and Bennett D (2006) Successful treatment of drug refractory ventricular tachycardia by omega-3 fatty acid supplementation, EP Europace, 10.1093/europace/eul007, 8:5, (330-332), Online publication date: 1-May-2006.

Capell W and Eckel R (2006) Treatment of hypertriglyceridemia, Current Diabetes Reports, 10.1007/s11892-006-0040-9, 6:3, (230-240), Online publication date: 1-May-2006.

(2006) Guidelines for the management of acute coronary syndromes 2006, Medical Journal of Australia, 10.5694/j.1326-5377.2006.tb00304.x, 184:S8, Online publication date: 1-Apr-2006.

Beral V (2006) Review shows breast screening is effective, Practice Nursing, 10.12968/pnur.2006.17.4.20848, 17:4, (165-167), Online publication date: 1-Apr-2006.

Hoang A and Canada T (2006) Ω‐3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Controlled Trial, Nutrition in Clinical Practice, 10.1177/0115426506021002189, 21:2, (189-190), Online publication date: 1-Apr-2006.

Heller A, Rössler S, Litz R, Stehr S, Heller S, Koch R and Koch T (2006) Omega-3 fatty acids improve the diagnosis-related clinical outcome*, Critical Care Medicine, 10.1097/01.CCM.0000206309.83570.45, 34:4, (972-979), Online publication date: 1-Apr-2006.

Brouwer I, Heeringa J, Geleijnse J, Zock P and Witteman J (2006) Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study, American Heart Journal, 10.1016/j.ahj.2005.07.029, 151:4, (857-862), Online publication date: 1-Apr-2006.

Sanders T, Gleason K, Griffin B and Miller G (2007) Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6 n -3) and docosapentaenoic acid (22:5 n -6) on cardiovascular risk factors in healthy men and women , British Journal of Nutrition, 10.1079/BJN20051658, 95:3, (525-531), Online publication date: 1-Mar-2006.

Brown M, Hart C, Gazi E, Bagley S and Clarke N (2006) Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs, British Journal of Cancer, 10.1038/sj.bjc.6603030, 94:6, (842-853), Online publication date: 1-Mar-2006.

Parker G, Heruc G, Hilton T, Olley A, Brotchie H, Hadzi-Pavlovic D, Friend C, Walsh W and Stocker R (2006) Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression, Psychiatry Research, 10.1016/j.psychres.2005.08.005, 141:3, (279-286), Online publication date: 1-Mar-2006.

Moyad M (2006) Step-by-Step Lifestyle Changes That Can Improve Urologic Health in Men, Part II: What Do I Tell My Patients?, Primary Care: Clinics in Office Practice, 10.1016/j.pop.2005.11.003, 33:1, (165-185), Online publication date: 1-Mar-2006.

Chattipakorn N, Shinlapawittayatorn K, Sungnoon R and Chattipakorn S (2006) Effects of n-3 polyunsaturated fatty acid on upper limit of vulnerability shocks, International Journal of Cardiology, 10.1016/j.ijcard.2005.03.032, 107:3, (299-302), Online publication date: 1-Mar-2006.

Serhan C, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T, Yang R, Colgan S and Petasis N (2006) Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes, The Journal of Immunology, 10.4049/jimmunol.176.3.1848, 176:3, (1848-1859), Online publication date: 1-Feb-2006.

Xiao Y, Ma L, Wang S, Josephson M, Wang G, Morgan J and Leaf A (2006) Potent block of inactivation-deficient Na + channels by n-3 polyunsaturated fatty acids , American Journal of Physiology-Cell Physiology, 10.1152/ajpcell.00296.2005, 290:2, (C362-C370), Online publication date: 1-Feb-2006.

Ratledge C and Hopkins S (2006) Applications and safety of microbial oils in food Modifying Lipids for Use in Food, 10.1533/9781845691684.3.567, (567-586), .

Arannilewa S, Salawu S, Sorungbe A and Ola-Salawu B (2016) Effect of Frozen Period on The Chemical, Microbiological and Sensory Quality of Frozen Tilapia Fish ( Sarotherodun Galiaenus ) , Nutrition and Health, 10.1177/026010600601800210, 18:2, (185-192), Online publication date: 1-Jan-2006.

Colić Barić I, Šatalić Z and Keser I (2016) Nutritional Quality of Meals in Nursing Homes and Meals on Wheels for Elderly Persons in Croatia, Nutrition and Health, 10.1177/026010600601800203, 18:2, (119-125), Online publication date: 1-Jan-2006.

Lanyau Domínguez Y, Hernández M, Macías Matos C and Zhou D (2016) Is B Vitamins Deficiency Associated with Prevalence of Alzheimer's Disease in Cuban Elderly?, Nutrition and Health, 10.1177/026010600601800202, 18:2, (103-118), Online publication date: 1-Jan-2006.

Engler M and Engler M (2006) Omega-3 Fatty Acids, The Journal of Cardiovascular Nursing, 10.1097/00005082-200601000-00005, 21:1, (17-24), Online publication date: 1-Jan-2006.

Boos C, Anderson R and Lip G (2005) Is atrial fibrillation an inflammatory disorder?, European Heart Journal, 10.1093/eurheartj/ehi645, 27:2, (136-149), Online publication date: 1-Jan-2006.

Lee K, Blann A and Lip G (2006) Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction, Thrombosis Research, 10.1016/j.thromres.2005.07.018, 118:3, (305-312), Online publication date: 1-Jan-2006.

Boran G, Karaçam H and Boran M (2006) Changes in the quality of fish oils due to storage temperature and time, Food Chemistry, 10.1016/j.foodchem.2005.06.041, 98:4, (693-698), Online publication date: 1-Jan-2006.

Bover R, Villacastín J, Pérez-Castellano N, Moreno J, Morales R and Macaya C (2006) Supresión de arritmias supraventriculares y ventriculares. ¿Qué papel pueden desempeñar los ácidos grasos omega-3?, Revista Española de Cardiología Suplementos, 10.1016/S1131-3587(06)74825-7, 6:4, (38D-51D), Online publication date: 1-Jan-2006.

López Farré A and Macaya C (2006) Efectos antitrombóticos y antiinflamatorios de los ácidos grasos omega-3, Revista Española de Cardiología Suplementos, 10.1016/S1131-3587(06)74824-5, 6:4, (31D-37D), Online publication date: 1-Jan-2006.

Martínez-González J and Badimon L (2006) Estatinas y ácidos grasos omega-3. Disminución de la mortalidad cardiovascular dependiente e independiente de la reducción de la colesterolemia, Revista Española de Cardiología Suplementos, 10.1016/S1131-3587(06)74823-3, 6:4, (20D-30D), Online publication date: 1-Jan-2006.

Caballero R, Gómez R, Núñez L, Vaquero M, Tamargo J and Delpón E (2006) Farmacología de los ácidos grasos omega-3, Revista Española de Cardiología Suplementos, 10.1016/S1131-3587(06)74822-1, 6:4, (3D-19D), Online publication date: 1-Jan-2006.

Serhan C and Savill J (2005) Resolution of inflammation: the beginning programs the end, Nature Immunology, 10.1038/ni1276, 6:12, (1191-1197), Online publication date: 1-Dec-2005.

Rivellese A (2005) Diet and cardiovascular disease: Beyond cholesterol, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2005.10.004, 15:6, (395-398), Online publication date: 1-Dec-2005.

Patch C, Tapsell L, Mori T, Meyer B, Murphy K, Mansour J, Noakes M, Clifton P, Puddey I, Beilin L, Annison G and Howe P (2005) The Use of Novel Foods Enriched with Long-Chain n-3 Fatty Acids to Increase Dietary Intake: A Comparison of Methodologies Assessing Nutrient Intake, Journal of the American Dietetic Association, 10.1016/j.jada.2005.09.001, 105:12, (1918-1926), Online publication date: 1-Dec-2005.

Hennekens C, Hennekens A, Hollar D and Casey D (2005) Schizophrenia and increased risks of cardiovascular disease, American Heart Journal, 10.1016/j.ahj.2005.02.007, 150:6, (1115-1121), Online publication date: 1-Dec-2005.

Wohl D, Tien H, Busby M, Cunningham C, MacIntosh B, Napravnik S, Danan E, Donovan K, Hossenipour M and Simpson R (2005) Randomized Study of the Safety and Efficacy of Fish Oil (Omega-3 Fatty Acid) Supplementation with Dietary and Exercise Counseling for the Treatment of Antiretroviral Therapy--Associated Hypertriglyceridemia, Clinical Infectious Diseases, 10.1086/497273, 41:10, (1498-1504), Online publication date: 15-Nov-2005.

NINIO D, MURPHY K, HOWE P and SAINT D (2005) Dietary Fish Oil Protects Against Stretch‐Induced Vulnerability to Atrial Fibrillation in a Rabbit Model, Journal of Cardiovascular Electrophysiology, 10.1111/j.1540-8167.2005.50007.x, 16:11, (1189-1194), Online publication date: 1-Nov-2005.

Kastelein J (2005) Modifying Plasma Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol: What Combinations Are Available in the Future?, The American Journal of Cardiology, 10.1016/j.amjcard.2005.08.004, 96:9, (20-27), Online publication date: 1-Nov-2005.

Reiffel J (2009) Practical algorithms for pharmacologic management of the post myocardial infarction patient, Clinical Cardiology, 10.1002/clc.4960281306, 28:S1, (28-37)

Stamp L, James M and Cleland L (2005) Diet and Rheumatoid Arthritis: A Review of the Literature, Seminars in Arthritis and Rheumatism, 10.1016/j.semarthrit.2005.05.001, 35:2, (77-94), Online publication date: 1-Oct-2005.

Gohlke H (2005) Ernährung Nutrition, Zeitschrift für Kardiologie, 10.1007/s00392-005-1304-0, 94:S3, (iii15-iii21), Online publication date: 1-Oct-2005.

Denke M (2005) Diet, Lifestyle, and Nonstatin Trials: Review of Time to Benefit, The American Journal of Cardiology, 10.1016/j.amjcard.2005.06.014, 96:5, (3-10), Online publication date: 1-Sep-2005.

Wyne K (2005) Metabolic syndrome: Demographic features, etiology, and clinical management, Current Atherosclerosis Reports, 10.1007/s11883-005-0051-z, 7:5, (381-388), Online publication date: 1-Sep-2005.

Raimondi L, Lodovici M, Visioli F, Sartiani L, Cioni L, Alfarano C, Banchelli G, Pirisino R, Cecchi E, Cerbai E and Mugelli A (2004) n–3 polyunsaturated fatty acids supplementation decreases asymmetric dimethyl arginine and arachidonate accumulation in aging spontaneously hypertensive rats, European Journal of Nutrition, 10.1007/s00394-004-0528-5, 44:6, (327-333), Online publication date: 1-Sep-2005.

Upritchard J, Zeelenberg M, Huizinga H, Verschuren P and Trautwein E (2007) Modern fat technology: what is the potential for heart health?, Proceedings of the Nutrition Society, 10.1079/PNS2005446, 64:3, (379-386), Online publication date: 1-Aug-2005.

Macchia A, Levantesi G, Franzosi M, Geraci E, Maggioni A, Marfisi R, Nicolosi G, Schweiger C, Tavazzi L, Tognoni G, Valagussa F and Marchioli R (2005) Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n‐3 polyunsaturated fatty acids, European Journal of Heart Failure, 10.1016/j.ejheart.2005.04.008, 7:5, (904-909), Online publication date: 1-Aug-2005.

Ackman R (2005) Fish Oils Bailey's Industrial Oil and Fat Products, 10.1002/047167849X.bio078

(2005) Opinion of the Scientific Panel on contaminants in the food chain [CONTAM] related to the safety assessment of wild and farmed fish, EFSA Journal, 10.2903/j.efsa.2005.236, 3:7, (236), Online publication date: 1-Jul-2005.

Leaf A, Xiao Y, Kang J and Billman G (2005) Membrane Effects of the n-3 Fish Oil Fatty Acids, which Prevent Fatal Ventricular Arrhythmias, Journal of Membrane Biology, 10.1007/s00232-005-0789-9, 206:2, (129-139), Online publication date: 1-Jul-2005.

Marchioli R, Levantesi G, Macchia A, Maggioni A, Marfisi R, Silletta M, Tavazzi L, Tognoni G and Valagussa F (2005) Antiarrhythmic Mechanisms of n-3 PUFA and the Results of the GISSI-Prevenzione Trial, Journal of Membrane Biology, 10.1007/s00232-005-0788-x, 206:2, (117-128), Online publication date: 1-Jul-2005.

McLennan P and Abeywardena M (2005) Membrane Basis for Fish Oil Effects on the Heart: Linking Natural Hibernators to Prevention of Human Sudden Cardiac Death, Journal of Membrane Biology, 10.1007/s00232-005-0787-y, 206:2, (85-102), Online publication date: 1-Jul-2005.

Burr M, Dunstan F and George C (2005) Is Fish Oil Good or Bad for Heart Disease? Two Trials with Apparently Conflicting Results, Journal of Membrane Biology, 10.1007/s00232-005-0784-1, 206:2, (155-163), Online publication date: 1-Jul-2005.

Maki K, Van Elswyk M, McCarthy D, Hess S, Veith P, Bell M, Subbaiah P and Davidson M (2005) Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol, Journal of the American College of Nutrition, 10.1080/07315724.2005.10719465, 24:3, (189-199), Online publication date: 1-Jun-2005.

Geelen A, Zock P, Brouwer I, Katan M, Kors J, Ritsema van Eck H and Schouten E (2007) Effect of n -3 fatty acids from fish on electrocardiographic characteristics in patients with frequent premature ventricular complexes , British Journal of Nutrition, 10.1079/BJN20051429, 93:6, (787-790), Online publication date: 1-Jun-2005.

Calò L, Bianconi L, Colivicchi F, Lamberti F, Loricchio M, de Ruvo E, Meo A, Pandozi C, Staibano M and Santini M (2005) N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.02.079, 45:10, (1723-1728), Online publication date: 1-May-2005.

Colquhoun D (2005) Omega-3 Fatty Acids for Secondary Prevention, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.02.028, 45:9, (1552), Online publication date: 1-May-2005.

(2005) References Cardiovascular Disease, 10.1002/9780470774663.refs, (312-370), Online publication date: 6-Apr-2005.

Lee Y and Wander R (2005) Reduced effect on apoptosis of 4-hydroxyhexenal and oxidized LDL enriched with n-3 fatty acids from postmenopausal women, The Journal of Nutritional Biochemistry, 10.1016/j.jnutbio.2004.09.006, 16:4, (213-221), Online publication date: 1-Apr-2005.

Holguin F, Téllez-Rojo M, Lazo M, Mannino D, Schwartz J, Hernández M and Romieu I (2005) Cardiac Autonomic Changes Associated With Fish Oil vs Soy Oil Supplementation in the Elderly, Chest, 10.1016/S0012-3692(15)34453-6, 127:4, (1102-1107), Online publication date: 1-Apr-2005.

Harrison N and Abhyankar B (2004) The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction, Current Medical Research and Opinion, 10.1185/030079904X17956, 21:1, (95-100), Online publication date: 1-Mar-2005.

Bautista M and Engler M (2007) The Mediterranean Diet: Is It Cardioprotective?, Progress in Cardiovascular Nursing, 10.1111/j.0889-7204.2005.04558.x, 20:2, (70-76), Online publication date: 1-Mar-2005.

McCowen K and Bistrian B (2005) Essential fatty acids and their derivatives, Current Opinion in Gastroenterology, 10.1097/01.mog.0000153361.90653.cb, 21:2, (207-215), Online publication date: 1-Mar-2005.

Serhan C (2005) Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins, Current Opinion in Clinical Nutrition and Metabolic Care, 10.1097/00075197-200503000-00003, 8:2, (115-121), Online publication date: 1-Mar-2005.

Dhein S, Michaelis B and Mohr F (2005) Antiarrhythmic and electrophysiological effects of long-chain ω-3 polyunsaturated fatty acids, Naunyn-Schmiedeberg's Archives of Pharmacology, 10.1007/s00210-005-1024-z, 371:3, (202-211), Online publication date: 1-Mar-2005.

Schwarz S and Leweling H (2016) Multiple sclerosis and nutrition, Multiple Sclerosis Journal, 10.1191/1352458505ms1119oa, 11:1, (24-32), Online publication date: 1-Feb-2005.

Geelen A, Brouwer I, Schouten E, Maan A, Katan M and Zock P (2005) Effects of n–3 fatty acids from fish on premature ventricular complexes and heart rate in humans, The American Journal of Clinical Nutrition, 10.1093/ajcn.81.2.416, 81:2, (416-420), Online publication date: 1-Feb-2005.

Robinson J and Maheshwari N (2005) A “poly-portfolio” for secondary prevention: A strategy to reduce subsequent events by up to 97% over five years, The American Journal of Cardiology, 10.1016/j.amjcard.2004.09.036, 95:3, (373-378), Online publication date: 1-Feb-2005.

Schwarz S and Leweling H (2005) Multiple Sklerose und Ernährung Diet and multiple sclerosis, Der Nervenarzt, 10.1007/s00115-004-1783-7, 76:2, (131-142), Online publication date: 1-Feb-2005.

Oda E, Hatada K, Kimura J, Aizawa Y, Thanikachalam P and Watanabe K (2005) Relationships Between Serum Unsaturated Fatty Acids and Coronary Risk Factors Negative Relations Between Nervonic Acid and Obesity-Related Risk Factors, International Heart Journal, 10.1536/ihj.46.975, 46:6, (975-985), .

Oda E, Hatada K, Katoh K, Kodama M, Nakamura Y and Aizawa Y (2005) A Case-control Pilot Study on n-3 Polyunsaturated Fatty Acid as a Negative Risk Factor for Myocardial Infarction, International Heart Journal, 10.1536/ihj.46.583, 46:4, (583-591), .

TOMIYAMA H, TAKAZAWA K, OSA S, HIROSE K, HIRAI A, IKETANI T, MONDEN M, SANOYAMA K and YAMASHINA A (2005) Do Eicosapentaenoic Acid Supplements Attenuate Age-Related Increases in Arterial Stiffness in Patients with Dyslipidemia ?: A Preliminary Study, Hypertension Research, 10.1291/hypres.28.651, 28:8, (651-655), .

Frost L and Vestergaard P (2005) n−3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study1–3, The American Journal of Clinical Nutrition, 10.1093/ajcn/81.1.50, 81:1, (50-54), Online publication date: 1-Jan-2005.

Moyad M (2005) An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part I, Urologic Oncology: Seminars and Original Investigations, 10.1016/j.urolonc.2005.01.016, 23:1, (28-35), Online publication date: 1-Jan-2005.

Yamashita T, Oda E, Sano T, Yamashita T, Ijiru Y, Giddings J and Yamamoto J (2005) Varying the ratio of dietary n−6/n−3 polyunsaturated fatty acid alters the tendency to thrombosis and progress of atherosclerosis in apoE−/− LDLR−/− double knockout mouse, Thrombosis Research, 10.1016/j.thromres.2005.01.011, 116:5, (393-401), Online publication date: 1-Jan-2005.

Schmidt E, Arnesen H, Christensen J, Rasmussen L, Kristensen S and De Caterina R (2005) Marine n−3 polyunsaturated fatty acids and coronary heart disease, Thrombosis Research, 10.1016/j.thromres.2004.09.007, 115:4, (257-262), Online publication date: 1-Jan-2005.

Bergé J and Barnathan G (2005) Fatty Acids from Lipids of Marine Organisms: Molecular Biodiversity, Roles as Biomarkers, Biologically Active Compounds, and Economical Aspects Marine Biotechnology I, 10.1007/b135782, (49-125)

Connor S and Connor W (2005) n-3 Fatty Acids from Fish and Plants Preventive Nutrition, 10.1007/978-1-59259-880-9_9, (221-244), .

Cascio W Mechanisms of Sudden Cardiac Death Principles of Molecular Cardiology, 10.1007/978-1-59259-878-6_19, (323-351)

Hersberger M and von Eckardstein A (2005) Modulation of High-Density Lipoprotein Cholesterol Metabolism and Reverse Cholesterol Transport Atherosclerosis: Diet and Drugs, 10.1007/3-540-27661-0_20, (537-561), .

Gæde P and Pedersen O (2004) Intensive Integrated Therapy of Type 2 Diabetes, Diabetes, 10.2337/diabetes.53.suppl_3.S39, 53:suppl_3, (S39-S47), Online publication date: 1-Dec-2004.

Wierzbicki A (2005) Lipid-lowering therapies in development, Expert Opinion on Investigational Drugs, 10.1517/13543784.13.11.1405, 13:11, (1405-1418), Online publication date: 1-Nov-2004.

McNaughton S, Steer T and Jebb S (2004) Women and food FAQs, Women's Health Medicine, 10.1383/wohm.1.1.49.55410, 1:1, (49-51), Online publication date: 1-Nov-2004.

Wierzbicki A (2004) Lipid-altering agents: the future, International Journal of Clinical Practice, 10.1111/j.1742-1241.2004.00087.x, 58:11, (1063-1072)

Goldrosen M and Straus S (2004) Complementary and alternative medicine: assessing the evidence for immunological benefits, Nature Reviews Immunology, 10.1038/nri1486, 4:11, (912-921), Online publication date: 1-Nov-2004.

Chahoud G, Aude Y and Mehta J (2004) Dietary recommendations in the prevention and treatment of coronary heart disease: Do we have the ideal diet yet?, The American Journal of Cardiology, 10.1016/j.amjcard.2004.07.109, 94:10, (1260-1267), Online publication date: 1-Nov-2004.

Harris W (2004) Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?, Current Atherosclerosis Reports, 10.1007/s11883-004-0085-7, 6:6, (447-452), Online publication date: 1-Nov-2004.

Serhan C, Arita M, Hong S and Gotlinger K (2004) Resolvins, docosatrienes, and neuroprotectins, novel omega‐3‐derived mediators, and their endogenous aspirin‐triggered epimers, Lipids, 10.1007/s11745-004-1339-7, 39:11, (1125-1132), Online publication date: 1-Nov-2004.

Hooper L, Harrison R, Summerbell C, Moore H, Worthington H, Ness A, Capps N, Davey Smith G, Riemersma R and Ebrahim S (2004) Omega 3 fatty acids for prevention and treatment of cardiovascular disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003177.pub2

Windler E (2004) Pr�vention der KHK, CME, 10.1007/s11298-004-0002-y

Harris J, Hibbeln J, Mackey R and Muldoon M (2004) Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2004.06.001, 71:4, (263-269), Online publication date: 1-Oct-2004.

Root M and Anderson J (2004) Dietary effects on nontraditional risk factors for heart disease, Nutrition Research, 10.1016/j.nutres.2004.06.006, 24:10, (827-838), Online publication date: 1-Oct-2004.

Calder P (2004) Long-chain n-3 fatty acids and cardiovascular disease: further evidence and insights, Nutrition Research, 10.1016/j.nutres.2004.04.008, 24:10, (761-772), Online publication date: 1-Oct-2004.

Singh S and Patrick J (2004) Antiarrhythmic drugs, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-004-0019-2, 6:5, (357-364), Online publication date: 1-Oct-2004.

Serhan C (2004) A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution, Histochemistry and Cell Biology, 10.1007/s00418-004-0695-8, 122:4, (305-321), Online publication date: 1-Oct-2004.

Harris W, Sands S, Windsor S, Ali H, Stevens T, Magalski A, Porter C and Borkon A (2004) Omega-3 Fatty Acids in Cardiac Biopsies From Heart Transplantation Patients, Circulation, 110:12, (1645-1649), Online publication date: 21-Sep-2004.

Wild S and Byrne C (2004) The role of treatment to increase HDL‐cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes, Diabetic Medicine, 10.1111/j.1464-5491.2004.1424-5.x, 21:s4, (8-11), Online publication date: 1-Sep-2004.

Singer P and Wirth M (2004) Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial, Prostaglandins, Leukotrienes and Essential Fatty Acids, 10.1016/j.plefa.2004.03.003, 71:3, (153-159), Online publication date: 1-Sep-2004.

Engler M, Engler M, Arterburn L, Bailey E, Chiu E, Malloy M and Mietus-Snyder M (2004) Docosahexaenoic acid supplementation alters plasma phospholipid fatty acid composition in hyperlipidemic children: Results from the Endothelial Assessment of Risk from Lipids in Youth (EARLY) study, Nutrition Research, 10.1016/j.nutres.2004.06.004, 24:9, (721-729), Online publication date: 1-Sep-2004.

Katz D (2004) Lifestyle and dietary modification for prevention of heart failure, Medical Clinics of North America, 10.1016/j.mcna.2004.02.003, 88:5, (1295-1320), Online publication date: 1-Sep-2004.

Lee K, Hamaad A, MacFadyen R and Lip G (2004) Effects of dietary fat intake in sudden death: Reduction of death with omega-3 fatty acids, Current Cardiology Reports, 10.1007/s11886-004-0040-9, 6:5, (371-378), Online publication date: 1-Sep-2004.

Sundaram S and Goldberger J (2004) Risk stratification and epidemiology of sudden death, Current Cardiology Reports, 10.1007/s11886-004-0035-6, 6:5, (333-338), Online publication date: 1-Sep-2004.

Nojiri S, Daida H and Inaba Y (2004) Antioxidants and cardiovascular disease: Still a topic of interest, Environmental Health and Preventive Medicine, 10.1007/BF02898101, 9:5, (200-213), Online publication date: 1-Sep-2004.

Siddiqui R, Shaikh S, Kovacs R, Stillwell W and Zaloga G (2004) Inhibition of phenylephrine‐induced cardiac hypertrophy by docosahexaenoic acid, Journal of Cellular Biochemistry, 10.1002/jcb.20135, 92:6, (1141-1159), Online publication date: 15-Aug-2004.

Witte K and Clark A (2016) Fish oils – adjuvant therapy in chronic heart failure?, European Journal of Cardiovascular Prevention & Rehabilitation, 10.1097/01.hjr.0000136728.27524.f5, 11:4, (267-274), Online publication date: 1-Aug-2004.

Tavazzi L, Tognoni G, Franzosi M, Latini R, Maggioni A, Marchioli R, Nicolosi G and Porcu M (2004) Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n‐3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure, European Journal of Heart Failure, 10.1016/j.ejheart.2004.03.001, 6:5, (635-641), Online publication date: 1-Aug-2004.

CALDER P (2004) n –3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored , Clinical Science, 10.1042/CS20040119, 107:1, (1-11), Online publication date: 1-Jul-2004.

Dyerberg J, Eskesen D, Andersen P, Astrup A, Buemann B, Christensen J, Clausen P, Rasmussen B, Schmidt E, Tholstrup T, Toft E, Toubro S and Stender S (2004) Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study, European Journal of Clinical Nutrition, 10.1038/sj.ejcn.1601934, 58:7, (1062-1070), Online publication date: 1-Jul-2004.

Harris W and von Schacky C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease?, Preventive Medicine, 10.1016/j.ypmed.2004.02.030, 39:1, (212-220), Online publication date: 1-Jul-2004.

Surette M, Edens M, Chilton F and Tramposch K (2004) Dietary Echium Oil Increases Plasma and Neutrophil Long-Chain (n-3) Fatty Acids and Lowers Serum Triacylglycerols in Hypertriglyceridemic Humans, The Journal of Nutrition, 10.1093/jn/134.6.1406, 134:6, (1406-1411), Online publication date: 1-Jun-2004.

Sutherland J, McKinley B and Eckel R (2004) The Metabolic Syndrome and Inflammation, Metabolic Syndrome and Related Disorders, 10.1089/met.2004.2.82, 2:2, (82-104), Online publication date: 1-Jun-2004.

Moyad M and Carroll P (2004) Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?, Urologic Clinics of North America, 10.1016/j.ucl.2004.03.007, 31:2, (301-311), Online publication date: 1-May-2004.

Harris W (2004) Omega-3 fatty acids, thrombosis and vascular disease, International Congress Series, 10.1016/j.ics.2003.12.097, 1262, (380-383), Online publication date: 1-May-2004.

Albert C (2004) Fish oil—an appetising alternative to anti-arrhythmic drugs?, The Lancet, 10.1016/S0140-6736(04)16135-7, 363:9419, (1412-1413), Online publication date: 1-May-2004.

Schrepf R, Limmert T, Weber P, Theisen K and Sellmayer A (2004) Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia, The Lancet, 10.1016/S0140-6736(04)16105-9, 363:9419, (1441-1442), Online publication date: 1-May-2004.

Serhan C, Gotlinger K, Hong S and Arita M (2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis, Prostaglandins & Other Lipid Mediators, 10.1016/j.prostaglandins.2004.03.005, 73:3-4, (155-172), Online publication date: 1-Apr-2004.

Lecerf J (2004) Poisson, acides gras oméga 3 et risque cardiovasculaire : données épidémiologiques, Cahiers de Nutrition et de Diététique, 10.1016/S0007-9960(04)94447-1, 39:2, (143-150), Online publication date: 1-Apr-2004.

von Schacky C (2004) Omega-3 fatty acids and cardiovascular disease, Current Opinion in Clinical Nutrition and Metabolic Care, 10.1097/00075197-200403000-00005, 7:2, (131-136), Online publication date: 1-Mar-2004.

YUEN A and SANDER J (2004) Is omega-3 fatty acid deficiency a factor contributing to refractory seizures and SUDEP?, Seizure, 10.1016/S1059-1311(03)00108-0, 13:2, (104-107), Online publication date: 1-Mar-2004.

Geelen A, Brouwer I, Zock P and Katan M (2004) Antiarrhythmic effects of n-3 fatty acids: evidence from human studies, Current Opinion in Lipidology, 10.1097/00041433-200402000-00006, 15:1, (25-30), Online publication date: 1-Feb-2004.

Yaqoob P (2007) Fatty acids and the immune system: from basic science to clinical applications, Proceedings of the Nutrition Society, 10.1079/PNS2003328, 63:1, (89-105), Online publication date: 1-Feb-2004.

O'Keefe J and Cordain L (2004) Cardiovascular Disease Resulting From a Diet and Lifestyle at Odds With Our Paleolithic Genome: How to Become a 21st-Century Hunter-Gatherer, Mayo Clinic Proceedings, 10.4065/79.1.101, 79:1, (101-108), Online publication date: 1-Jan-2004.

Dwyer J, Allayee H, Dwyer K, Fan J, Wu H, Mar R, Lusis A and Mehrabian M (2004) Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis, New England Journal of Medicine, 10.1056/NEJMoa025079, 350:1, (29-37), Online publication date: 1-Jan-2004.

Iribarren C, Markovitz J, Jacobs D, Schreiner P, Daviglus M and Hibbeln J (2003) Dietary intake of n-3, n-6 fatty acids and fish: Relationship with hostility in young adults—the CARDIA study, European Journal of Clinical Nutrition, 10.1038/sj.ejcn.1601739, 58:1, (24-31), Online publication date: 1-Jan-2004.

Cleland J, Freemantle N, Kaye G, Nasir M, Velavan P, Lalukota K, Mudawi T, Shelton R, Clark A and Coletta A (2004) Clinical trials update from the American Heart Association meeting: Ω‐3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE, European Journal of Heart Failure, 10.1016/j.ejheart.2003.12.002, 6:1, (109-115), Online publication date: 1-Jan-2004.

Goldberger J, Weinberg K and Kadish A (2004) Impact of Nontraditional Antiarrhythmic Drugs on Sudden Cardiac Death Cardiac Electrophysiology, 10.1016/B0-7216-0323-8/50106-8, (950-958), .

Wolf A, Wolf F, Wolf G, Gohlke H, Klotz T, Sommer F, Ebert T, Zaun S and Kleine-Gunk B (2004) Der ganze Patient Männersprechstunde, 10.1007/978-3-642-18705-6_9, (375-405), .

Gohlke H (2004) Prävention der koronaren Herzerkrankung Herzkrankheiten, 10.1007/978-3-642-18649-3_56, (1119-1147), .

Witte K and Haller C Arteriosklerose und Durchblutungsstörungen Pharmakotherapie, 10.1007/3-540-35149-3_19, (311-331)

RODEN D (2003) Antiarrhythmic Drugs:, Pacing and Clinical Electrophysiology, 10.1111/j.1540-8159.2003.00375.x, 26:12, (2340-2348), Online publication date: 1-Dec-2003.

De Backer G, Ambrosioni E, Broch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats V, Orth-Gom??r K, Perk J, Py??r??l?? K, Rodicio J, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T and Wood D (2003) European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts), European Journal of Cardiovascular Prevention and Rehabilitation, 10.1097/00149831-200312001-00001, 10:Supplement 1, (S1-S78), Online publication date: 1-Dec-2003.

RODEN D (2003) Antiarrhythmic Drugs:, Journal of Cardiovascular Electrophysiology, 10.1046/j.1540-8167.2003.03441.x, 14:12, (1389-1396), Online publication date: 1-Dec-2003.

Harris W and O’Keefe J (2003) Preventive Use of N-3 Fatty Acids, Circulation, 108:19, (e139-e139), Online publication date: 11-Nov-2003.

Brouwer I, Zock P, Wever E, Hauer R, Camm A, Böcker D, Otto-Terlouw P, Katan M and Schouten E (2003) Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA, European Journal of Clinical Nutrition, 10.1038/sj.ejcn.1601695, 57:10, (1323-1330), Online publication date: 1-Oct-2003.

De Caterina R, Madonna R, Zucchi R and La Rovere M (2003) Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside, American Heart Journal, 10.1016/S0002-8703(03)00327-2, 146:3, (420-430), Online publication date: 1-Sep-2003.

Dallongeville J, Yarnell J, Ducimetière P, Arveiler D, Ferrières J, Montaye M, Luc G, Evans A, Bingham A, Hass B, Ruidavets J and Amouyel P (2003) Fish Consumption Is Associated With Lower Heart Rates, Circulation, 108:7, (820-825), Online publication date: 19-Aug-2003.

Stone N and Kushner R (2003) Effects of dietary modification to reduce vascular risks and treatment of obesity, Cardiology Clinics, 10.1016/S0733-8651(03)00057-2, 21:3, (415-433), Online publication date: 1-Aug-2003.

Durrington P (2003) Dyslipidaemia, The Lancet, 10.1016/S0140-6736(03)14234-1, 362:9385, (717-731), Online publication date: 1-Aug-2003.

Harper C and Jacobson T (2007) Beyond the Mediterranean Diet: The Role of Omega‐3 Fatty Acids in the Prevention of Coronary Heart Disease, Preventive Cardiology, 10.1111/j.1520-037X.2003.1332.x, 6:3, (136-146), Online publication date: 1-Jul-2003.

Lee K and Lip G (2003) The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease, QJM, 10.1093/qjmed/hcg092, 96:7, (465-480), Online publication date: 1-Jul-2003.

Erkkilä A, Lehto S, Pyörälä K and Uusitupa M (2003) n−3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease, The American Journal of Clinical Nutrition, 10.1093/ajcn/78.1.65, 78:1, (65-71), Online publication date: 1-Jul-2003.

Pacifico A and Henry P (2003) Structural Pathways and Prevention of Heart Failure and Sudden Death, Journal of Cardiovascular Electrophysiology, 10.1046/j.1540-8167.2003.02543.x, 14:7, (764-774), Online publication date: 1-Jul-2003.

Anderson K (2003) Lipid-lowering therapy for prevention of ventricular tachyarrhythmias, Journal of the American College of Cardiology, 10.1016/S0735-1097(03)00497-2, 42:1, (88-92), Online publication date: 1-Jul-2003.

Siscovick D, Lemaitre R and Mozaffarian D (2003) The Fish Story, Circulation, 107:21, (2632-2634), Online publication date: 3-Jun-2003.

Leaf A, Kang J, Xiao Y and Billman G (2003) Clinical Prevention of Sudden Cardiac Death by n-3 Polyunsaturated Fatty Acids and Mechanism of Prevention of Arrhythmias by n-3 Fish Oils, Circulation, 107:21, (2646-2652), Online publication date: 3-Jun-2003.

Harrison D, Hua Cai , Landmesser U and Griendling K (2016) The Pickering Lecture British Hypertension Society, 10th September 2002, Journal of the Renin-Angiotensin-Aldosterone System, 10.3317/jraas.2003.014, 4:2, (51-61), Online publication date: 1-Jun-2003.

Ogita H, Node K, Asanuma H, Sanada S, Takashima S, Minamino T, Soma M, Kim J, Hori M and Kitakaze M (2003) Eicosapentaenoic Acid Reduces Myocardial Injury Induced by Ischemia and Reperfusion in Rabbit Hearts, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200306000-00020, 41:6, (964-969), Online publication date: 1-Jun-2003.

Leaf A, Xiao Y, Kang J and Billman G (2003) Prevention of sudden cardiac death by n−3 polyunsaturated fatty acids, Pharmacology & Therapeutics, 10.1016/S0163-7258(03)00039-1, 98:3, (355-377), Online publication date: 1-Jun-2003.

Durrington P (2016) Clinical trials of lipid-lowering medication in diabetes, The British Journal of Diabetes & Vascular Disease, 10.1177/14746514030030031101, 3:3, (217-220), Online publication date: 1-May-2003.

Bhatnagar D and Durrington P (2003) OMEGA‐3 FATTY ACIDS: THEIR ROLE IN THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS RELATED RISK FACTORS AND COMPLICATIONS, International Journal of Clinical Practice, 10.1111/j.1742-1241.2003.tb10490.x, 57:4, (305-314), Online publication date: 1-May-2003.

Hu F, Cho E, Rexrode K, Albert C and Manson J (2003) Fish and Long-Chain ω-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women, Circulation, 107:14, (1852-1857), Online publication date: 15-Apr-2003.

Grundy S (2003) N-3 Fatty Acids, Circulation, 107:14, (1834-1836), Online publication date: 15-Apr-2003.

Hong S, Gronert K, Devchand P, Moussignac R and Serhan C (2003) Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells, Journal of Biological Chemistry, 10.1074/jbc.M300218200, 278:17, (14677-14687), Online publication date: 1-Apr-2003.

Ziouzenkova O, Perrey S, Asatryan L, Hwang J, MacNaul K, Moller D, Rader D, Sevanian A, Zechner R, Hoefler G and Plutzky J (2003) Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase, Proceedings of the National Academy of Sciences, 10.1073/pnas.0538015100, 100:5, (2730-2735), Online publication date: 4-Mar-2003.

Calder P and Deckelbaum R (2003) Fat as a physiological regulator: the news gets better, Current Opinion in Clinical Nutrition and Metabolic Care, 10.1097/00075197-200303000-00001, 6:2, (127-131), Online publication date: 1-Mar-2003.

von Schacky C (2003) The role of omega-3 fatty acids in cardiovascular disease, Current Atherosclerosis Reports, 10.1007/s11883-003-0086-y, 5:2, (139-145), Online publication date: 1-Mar-2003.

Grodstein F, Clarkson T and Manson J (2003) Understanding the Divergent Data on Postmenopausal Hormone Therapy, New England Journal of Medicine, 10.1056/NEJMsb022365, 348:7, (645-650), Online publication date: 13-Feb-2003.

Kris-Etherton P, Harris W and Appel L (2003) Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 23:2, (e20-e30), Online publication date: 1-Feb-2003.

Lada A and Rudel L (2003) Dietary monounsaturated versus polyunsaturated fatty acids: which is really better for protection from coronary heart disease?, Current Opinion in Lipidology, 10.1097/00041433-200302000-00008, 14:1, (41-46), Online publication date: 1-Feb-2003.

Harris W, Park Y and Isley W (2003) Cardiovascular disease and long-chain omega-3 fatty acids, Current Opinion in Lipidology, 10.1097/00041433-200302000-00003, 14:1, (9-14), Online publication date: 1-Feb-2003.

Lemaitre R, King I, Mozaffarian D, Kuller L, Tracy R and Siscovick D (2003) n−3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study, The American Journal of Clinical Nutrition, 10.1093/ajcn/77.2.319, 77:2, (319-325), Online publication date: 1-Feb-2003.

Harris W (2003) n−3 Long-chain polyunsaturated fatty acids reduce risk of coronary heart disease death: extending the evidence to the elderly, The American Journal of Clinical Nutrition, 10.1093/ajcn/77.2.279, 77:2, (279-280), Online publication date: 1-Feb-2003.

Thies F, Garry J, Yaqoob P, Rerkasem K, Williams J, Shearman C, Gallagher P, Calder P and Grimble R (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial, The Lancet, 10.1016/S0140-6736(03)12468-3, 361:9356, (477-485), Online publication date: 1-Feb-2003.

Barzilay J and Freedland E (2003) Inflammation and its Association with Glucose Disorders and Cardiovascular Disease, Treatments in Endocrinology, 10.2165/00024677-200302020-00002, 2:2, (85-94), .

Hersberger M and von Eckardstein A (2003) Low High-Density Lipoprotein Cholesterol, Drugs, 10.2165/00003495-200363180-00003, 63:18, (1907-1945), .

Cleland L, James M and Proudman S (2003) The Role of Fish Oils in the Treatment of Rheumatoid Arthritis, Drugs, 10.2165/00003495-200363090-00001, 63:9, (845-853), .

Clusin W (2008) Calcium and Cardiac Arrhythmias: DADs, EADs, and Alternans, Critical Reviews in Clinical Laboratory Sciences, 10.1080/713609356, 40:3, (337-375), Online publication date: 1-Jan-2003.

Schmidt E (2003) Marine n-3 fatty acids and thrombosis, Thrombosis Research, 10.1016/j.thromres.2003.09.001, 111:1-2, (9-10), Online publication date: 1-Jan-2003.

Porres aracama J and Marco garde P (2003) Muerte súbita cardíaca y MADIT II, Medicina Intensiva, 10.1016/S0210-5691(03)79921-5, 27:6, (410-416), Online publication date: 1-Jan-2003.

Brilakis E, Reeder G and Gersh B (2003) Modern management of acute myocardial infarction, Current Problems in Cardiology, 10.1016/S0146-2806(03)70001-2, 28:1, (7-127), Online publication date: 1-Jan-2003.

Alonso Á, Ángel Martínez-González M and Serrano-Martínez M (2003) Ácidos grasos omega-3 de pescado y riesgo de enfermedad coronaria, Medicina Clínica, 10.1016/S0025-7753(03)74116-5, 121:1, (28-35), Online publication date: 1-Jan-2003.

Carroll D and Roth M (2016) Evidence for the Cardioprotective Effects of Omega-3 Fatty Acids, Annals of Pharmacotherapy, 10.1345/aph.1A314, 36:12, (1950-1956), Online publication date: 1-Dec-2002.

Kris-Etherton P, Harris W and Appel L (2002) Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease, Circulation, 106:21, (2747-2757), Online publication date: 19-Nov-2002.

Stone N and Van Horn L (2002) Therapeutic lifestyle change and adult treatment panel III: Evidence then and now, Current Atherosclerosis Reports, 10.1007/s11883-002-0047-x, 4:6, (433-443), Online publication date: 1-Nov-2002.

Miller M, Cosgrove B and Havas S (2002) Update on the role of triglycerides as a risk factor for coronary heart disease, Current Atherosclerosis Reports, 10.1007/s11883-002-0044-0, 4:6, (414-418), Online publication date: 1-Nov-2002.

Serhan C, Hong S, Gronert K, Colgan S, Devchand P, Mirick G and Moussignac R (2002) Resolvins, The Journal of Experimental Medicine, 10.1084/jem.20020760, 196:8, (1025-1037), Online publication date: 21-Oct-2002.

Geelen A, Brouwer I, Zock P, Kors J, Swenne C, Katan M and Schouten E (2002) (n-3) Fatty Acids Do Not Affect Electrocardiographic Characteristics of Healthy Men and Women, The Journal of Nutrition, 10.1093/jn/131.10.3051, 132:10, (3051-3054), Online publication date: 1-Oct-2002.

Dessein P, Joffe B and Stanwix A (2002) Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study, Arthritis Research & Therapy, 10.1186/ar597, 4:6

Curtis B and O'Keefe J (2015) Understanding the Mediterranean diet, Postgraduate Medicine, 10.3810/pgm.2002.08.1281, 112:2, (35-45), Online publication date: 1-Aug-2002.

&NA; (2002) Omega-3 fatty acids protect against sudden cardiac death?, Inpharma Weekly, 10.2165/00128413-200213420-00039, &NA;:1342, (18), Online publication date: 1-Jun-2002.

Leaf A (2002) On the Reanalysis of the GISSI-Prevenzione, Circulation, 105:16, (1874-1875), Online publication date: 23-Apr-2002.

April 23, 2002
Vol 105, Issue 16

Article Information

Metrics

https://doi.org/10.1161/01.CIR.0000014682.14181.F2

PMID: 11997274

Originally publishedApril 8, 2002

Keywords

PDF download

OpenAthens/Shibboleth »

Jump to

Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction

You are viewing the most recent version of this article. Previous versions: